{
    "items": "260",
    "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish",
    "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.",
    "feed": [
        {
            "title": "NANOBIOTIX Announces Launch of Global Follow-On Offering and a Concurrent Private Placement Along with the Removal of the EIB Cash Covenant",
            "url": "https://www.globenewswire.com/news-release/2023/11/01/2771818/0/en/NANOBIOTIX-Announces-Launch-of-Global-Follow-On-Offering-and-a-Concurrent-Private-Placement-Along-with-the-Removal-of-the-EIB-Cash-Covenant.html",
            "time_published": "20231101T223200",
            "authors": [
                "Nanobiotix S.A."
            ],
            "summary": "PARIS and CAMBRIDGE, Mass., Nov. 01, 2023 ( GLOBE NEWSWIRE ) -- NANOBIOTIX ( Euronext: NANO - NASDAQ: NBTX - \"Nanobiotix\" or the \"Company\" ) , a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, announces the ...",
            "banner_image": "https://ml.globenewswire.com/Resource/Download/36fb7b98-27d7-46cb-b989-fa31626657b8",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.682689"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.162967,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "STT",
                    "relevance_score": "0.011762",
                    "ticker_sentiment_score": "0.048841",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FCAP",
                    "relevance_score": "0.011762",
                    "ticker_sentiment_score": "0.05952",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NBTX",
                    "relevance_score": "0.128822",
                    "ticker_sentiment_score": "0.052608",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.011762",
                    "ticker_sentiment_score": "0.06556",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CRYPTO:NANO",
                    "relevance_score": "0.023521",
                    "ticker_sentiment_score": "0.102479",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "NANOBIOTIX Announces Launch of Global Follow-On Offering and a Concurrent Private Placement Along with the Removal of the EIB Cash Covenant",
            "url": "https://www.globenewswire.com/news-release/2023/11/01/2771817/0/en/NANOBIOTIX-Announces-Launch-of-Global-Follow-On-Offering-and-a-Concurrent-Private-Placement-Along-with-the-Removal-of-the-EIB-Cash-Covenant.html",
            "time_published": "20231101T223000",
            "authors": [
                "Nanobiotix S.A."
            ],
            "summary": "PARIS and CAMBRIDGE, Mass., Nov. 01, 2023 ( GLOBE NEWSWIRE ) -- NANOBIOTIX ( Euronext: NANO - NASDAQ: NBTX - \"Nanobiotix\" or the \"Company\" ) , a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, announces the ...",
            "banner_image": "https://ml.globenewswire.com/Resource/Download/36fb7b98-27d7-46cb-b989-fa31626657b8",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.769861"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.158462,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "STT",
                    "relevance_score": "0.012624",
                    "ticker_sentiment_score": "0.049201",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FCAP",
                    "relevance_score": "0.012624",
                    "ticker_sentiment_score": "0.059939",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NBTX",
                    "relevance_score": "0.150592",
                    "ticker_sentiment_score": "0.057426",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.012624",
                    "ticker_sentiment_score": "0.065986",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CRYPTO:NANO",
                    "relevance_score": "0.025245",
                    "ticker_sentiment_score": "0.103418",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Prostate Cancer Minimally Invasive Surgery Market Size is Envisioned to Grow at a CAGR of 3.6% and reach USD 3.9 billion by 2031|Report by TMR",
            "url": "https://www.benzinga.com/pressreleases/23/11/g35543727/prostate-cancer-minimally-invasive-surgery-market-size-is-envisioned-to-grow-at-a-cagr-of-3-6-and-",
            "time_published": "20231101T170000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "Wilmington, Delaware, United States, Nov. 01, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. The global prostate cancer minimally invasive surgery market stood at US$ 2.9 billion in 2022 and is projected to reach US$ 3.9 billion in 2031.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.074333,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "ISRG",
                    "relevance_score": "0.040484",
                    "ticker_sentiment_score": "0.254161",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BDX",
                    "relevance_score": "0.040484",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.040484",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TFX",
                    "relevance_score": "0.040484",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Sanitary Napkin Market to hit USD 41 billion by 2031, says Transparency Market Research Inc.",
            "url": "https://www.benzinga.com/pressreleases/23/11/g35539142/sanitary-napkin-market-to-hit-usd-41-billion-by-2031-says-transparency-market-research-inc",
            "time_published": "20231101T143000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "Wilmington, Delaware, United States, Nov. 01, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc- The global sanitary napkin market was estimated to have acquired US$ 24.5 billion in 2021. It is anticipated to register a 5.0% CAGR from 2022 to 2031 and by 2031, the market is likely to ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.386125,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "HEGIF",
                    "relevance_score": "0.046452",
                    "ticker_sentiment_score": "-0.145419",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "EPC",
                    "relevance_score": "0.046452",
                    "ticker_sentiment_score": "-0.145419",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KMB",
                    "relevance_score": "0.046452",
                    "ticker_sentiment_score": "-0.145419",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.046452",
                    "ticker_sentiment_score": "0.101757",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.046452",
                    "ticker_sentiment_score": "0.187375",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "3 Dividend Kings Whose Growth Streaks Could Break Before 2030",
            "url": "https://www.fool.com/investing/2023/11/01/3-dividend-kings-whose-growth-streaks-could-break/",
            "time_published": "20231101T141200",
            "authors": [
                "David Jagielski"
            ],
            "summary": "Investors should be careful with these high-yielding dividend stocks, as they aren't as safe as they may have been even a few years ago.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.996023"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.744043"
                }
            ],
            "overall_sentiment_score": 0.031596,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.090816",
                    "ticker_sentiment_score": "-0.011616",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MO",
                    "relevance_score": "0.224487",
                    "ticker_sentiment_score": "0.215834",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.267804",
                    "ticker_sentiment_score": "0.028821",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johnson & Johnson Innovation Launches Singapore QuickFire Challenge with the Singapore Economic Development Board",
            "url": "https://www.prnewswire.com/apac/news-releases/johnson--johnson-innovation-launches-singapore-quickfire-challenge-with-the-singapore-economic-development-board-301974279.html",
            "time_published": "20231101T140500",
            "authors": [
                "Johnson & Johnson Innovation LLC"
            ],
            "summary": "Johnson & Johnson Innovation Launches Singapore QuickFire Challenge with the Singapore Economic Development ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/2219093/Johnson_Johnson_Innovation_JLABS_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.744043"
                }
            ],
            "overall_sentiment_score": 0.40951,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.539522",
                    "ticker_sentiment_score": "0.489524",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "The Mullings Group Acquires M. J. Moore & Associates and Names Michael Moore Partner",
            "url": "https://www.prnewswire.com/news-releases/the-mullings-group-acquires-m-j-moore--associates-and-names-michael-moore-partner-301974041.html",
            "time_published": "20231101T130000",
            "authors": [
                "The Mullings Group"
            ],
            "summary": "DELRAY BEACH, Fla., Nov. 1, 2023 /PRNewswire/ -- The Mullings Group, a leading talent acquisition firm headquartered in the U.S. specializing in medical & health technology, life sciences, and emerging high-tech industries, announces the acquisition of M. J. Moore & Associates. The founder of M.",
            "banner_image": "https://mma.prnewswire.com/media/2262635/The_Mullings_Group___Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.278049,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MDT",
                    "relevance_score": "0.062926",
                    "ticker_sentiment_score": "0.170157",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.062926",
                    "ticker_sentiment_score": "0.170157",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Can Kenvue Be a Reliable Dividend Stock to Hold for the Long Haul?",
            "url": "https://www.fool.com/investing/2023/11/01/can-kenvue-be-a-reliable-dividend-stock-to-hold-fo/",
            "time_published": "20231101T114400",
            "authors": [
                "David Jagielski"
            ],
            "summary": "Kenvue's operations are diverse, boasting many strong brands. Is that enough to make this a solid dividend stock to own?",
            "banner_image": "https://g.foolcdn.com/editorial/images/752766/a-person-counting-money-in-their-living-room.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.99793"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.938238"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.193505,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.818793",
                    "ticker_sentiment_score": "0.315277",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.261818",
                    "ticker_sentiment_score": "0.026237",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Acquisition of Industrial Vision Systems Ltd and Issue of Equity",
            "url": "https://www.globenewswire.com/news-release/2023/11/01/2770854/0/en/Acquisition-of-Industrial-Vision-Systems-Ltd-and-Issue-of-Equity.html",
            "time_published": "20231101T090000",
            "authors": [
                "Oxford Metrics"
            ],
            "summary": "1 November ...",
            "banner_image": "",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.929393"
                }
            ],
            "overall_sentiment_score": 0.465724,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.02799",
                    "ticker_sentiment_score": "0.243977",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LDNXF",
                    "relevance_score": "0.02799",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Agriculture Stock News - MustGrow  ( TSXV: MGRO )   ( OTCQB: MGROF )  Receives USDA Organic Approval for Biological Fertilizer and Soil Amendment Technology",
            "url": "https://www.investorideas.com/news/2023/agriculture/10311TSXV-MGRO.asp",
            "time_published": "20231031T194030",
            "authors": [],
            "summary": "Agriculture Stock News - MustGrow ( TSXV: MGRO ) ( OTCQB ... ...",
            "banner_image": null,
            "source": "Investor Ideas",
            "category_within_source": "n/a",
            "source_domain": "www.investorideas.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.538269"
                }
            ],
            "overall_sentiment_score": 0.222902,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "GLP",
                    "relevance_score": "0.069832",
                    "ticker_sentiment_score": "0.141191",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SSUMF",
                    "relevance_score": "0.046588",
                    "ticker_sentiment_score": "0.139166",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.023304",
                    "ticker_sentiment_score": "0.144156",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Kenvue Inc.  ( KVUE )  - Kenvue  ( NYSE:KVUE ) ",
            "url": "https://www.benzinga.com/pressreleases/23/10/g35519632/glancy-prongay-murray-llp-reminds-investors-of-looming-deadline-in-the-class-action-lawsuit-agains",
            "time_published": "20231031T164314",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "LOS ANGELES, Oct. 31, 2023 ( GLOBE NEWSWIRE ) -- Glancy Prongay & Murray LLP ( \"GPM\" ) reminds investors of the upcoming December 8, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Kenvue Inc. ( \"Kenvue\" or the ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.890401"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.858979"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.021733,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.612343",
                    "ticker_sentiment_score": "0.039842",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.062597",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.062597",
                    "ticker_sentiment_score": "0.086023",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johnson & Johnson Offloads Rights For Hepatitis B Candidate To GSK - Johnson & Johnson  ( NYSE:JNJ ) , GSK  ( NYSE:GSK ) ",
            "url": "https://www.benzinga.com/general/biotech/23/10/35515126/johnson-johnson-offloads-rights-for-hepatitis-b-candidate-to-gsk",
            "time_published": "20231031T150514",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "GSK plc GSK and Arrowhead Pharmaceuticals Inc ARWR have reached an agreement with Janssen Pharmaceuticals Inc, a Johnson & Johnson company JNJ, to transfer exclusive worldwide rights to further develop and commercialize JNJ-3989 to GSK.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/31/jnj.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.199588,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ARWR",
                    "relevance_score": "0.348919",
                    "ticker_sentiment_score": "0.34462",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GSK",
                    "relevance_score": "0.772194",
                    "ticker_sentiment_score": "0.314242",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.772194",
                    "ticker_sentiment_score": "0.292504",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Cybin Announces Unprecedented Positive Interim Phase 2 Data for CYB003 in Major Depressive Disorder Meeting ... - Canada NewsWire",
            "url": "https://www.newswire.ca/news-releases/cybin-announces-unprecedented-positive-interim-phase-2-data-for-cyb003-in-major-depressive-disorder-meeting-primary-efficacy-endpoint-with-rapid-and-significant-improvements-in-depression-symptoms-after-single-dose-full-topline-data-on-trac-810755830.html",
            "time_published": "20231031T130000",
            "authors": [],
            "summary": "Cybin Announces Unprecedented Positive Interim Phase 2 Data for CYB003 in Major Depressive Disorder Meeting ... Canada ...",
            "banner_image": null,
            "source": "Canada Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.newswire.ca",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.495866"
                }
            ],
            "overall_sentiment_score": 0.070069,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.018568",
                    "ticker_sentiment_score": "0.105366",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.055664",
                    "ticker_sentiment_score": "0.035973",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AXSM",
                    "relevance_score": "0.018568",
                    "ticker_sentiment_score": "0.031183",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.018568",
                    "ticker_sentiment_score": "0.031183",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "GSK to pay $1 bln for exclusive license to J&J's hepatitis B therapy",
            "url": "https://www.reuters.com/markets/deals/gsk-signs-1-bln-deal-exclusive-license-jjs-hepatitis-b-therapy-2023-10-31/",
            "time_published": "20231031T123800",
            "authors": [
                "Reuters"
            ],
            "summary": "[1/2] GSK ( GlaxoSmithKline ) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing Rights",
            "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/CCYR4QTBVVNURO7TOQFOF6BLDU.jpg",
            "source": "Reuters",
            "category_within_source": "Markets",
            "source_domain": "www.reuters.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.349138,
            "overall_sentiment_label": "Somewhat-Bearish",
            "ticker_sentiment": [
                {
                    "ticker": "ARWR",
                    "relevance_score": "0.263942",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.499789",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Coalition calls on Congress to repeal Biden's prescription drug price controls",
            "url": "https://www.foxbusiness.com/politics/coalition-calls-congress-repeal-bidens-prescription-drug-price-controls",
            "time_published": "20231031T090050",
            "authors": [
                "Breck Dumas"
            ],
            "summary": "EXCLUSIVE - A coalition of more than 40 groups is calling on Congress to repeal the Drug Price Negotiation Program included in the Inflation Reduction Act ( IRA ) that passed last year, arguing that the price control scheme run by the Biden administration will ultimately lead to shortages of ...",
            "banner_image": "https://cf-images.us-east-1.prod.boltdns.net/v1/static/854081161001/1c3620e2-c804-45ff-8400-5e325983a2fc/96f9631f-af4b-4b42-ba9e-c02ed156a1d8/1280x720/match/image.jpg",
            "source": "Fox Business News",
            "category_within_source": "n/a",
            "source_domain": "www.foxbusiness.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.05953,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.064797",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CCZ",
                    "relevance_score": "0.064797",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.064797",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.064797",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Kenvue Inc.  ( KVUE )  Investors and Encourages Investors to Contact the Firm Before December 8, 2023 - Kenvue  ( NYSE:KVUE ) ",
            "url": "https://www.benzinga.com/pressreleases/23/10/g35491796/kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-on-behalf-of-kenv",
            "time_published": "20231030T142146",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "NEW YORK, Oct. 30, 2023 ( GLOBE NEWSWIRE ) -- The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.890401"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.045664,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.692465",
                    "ticker_sentiment_score": "0.053559",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.16171",
                    "ticker_sentiment_score": "0.052379",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Nearly 70% of Warren Buffett's $326 Billion Portfolio Is Invested in These 9 Megacap Stocks",
            "url": "https://www.fool.com/investing/2023/10/30/nearly-70-of-warren-buffetts-326-billion-portfolio/",
            "time_published": "20231030T095000",
            "authors": [
                "Keith Speights"
            ],
            "summary": "The Oracle of Omaha likes big stocks.",
            "banner_image": "https://g.foolcdn.com/editorial/images/751796/buffett17-tmf.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.990999"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.2105,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.112008",
                    "ticker_sentiment_score": "0.061548",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.221819",
                    "ticker_sentiment_score": "0.324324",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CVX",
                    "relevance_score": "0.221819",
                    "ticker_sentiment_score": "0.085841",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.167322",
                    "ticker_sentiment_score": "0.056933",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MA",
                    "relevance_score": "0.112008",
                    "ticker_sentiment_score": "0.085853",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "V",
                    "relevance_score": "0.167322",
                    "ticker_sentiment_score": "0.133286",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.056143",
                    "ticker_sentiment_score": "0.005",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.112008",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.112008",
                    "ticker_sentiment_score": "0.028381",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.167322",
                    "ticker_sentiment_score": "0.156397",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Smoke Evacuation Systems Market Revenue to Cross USD 298.8 million by 2031, Garnering 6.6% CAGR: TMR Report",
            "url": "https://www.benzinga.com/pressreleases/23/10/g35484877/smoke-evacuation-systems-market-revenue-to-cross-usd-298-8-million-by-2031-garnering-6-6-cagr-tmr-",
            "time_published": "20231030T093000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "Wilmington, Delaware, United States, Oct. 30, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The smoke evacuation systems market was estimated to have acquired US$ 158.5 million in 2021. It is anticipated to register a 6.6% CAGR from 2022 to 2031, and by 2031, the market is likely ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.210611,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "UTMD",
                    "relevance_score": "0.03798",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.03798",
                    "ticker_sentiment_score": "0.15617",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CNMD",
                    "relevance_score": "0.075874",
                    "ticker_sentiment_score": "0.124109",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ECL",
                    "relevance_score": "0.03798",
                    "ticker_sentiment_score": "-0.099276",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.03798",
                    "ticker_sentiment_score": "0.051531",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Warren Buffett's $690 Million Secret Portfolio Is Buying 3 Historically Cheap Stocks",
            "url": "https://www.fool.com/investing/2023/10/30/warren-buffett-secret-portfolio-buy-3-cheap-stocks/",
            "time_published": "20231030T090600",
            "authors": [
                "Sean Williams"
            ],
            "summary": "The Oracle of Omaha's under-the-radar investment portfolio is buying shares of three industry-leading businesses.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F752005%2Fbuffett11-tmf.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.989041"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.196573,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.031322",
                    "ticker_sentiment_score": "0.09646",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.216583",
                    "ticker_sentiment_score": "0.136145",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.031322",
                    "ticker_sentiment_score": "0.063081",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.093775",
                    "ticker_sentiment_score": "0.108779",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.155652",
                    "ticker_sentiment_score": "0.146779",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "KENVUE ONGOING DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/kenvue-ongoing-deadline-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-in-kenvue-to-contact-him-directly-to-discuss-their-options-301970622.html",
            "time_published": "20231030T004500",
            "authors": [],
            "summary": "KENVUE ONGOING DEADLINE ALERT: Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.769861"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.495866"
                }
            ],
            "overall_sentiment_score": 0.150018,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.600121",
                    "ticker_sentiment_score": "0.021496",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.061003",
                    "ticker_sentiment_score": "0.093005",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against Kenvue Inc.",
            "url": "https://www.prnewswire.com/news-releases/kessler-topaz-meltzer--check-llp-announces-investor-securities-fraud-class-action-lawsuit-filed-against-kenvue-inc-301970546.html",
            "time_published": "20231029T142000",
            "authors": [
                "LLP",
                "Kessler Topaz Meltzer & Check"
            ],
            "summary": "Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against Kenvue ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/277422/ktmc_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.682689"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.650727"
                }
            ],
            "overall_sentiment_score": 0.104448,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.63188",
                    "ticker_sentiment_score": "-0.014767",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.059785",
                    "ticker_sentiment_score": "0.135003",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Dermatitis is not just skin-deep: A common skin condition, it can be irritating and painful",
            "url": "https://www.financialexpress.com/healthcare/dermatitis-is-not-just-skin-deep-a-common-skin-condition-it-can-be-irritating-and-painful/3289895/",
            "time_published": "20231028T221500",
            "authors": [
                "Vaishali Dar"
            ],
            "summary": "What do Jessica Simpson, Kerry Washington, Elle Fanning, Tia Mowry, Kristen Bell and Seonghwa have in common? Well, apart from being well-known celebrities, they have all battled with skin conditions and have either announced or discussed them on social media.",
            "banner_image": "https://www.financialexpress.com/wp-content/uploads/2023/10/rash.jpg",
            "source": "The Financial Express",
            "category_within_source": "n/a",
            "source_domain": "www.financialexpress.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.126965,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.07446",
                    "ticker_sentiment_score": "0.058159",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.024852",
                    "ticker_sentiment_score": "0.012074",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Meta's Plans, Cyberattacks, and the EV Race",
            "url": "https://www.fool.com/investing/2023/10/28/metas-plans-cyberattacks-and-the-ev-race/",
            "time_published": "20231028T134500",
            "authors": [
                "Motley Fool Staff"
            ],
            "summary": "And we've got a look at two stocks worth watching: Chevron and Burford Capital.",
            "banner_image": "https://g.foolcdn.com/editorial/images/750412/mfm_2023106.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.714479"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.166667"
                }
            ],
            "overall_sentiment_score": 0.098033,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "ASR",
                    "relevance_score": "0.012831",
                    "ticker_sentiment_score": "0.022594",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PYPL",
                    "relevance_score": "0.025658",
                    "ticker_sentiment_score": "0.032892",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BC",
                    "relevance_score": "0.006416",
                    "ticker_sentiment_score": "-0.021367",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.019245",
                    "ticker_sentiment_score": "0.016558",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.038479",
                    "ticker_sentiment_score": "0.010865",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.006416",
                    "ticker_sentiment_score": "0.041714",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CRWD",
                    "relevance_score": "0.006416",
                    "ticker_sentiment_score": "0.16004",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.006416",
                    "ticker_sentiment_score": "0.109807",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.006416",
                    "ticker_sentiment_score": "0.080732",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CLX",
                    "relevance_score": "0.012831",
                    "ticker_sentiment_score": "-0.089339",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.012831",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JCI",
                    "relevance_score": "0.006416",
                    "ticker_sentiment_score": "-0.021367",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.064087",
                    "ticker_sentiment_score": "0.053087",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CPB",
                    "relevance_score": "0.006416",
                    "ticker_sentiment_score": "-0.021367",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FTNT",
                    "relevance_score": "0.006416",
                    "ticker_sentiment_score": "0.16004",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.006416",
                    "ticker_sentiment_score": "0.080732",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.019245",
                    "ticker_sentiment_score": "0.094921",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ZS",
                    "relevance_score": "0.006416",
                    "ticker_sentiment_score": "0.16004",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CZR",
                    "relevance_score": "0.012831",
                    "ticker_sentiment_score": "-0.022509",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FSLY",
                    "relevance_score": "0.006416",
                    "ticker_sentiment_score": "0.16004",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Got $2,500? 2 Top Stocks That You Can Buy and Hold for a Lifetime",
            "url": "https://www.fool.com/investing/2023/10/28/got-2500-2-top-stocks-that-you-can-buy-and-hold-fo/",
            "time_published": "20231028T090300",
            "authors": [
                "Matthew DiLallo"
            ],
            "summary": "These elite companies make exceptional foundational investments for any portfolio.",
            "banner_image": "https://media.ycharts.com/charts/3c06d1f2f316d1582497ce1299ae622f.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.99793"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.444475,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "CRBO",
                    "relevance_score": "0.054483",
                    "ticker_sentiment_score": "0.240929",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.318211",
                    "ticker_sentiment_score": "0.470206",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "NEE",
                    "relevance_score": "0.267413",
                    "ticker_sentiment_score": "0.485279",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Have $500? 2 Absurdly Cheap Stocks Long-Term Investors Should Buy Right Now",
            "url": "https://www.fool.com/investing/2023/10/28/have-500-dollars-2-absurdly-cheap-stocks-to-buy/",
            "time_published": "20231028T090000",
            "authors": [
                "Adria Cimino"
            ],
            "summary": "A few hundred dollars invested today could go a long way over time.",
            "banner_image": "https://media.ycharts.com/charts/3b81ea44fb824b020c874af7387f846c.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.684621"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999816"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.364536,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KO",
                    "relevance_score": "0.303175",
                    "ticker_sentiment_score": "0.370779",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.123844",
                    "ticker_sentiment_score": "0.124049",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johnson & Johnson produces documents in DoJ civil investigation of eye products",
            "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/johnson-johnson-produces-documents-doj-civil-investigation-eye-products-2023-10-27/",
            "time_published": "20231027T212300",
            "authors": [
                "Reuters"
            ],
            "summary": "The logo of Johnson & Johnson is seen on a Brussels' office of the company in Diegem, Belgium September 21, 2023. REUTERS/Yves Herman/File Photo Acquire Licensing Rights Oct 27 ( Reuters ) - Johnson & Johnson ( JNJ.N ) has begun providing documents and information in response to a civil ...",
            "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/S2PVLT5FPJKPZGMG67RYMKUCTE.jpg",
            "source": "Reuters",
            "category_within_source": "Business",
            "source_domain": "www.reuters.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.228432,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.760593",
                    "ticker_sentiment_score": "0.420122",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Kessler Topaz Meltzer & Check, LLP ANNOUNCES A SECURITIES FRAUD CLASS ACTION FILED AGAINST KENVUE INC. - Kenvue  ( NYSE:KVUE ) ",
            "url": "https://www.benzinga.com/pressreleases/23/10/g35474631/kessler-topaz-meltzer-check-llp-announces-a-securities-fraud-class-action-filed-against-kenvue-inc",
            "time_published": "20231027T210159",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "RADNOR, Pa., Oct. 27, 2023 ( GLOBE NEWSWIRE ) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey against Kenvue Inc. ( \"Kenvue\" ) KVUE. ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.684621"
                }
            ],
            "overall_sentiment_score": 0.096899,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.526003",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.057079",
                    "ticker_sentiment_score": "0.129961",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Is Ozempic Killing Liposuction? A Stock That Could Get Hit Hard From New Weight-Loss Drugs - Novo Nordisk  ( NYSE:NVO ) ",
            "url": "https://www.benzinga.com/general/health-care/23/10/35469218/is-ozempic-killing-liposuction-a-stock-that-could-get-hit-hard-from-new-weight-loss-drugs",
            "time_published": "20231027T191555",
            "authors": [
                "Aaron Bry"
            ],
            "summary": "Ozempic, Novo Nordisk's NVO diabetes drug, is now popular for weight loss. The rise of the drug could become a major headwind for other companies that provide weight-loss services such as liposuction and bariatric surgeries. Some companies are already seeing the impact of widespread Ozempic use.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/27/weightloss.shutterstock_2270507665.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.062611,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.316846",
                    "ticker_sentiment_score": "-0.116065",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.316846",
                    "ticker_sentiment_score": "-0.073174",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.316846",
                    "ticker_sentiment_score": "-0.31328",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kenvue Inc. - KVUE - Kenvue  ( NYSE:KVUE ) ",
            "url": "https://www.benzinga.com/pressreleases/23/10/g35470371/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-kenvue-inc-kvue",
            "time_published": "20231027T174247",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "NEW YORK, Oct. 27, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Kenvue Inc. ( \"Kenvue\" or the \"Company\" ) KVUE. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.77141"
                }
            ],
            "overall_sentiment_score": 0.021762,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.691995",
                    "ticker_sentiment_score": "0.011422",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.115787",
                    "ticker_sentiment_score": "0.021477",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "AbbVie  ( ABBV )  Q3 Earnings Beat, Shares Down Despite Raised View",
            "url": "https://www.zacks.com/stock/news/2173886/abbvie-abbv-q3-earnings-beat-shares-down-despite-raised-view",
            "time_published": "20231027T145100",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "AbbVie's (ABBV) third-quarter 2023 earnings and sales beat estimates. Though the company raised its EPS outlook for both 2023 and 2024, share price dives as some key drugs misses out on estimates.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/d5/8276.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.993856"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.121556,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "CHRS",
                    "relevance_score": "0.037213",
                    "ticker_sentiment_score": "-0.05635",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.291038",
                    "ticker_sentiment_score": "0.312919",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.148045",
                    "ticker_sentiment_score": "-0.029829",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GMAB",
                    "relevance_score": "0.037213",
                    "ticker_sentiment_score": "0.285488",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.074345",
                    "ticker_sentiment_score": "0.131252",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "FDA Gives Nod To Eli Lilly's First Treatment For Type Of Inflammatory Bowel Disease, To Compete With JNJ, Pfizer, AbbVie - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/general/biotech/23/10/35465199/fda-gives-nod-to-eli-lillys-first-treatment-for-type-of-inflammatory-bowel-disease-to-compete-wit",
            "time_published": "20231027T142819",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "The FDA approved Eli Lilly And Co's LLY Omvoh ( mirikizumab-mrkz ) for moderately to severely active ulcerative colitis ( UC ) in adults, marking Lilly's first approved treatment for a type of inflammatory bowel disease.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/27/lly.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.259077,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.642555",
                    "ticker_sentiment_score": "0.486525",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.2872",
                    "ticker_sentiment_score": "0.447515",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.2872",
                    "ticker_sentiment_score": "0.447515",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.2872",
                    "ticker_sentiment_score": "0.447515",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Sanofi loses $21 bn in market value after dropping 2025 profit target",
            "url": "https://www.business-standard.com/companies/news/sanofi-loses-21-bn-in-market-value-after-dropping-2025-profit-target-123102701074_1.html",
            "time_published": "20231027T141823",
            "authors": [
                "Reuters"
            ],
            "summary": "Sanofi stock plunged on Friday, wiping 20 billion euros ( $21 billion ) off its market value, after it abandoned its 2025 profit target under a plan to list its consumer healthcare business to focus on its core innovative drugs business.",
            "banner_image": "https://bsmedia.business-standard.com/_media/bs/img/article/2023-01/30/full/1675098773-8562.jpg?im=FitAndFill=(826,465)",
            "source": "Business Standard",
            "category_within_source": "GoogleRSS",
            "source_domain": "www.business-standard.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.998287"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.129293,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.049526",
                    "ticker_sentiment_score": "0.001999",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BCS",
                    "relevance_score": "0.049526",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HLN",
                    "relevance_score": "0.049526",
                    "ticker_sentiment_score": "0.001999",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.049526",
                    "ticker_sentiment_score": "0.001999",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.049526",
                    "ticker_sentiment_score": "0.001999",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.423843",
                    "ticker_sentiment_score": "0.137287",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Is iShares Core High Dividend ETF  ( HDV )  a Strong ETF Right Now?",
            "url": "https://www.zacks.com/stock/news/2173449/is-ishares-core-high-dividend-etf-hdv-a-strong-etf-right-now",
            "time_published": "20231027T102007",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Smart Beta ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default288.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.273753,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BLK",
                    "relevance_score": "0.056808",
                    "ticker_sentiment_score": "0.048934",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MORN",
                    "relevance_score": "0.113329",
                    "ticker_sentiment_score": "0.147499",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CVX",
                    "relevance_score": "0.113329",
                    "ticker_sentiment_score": "0.060706",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.113329",
                    "ticker_sentiment_score": "0.060706",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XOM",
                    "relevance_score": "0.113329",
                    "ticker_sentiment_score": "0.060706",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Global Medical Robotics Market is Forecast to Reach a Value of USD 28.77 Billion By 2030 with a Growing CAGR of 14.94% | Infinium Global Research",
            "url": "https://www.prnewswire.com/news-releases/global-medical-robotics-market-is-forecast-to-reach-a-value-of-usd-28-77-billion-by-2030-with-a-growing-cagr-of-14-94--infinium-global-research-301970015.html",
            "time_published": "20231027T100300",
            "authors": [
                "Infinium Global Research"
            ],
            "summary": "Global Medical Robotics Market is Forecast to Reach a Value of USD 28.77 Billion By 2030 with a Growing CAGR of ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/2244132/Infinium_Global_Research_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.305753,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ZBH",
                    "relevance_score": "0.038101",
                    "ticker_sentiment_score": "0.066226",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "EKSO",
                    "relevance_score": "0.038101",
                    "ticker_sentiment_score": "0.066226",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OMCL",
                    "relevance_score": "0.038101",
                    "ticker_sentiment_score": "0.066226",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SYK",
                    "relevance_score": "0.038101",
                    "ticker_sentiment_score": "0.066226",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BSX",
                    "relevance_score": "0.038101",
                    "ticker_sentiment_score": "0.066226",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.038101",
                    "ticker_sentiment_score": "0.066226",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "III",
                    "relevance_score": "0.038101",
                    "ticker_sentiment_score": "0.164249",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.038101",
                    "ticker_sentiment_score": "0.066226",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ISRG",
                    "relevance_score": "0.038101",
                    "ticker_sentiment_score": "0.066226",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Sanofi shares plunge after 2025 target dropped, consumer unit marked for spin-off",
            "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/sanofi-considering-consumer-unit-listing-late-next-year-2023-10-27/",
            "time_published": "20231027T080000",
            "authors": [
                "Ludwig Burger"
            ],
            "summary": "Sanofi shares plunge after 2025 target dropped, consumer unit marked for ...",
            "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/WRF25P62ZFJITPPAPS2ZD2I67A.jpg",
            "source": "Reuters",
            "category_within_source": "Business",
            "source_domain": "www.reuters.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.99237"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.163962,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.056943",
                    "ticker_sentiment_score": "0.002002",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HLN",
                    "relevance_score": "0.056943",
                    "ticker_sentiment_score": "0.002002",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.056943",
                    "ticker_sentiment_score": "0.002002",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.056943",
                    "ticker_sentiment_score": "0.002002",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.567965",
                    "ticker_sentiment_score": "0.318076",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Sanofi takes page from rivals' separation playbook",
            "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/sanofi-takes-page-rivals-separation-playbook-2023-10-27/",
            "time_published": "20231027T073600",
            "authors": [
                "Reuters"
            ],
            "summary": "FILE PHTOO: The logo of French drugmaker Sanofi is seen a the Sanofi Genzyme Polyclonals in Lyon, France, September 30, 2023. REUTERS/Gonzalo Fuentes/File photo Acquire Licensing Rights",
            "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/6TKBWAWBEBJ6HJV4QVUL3YP744.jpg",
            "source": "Reuters",
            "category_within_source": "Business",
            "source_domain": "www.reuters.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": -0.058979,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.100729",
                    "ticker_sentiment_score": "-0.018451",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HLN",
                    "relevance_score": "0.100729",
                    "ticker_sentiment_score": "-0.018451",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.100729",
                    "ticker_sentiment_score": "-0.018451",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.100729",
                    "ticker_sentiment_score": "-0.018451",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.295867",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Analysis: Healthcare companies counter investor worries over Wegovy effect",
            "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/healthcare-companies-counter-investor-worries-over-wegovy-effect-2023-10-27/",
            "time_published": "20231027T050020",
            "authors": [
                "Manas Mishra",
                "David Gaffen"
            ],
            "summary": "A selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023. REUTERS/Jim Vondruska/Illustration/File Photo Acquire Licensing Rights",
            "banner_image": "https://s3.amazonaws.com/arc-authors/reuters/64c98ae2-82dc-4c80-b81f-dc010b8de5de.png",
            "source": "Reuters",
            "category_within_source": "Business",
            "source_domain": "www.reuters.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.451494"
                }
            ],
            "overall_sentiment_score": 0.040704,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "RMD",
                    "relevance_score": "0.049221",
                    "ticker_sentiment_score": "0.003987",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ISRG",
                    "relevance_score": "0.049221",
                    "ticker_sentiment_score": "0.018908",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BSX",
                    "relevance_score": "0.049221",
                    "ticker_sentiment_score": "0.052759",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HCSG",
                    "relevance_score": "0.049221",
                    "ticker_sentiment_score": "0.016001",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.098255",
                    "ticker_sentiment_score": "0.124991",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.049221",
                    "ticker_sentiment_score": "-0.129072",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Wound Care Market to grow by USD 6.83 billion from 2022 to 2027|3M Co., Advancis Medical, Avery Dennison Corp ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/wound-care-market-to-grow-by-usd-6-83-billion-from-2022-to-20273m-co-advancis-medical-avery-dennison-corp-axio-biosolutions-pvt-ltd-and-more-among-the-key-companies-in-the-market---technavio-301969520.html",
            "time_published": "20231027T030000",
            "authors": [],
            "summary": "Wound Care Market to grow by USD 6.83 billion from 2022 to 2027|3M Co., Advancis Medical, Avery Dennison Corp ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.065474,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "SNN",
                    "relevance_score": "0.04872",
                    "ticker_sentiment_score": "0.082671",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AVY",
                    "relevance_score": "0.04872",
                    "ticker_sentiment_score": "0.082671",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DSSMY",
                    "relevance_score": "0.04872",
                    "ticker_sentiment_score": "0.082671",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.04872",
                    "ticker_sentiment_score": "0.082671",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CAH",
                    "relevance_score": "0.04872",
                    "ticker_sentiment_score": "0.082671",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZLGF",
                    "relevance_score": "0.04872",
                    "ticker_sentiment_score": "0.082671",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.04872",
                    "ticker_sentiment_score": "0.082671",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MMM",
                    "relevance_score": "0.04872",
                    "ticker_sentiment_score": "0.082671",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CLPBY",
                    "relevance_score": "0.04872",
                    "ticker_sentiment_score": "0.082671",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ORGO",
                    "relevance_score": "0.04872",
                    "ticker_sentiment_score": "0.082671",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CNVVF",
                    "relevance_score": "0.04872",
                    "ticker_sentiment_score": "0.082671",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Kenvue  ( KVUE )  Q3 2023 Earnings Call Transcript",
            "url": "https://www.fool.com/earnings/call-transcripts/2023/10/26/kenvue-kvue-q3-2023-earnings-call-transcript/",
            "time_published": "20231026T183024",
            "authors": [
                "Motley Fool Transcribing"
            ],
            "summary": "KVUE earnings call for the period ending September 30, 2023.",
            "banner_image": "https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.769861"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999999"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999998"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.331389,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.039795",
                    "ticker_sentiment_score": "0.16753",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "C",
                    "relevance_score": "0.004976",
                    "ticker_sentiment_score": "0.182945",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.004976",
                    "ticker_sentiment_score": "0.182945",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.004976",
                    "ticker_sentiment_score": "0.182945",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ICNB",
                    "relevance_score": "0.029851",
                    "ticker_sentiment_score": "0.204375",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.009953",
                    "ticker_sentiment_score": "0.185623",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "FOREX:UYU",
                    "relevance_score": "0.004976",
                    "ticker_sentiment_score": "-0.126599",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:RUB",
                    "relevance_score": "0.004976",
                    "ticker_sentiment_score": "-0.126599",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:USD",
                    "relevance_score": "0.004976",
                    "ticker_sentiment_score": "0.032226",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "JNJ: 3 Pharma Stocks on the Rise - Buy Now",
            "url": "https://stocknews.com/news/jnj-azn-sny-3-pharma-stocks-on-the-rise-buy-now/",
            "time_published": "20231026T154843",
            "authors": [
                "StockNews.com Staff"
            ],
            "summary": "The pharmaceutical industry is set to grow in the coming years thanks to an aging population, chronic diseases, and new technologies. In this article, we'll look at the fundamentals of three pharma stocks, Sanofi ( SNY ) , Johnson & Johnson ( JNJ ) and AstraZeneca PLC ( AZN ) , which can boost ...",
            "banner_image": "https://stocknews.com/wp-content/uploads/2022/03/shutterstock_745024336-scaled.jpg",
            "source": "Stocknews.com",
            "category_within_source": "n/a",
            "source_domain": "stocknews.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999701"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.623304"
                }
            ],
            "overall_sentiment_score": 0.303463,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "FWBI",
                    "relevance_score": "0.034136",
                    "ticker_sentiment_score": "0.125736",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.202648",
                    "ticker_sentiment_score": "0.207864",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.068209",
                    "ticker_sentiment_score": "0.068173",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSOI",
                    "relevance_score": "0.034136",
                    "ticker_sentiment_score": "0.08627",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.202648",
                    "ticker_sentiment_score": "0.136799",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.235496",
                    "ticker_sentiment_score": "0.116023",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Scleroderma Market Outlook 2023-2027: Expected Market Size, Growth Drivers, And Key Trends As Per The Business Research Company's Scleroderma Global Market Report 2023",
            "url": "https://www.benzinga.com/pressreleases/23/10/g35444019/scleroderma-market-outlook-2023-2027-expected-market-size-growth-drivers-and-key-trends-as-per-the",
            "time_published": "20231026T153000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "LONDON, Oct. 26, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Scleroderma Global Market Report 2023, the global scleroderma market is on an upward trajectory, with expectations of reaching $2.15 billion in 2023, signifying a compound annual growth rate ( CAGR ) of 7.5%.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.251023,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.068698",
                    "ticker_sentiment_score": "0.071658",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAYZF",
                    "relevance_score": "0.068698",
                    "ticker_sentiment_score": "0.071658",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.068698",
                    "ticker_sentiment_score": "0.071658",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.068698",
                    "ticker_sentiment_score": "0.071658",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Fatty Liver Treatment Market Is Set To Grow At A CAGR Of 6%, Driven By Rise In Alcohol Consumption As Per The Business Research Company's Fatty Liver Treatment Global Market Report 2023",
            "url": "https://www.benzinga.com/pressreleases/23/10/g35444012/fatty-liver-treatment-market-is-set-to-grow-at-a-cagr-of-6-driven-by-rise-in-alcohol-consumption-a",
            "time_published": "20231026T153000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "LONDON, Oct. 26, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Fatty Liver Treatment Global Market Report 2023, the global fatty liver treatment market is gearing up for substantial growth, expected to rise from $20.83 billion in 2022 to $22.17 billion in 2023, with a ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.045999,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "AKRO",
                    "relevance_score": "0.05749",
                    "ticker_sentiment_score": "0.060046",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KNBWF",
                    "relevance_score": "0.05749",
                    "ticker_sentiment_score": "-0.09449",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.05749",
                    "ticker_sentiment_score": "0.06602",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.05749",
                    "ticker_sentiment_score": "0.06602",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.05749",
                    "ticker_sentiment_score": "0.06602",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Build Relationships that Drive Revenue at Transform 2023, Hosted by Showpad",
            "url": "https://www.benzinga.com/pressreleases/23/10/g35441300/build-relationships-that-drive-revenue-at-transform-2023-hosted-by-showpad",
            "time_published": "20231026T141324",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "Discover the trends shaping the industry and hear first-hand from sales enablement experts at Stanley Black & Decker, Kaiser Permanente, Regal Rexnord, and LastPass, on how to unlock sales potential at Showpad's Transform 2023",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.214378"
                }
            ],
            "overall_sentiment_score": 0.28752,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "GIC",
                    "relevance_score": "0.043818",
                    "ticker_sentiment_score": "0.077902",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RRX",
                    "relevance_score": "0.087503",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CCEP",
                    "relevance_score": "0.043818",
                    "ticker_sentiment_score": "0.067432",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.043818",
                    "ticker_sentiment_score": "0.067432",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SWK",
                    "relevance_score": "0.043818",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.043818",
                    "ticker_sentiment_score": "0.067432",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Kenvue tempers annual profit view on soft demand for cold, flu medicines",
            "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/kenvue-reports-higher-q3-revenue-self-care-products-strength-2023-10-26/",
            "time_published": "20231026T141100",
            "authors": [
                "Bhanvi Satija"
            ],
            "summary": "[1/2] The company logo for Kenvue Inc. Johnson & Johnson's consumer-health business, is displayed on a screen during the company's IPO at the New York Stock Exchange ( NYSE ) in New York City, U.S., May 4, 2023. REUTERS/Brendan McDermid/File Photo Acquire Licensing Rights",
            "banner_image": "https://s3.amazonaws.com/arc-authors/reuters/24e53264-190b-4097-835a-edeca236a9f4.png",
            "source": "Reuters",
            "category_within_source": "Business",
            "source_domain": "www.reuters.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.858979"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.05027,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.493128",
                    "ticker_sentiment_score": "0.067399",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HLN",
                    "relevance_score": "0.105604",
                    "ticker_sentiment_score": "0.129029",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.105604",
                    "ticker_sentiment_score": "-0.045208",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "2 Magnificent Dividend Stocks That Could Deliver a Lifetime of Passive Income",
            "url": "https://www.fool.com/investing/2023/10/26/2-magnifient-dividend-stocks-that-could-deliver-a/",
            "time_published": "20231026T114500",
            "authors": [
                "George Budwell"
            ],
            "summary": "These two healthcare stocks are proven passive income vehicles.",
            "banner_image": "https://media.ycharts.com/charts/5430b19acc87c6b192178bfb89679292.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.998356"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.875462"
                }
            ],
            "overall_sentiment_score": 0.313968,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "PFE",
                    "relevance_score": "0.38489",
                    "ticker_sentiment_score": "0.328703",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.1331",
                    "ticker_sentiment_score": "0.090457",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "3 Pharma Stocks That Are Screaming Buys in October",
            "url": "https://www.fool.com/investing/2023/10/26/3-pharma-stocks-that-are-screaming-buys-in-october/",
            "time_published": "20231026T113000",
            "authors": [
                "Jim Halley"
            ],
            "summary": "Each company delivers an above-average dividend and revenue growth.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.54554"
                }
            ],
            "overall_sentiment_score": 0.109768,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.076115",
                    "ticker_sentiment_score": "0.002043",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GILD",
                    "relevance_score": "0.076115",
                    "ticker_sentiment_score": "-0.044986",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.151539",
                    "ticker_sentiment_score": "0.035847",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.188781",
                    "ticker_sentiment_score": "0.100446",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johnson & Johnson  ( NYSE:JNJ )  Upgraded to Strong-Buy at StockNews.com",
            "url": "https://www.defenseworld.net/2023/10/26/johnson-johnson-nysejnj-upgraded-to-strong-buy-at-stocknews-com.html",
            "time_published": "20231026T072246",
            "authors": [
                "Defense World Staff"
            ],
            "summary": "Johnson & Johnson ( NYSE:JNJ ) Upgraded to Strong-Buy at ... Defense World ...",
            "banner_image": "https://www.marketbeat.com/logos/johnson--johnson-logo.png?v=20221020135923",
            "source": "Stocknews.com",
            "category_within_source": "n/a",
            "source_domain": "www.defenseworld.net",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.623304"
                }
            ],
            "overall_sentiment_score": 0.340403,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MS",
                    "relevance_score": "0.061003",
                    "ticker_sentiment_score": "0.07503",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.806749",
                    "ticker_sentiment_score": "0.538381",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "RBCPF",
                    "relevance_score": "0.061003",
                    "ticker_sentiment_score": "0.07503",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "InnovationRx: Ransomware Attacks On U.S. Health Systems Have Cost The Economy Nearly $80 Billion",
            "url": "https://www.forbes.com/sites/alexknapp/2023/10/25/innovationrx-ransomware-attacks-on-us-health-systems-have-cost-the-economy-nearly-8-billion/",
            "time_published": "20231026T004247",
            "authors": [
                "Alex Knapp"
            ],
            "summary": "InnovationRx is your weekly digest of healthcare news. To get it in your inbox, subscribe here.",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/6539b5a9b1998d930ede083e/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
            "source": "Forbes",
            "category_within_source": "n/a",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": -0.031463,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.106541",
                    "ticker_sentiment_score": "-0.055926",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CTXR",
                    "relevance_score": "0.05339",
                    "ticker_sentiment_score": "0.107688",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.05339",
                    "ticker_sentiment_score": "-0.114687",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.05339",
                    "ticker_sentiment_score": "0.059975",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.05339",
                    "ticker_sentiment_score": "-0.292031",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "CNC",
                    "relevance_score": "0.05339",
                    "ticker_sentiment_score": "0.120688",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TENK",
                    "relevance_score": "0.05339",
                    "ticker_sentiment_score": "0.107688",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "INSM",
                    "relevance_score": "0.05339",
                    "ticker_sentiment_score": "-0.068726",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BFLY",
                    "relevance_score": "0.05339",
                    "ticker_sentiment_score": "0.059975",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CRYPTO:PAY",
                    "relevance_score": "0.05339",
                    "ticker_sentiment_score": "0.107688",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Icertis Named a Leader in 2023 Gartner® Magic Quadrant™ for Contract Life Cycle Management",
            "url": "https://www.prnewswire.com/news-releases/icertis-named-a-leader-in-2023-gartner-magic-quadrant-for-contract-life-cycle-management-301966992.html",
            "time_published": "20231025T163000",
            "authors": [
                "Icertis"
            ],
            "summary": "BELLEVUE, Wash., Oct. 25, 2023 /PRNewswire/ -- Icertis announced today that it has been named a Leader in the 2023 Gartner Magic Quadrant for Contract Life Cycle Management ( CLM ) 1.",
            "banner_image": "https://mma.prnewswire.com/media/371539/Icertis_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.336683,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.09439",
                    "ticker_sentiment_score": "0.159633",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "HUM",
                    "relevance_score": "0.047278",
                    "ticker_sentiment_score": "0.095863",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.047278",
                    "ticker_sentiment_score": "0.095863",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BBY",
                    "relevance_score": "0.047278",
                    "ticker_sentiment_score": "0.095863",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IT",
                    "relevance_score": "0.047278",
                    "ticker_sentiment_score": "0.053193",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ACN",
                    "relevance_score": "0.047278",
                    "ticker_sentiment_score": "0.095863",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ICNB",
                    "relevance_score": "0.047278",
                    "ticker_sentiment_score": "0.046982",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Kenvue Inc.  ( KVUE )  - Kenvue  ( NYSE:KVUE ) ",
            "url": "https://www.benzinga.com/pressreleases/23/10/g35418916/glancy-prongay-murray-llp-reminds-investors-of-looming-deadline-in-the-class-action-lawsuit-agains",
            "time_published": "20231025T152300",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "LOS ANGELES, Oct. 25, 2023 ( GLOBE NEWSWIRE ) -- Glancy Prongay & Murray LLP ( \"GPM\" ) reminds investors of the upcoming December 8, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Kenvue Inc. ( \"Kenvue\" or the ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.890401"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.858979"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.021733,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.612343",
                    "ticker_sentiment_score": "0.039842",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.062597",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.062597",
                    "ticker_sentiment_score": "0.086023",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Transdermal Drug Delivery System Market to Hit 4.3% CAGR with Transdermal Gels Segment Driving Growth During 2022-2030 | The Insight Partners",
            "url": "https://www.benzinga.com/pressreleases/23/10/g35417362/transdermal-drug-delivery-system-market-to-hit-4-3-cagr-with-transdermal-gels-segment-driving-grow",
            "time_published": "20231025T144015",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "Pune, India, Oct. 25, 2023 ( GLOBE NEWSWIRE ) -- Transdermal drug delivery systems are dosage forms actively used to deliver a therapeutically effective amount of drug across a patient's skin.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.203812,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LYPHF",
                    "relevance_score": "0.229149",
                    "ticker_sentiment_score": "0.170559",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "UCBJF",
                    "relevance_score": "0.025817",
                    "ticker_sentiment_score": "0.061488",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GSK",
                    "relevance_score": "0.025817",
                    "ticker_sentiment_score": "0.061488",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HTSUF",
                    "relevance_score": "0.025817",
                    "ticker_sentiment_score": "0.061488",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.025817",
                    "ticker_sentiment_score": "0.061488",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VTRS",
                    "relevance_score": "0.025817",
                    "ticker_sentiment_score": "0.061488",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Drug, Biotech Stocks' Q3 Earnings Due on Oct 26: BMY, MRK, BPMC",
            "url": "https://www.zacks.com/stock/news/2171776/drug-biotech-stocks-q3-earnings-due-on-oct-26-bmy-mrk-bpmc",
            "time_published": "20231025T141500",
            "authors": [
                "Ahan Chakraborty"
            ],
            "summary": "Let's look at three biotech/drug companies, BMY, MRK and BPMC, slated to release quarterly results on Oct 26.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/7e/42272.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.160128,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BMY",
                    "relevance_score": "0.201523",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BPMC",
                    "relevance_score": "0.344987",
                    "ticker_sentiment_score": "0.138282",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.101582",
                    "ticker_sentiment_score": "0.131226",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Surgical Robots Market to Hit 14.8% CAGR, Globally Driven by Increase in Surgical Procedures During 2022-2028 | The Insight Partners",
            "url": "https://www.benzinga.com/pressreleases/23/10/g35416590/surgical-robots-market-to-hit-14-8-cagr-globally-driven-by-increase-in-surgical-procedures-during-",
            "time_published": "20231025T140919",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "Pune, India, Oct. 25, 2023 ( GLOBE NEWSWIRE ) -- Surgical Robots are robotic systems operated by surgeons consisting of miniaturized surgical instruments mounted on robotic arms. These are controlled by the surgeons on a computer console that offers HD and a magnified 3-D view of the surgical ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.243026,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ZBH",
                    "relevance_score": "0.034185",
                    "ticker_sentiment_score": "0.097864",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNN",
                    "relevance_score": "0.034185",
                    "ticker_sentiment_score": "0.097864",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SSMXF",
                    "relevance_score": "0.034185",
                    "ticker_sentiment_score": "0.152758",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "DSSMY",
                    "relevance_score": "0.034185",
                    "ticker_sentiment_score": "0.097864",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SSII",
                    "relevance_score": "0.034185",
                    "ticker_sentiment_score": "0.114334",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.034185",
                    "ticker_sentiment_score": "0.097864",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RNSHF",
                    "relevance_score": "0.034185",
                    "ticker_sentiment_score": "0.097864",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Powerful senators fire off letter decrying 'abusive' tactics in Corizon bankruptcy",
            "url": "https://www.businessinsider.com/senator-warren-oversight-letter-on-corizon-tehum-yescare-bankruptcy-deal-2023-10",
            "time_published": "20231025T120000",
            "authors": [
                "Dakin Campbell",
                "Nicole Einbinder"
            ],
            "summary": "Senators press for answers from executives of Corizon successor companies - Business Insider ...",
            "banner_image": null,
            "source": "Business Insider",
            "category_within_source": "GoogleRSS",
            "source_domain": "www.businessinsider.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.208222,
            "overall_sentiment_label": "Somewhat-Bearish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.029113",
                    "ticker_sentiment_score": "-0.073979",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:USD",
                    "relevance_score": "0.029113",
                    "ticker_sentiment_score": "-0.196194",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Self-Diagnostic Medical Devices Market Size Worth $39.88 Billion, Globally, by 2030- Exclusive Report by The Insight Partners",
            "url": "https://www.benzinga.com/pressreleases/23/10/g35410523/self-diagnostic-medical-devices-market-size-worth-39-88-billion-globally-by-2030-exclusive-report-",
            "time_published": "20231025T093022",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "Pune, India, Oct. 25, 2023 ( GLOBE NEWSWIRE ) -- According to our new research study on \"Self-Diagnostic Medical Devices Market covers analysis By Product Type ( Wearable Devices, Implantable Devices, Handheld/Portable Devices, Stationary Devices, and Others ) , Component ( Software, Devices, ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.00722,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "WLDS",
                    "relevance_score": "0.040553",
                    "ticker_sentiment_score": "-0.019693",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OMRNF",
                    "relevance_score": "0.040553",
                    "ticker_sentiment_score": "0.095195",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.040553",
                    "ticker_sentiment_score": "0.095195",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "2 Exceptional Dividend Stocks Near 52-Week Lows. Are They Bargains Now?",
            "url": "https://www.fool.com/investing/2023/10/25/2-exceptional-dividend-stocks-near-52-week-lows-ar/",
            "time_published": "20231025T091900",
            "authors": [
                "Cory Renauer"
            ],
            "summary": "Attractive valuation metrics don't always tell the whole story.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F751883%2Fconfident-investor-getty.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.459462"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.614606"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.140275,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.061473",
                    "ticker_sentiment_score": "0.139039",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BTI",
                    "relevance_score": "0.242285",
                    "ticker_sentiment_score": "-0.056487",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.122581",
                    "ticker_sentiment_score": "0.240911",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "The Global AI In Healthcare Diagnosis Market Set For Explosive Growth, Projected To Reach $71.24 Billion By 2027 As Per The Business Research Company's Artificial Intelligence In Healthcare Diagnosis Global Market Report 2023",
            "url": "https://www.benzinga.com/pressreleases/23/10/g35397852/the-global-ai-in-healthcare-diagnosis-market-set-for-explosive-growth-projected-to-reach-71-24-bil",
            "time_published": "20231024T153500",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "LONDON, Oct. 24, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Artificial Intelligence In Healthcare Diagnosis Global Market Report 2023, the global Artificial Intelligence ( AI ) in healthcare diagnosis market is poised for a remarkable surge, with a projected growth from ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.402041,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.055621",
                    "ticker_sentiment_score": "0.240059",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.055621",
                    "ticker_sentiment_score": "0.240059",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.055621",
                    "ticker_sentiment_score": "0.240059",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "INTC",
                    "relevance_score": "0.055621",
                    "ticker_sentiment_score": "0.240059",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.055621",
                    "ticker_sentiment_score": "0.240059",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "JNJ: Should You Invest in Johnson & Johnson  ( JNJ )  Following Q3 Results",
            "url": "https://stocknews.com/news/jnj-nvs-abbv-nvo-should-you-invest-in-johnson-johnson-jnj-following-q3/",
            "time_published": "20231024T144418",
            "authors": [
                "StockNews.com Staff"
            ],
            "summary": "JNJ: Should You Invest in Johnson & Johnson ( JNJ ) Following Q3 ... ...",
            "banner_image": "https://stocknews.com/wp-content/uploads/2020/09/jnj-mmm-dg.jpg",
            "source": "Stocknews.com",
            "category_within_source": "n/a",
            "source_domain": "stocknews.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.962106"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999975"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.217713,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.083687",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVS",
                    "relevance_score": "0.083687",
                    "ticker_sentiment_score": "0.067449",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.083687",
                    "ticker_sentiment_score": "0.067449",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.083687",
                    "ticker_sentiment_score": "0.067449",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.628234",
                    "ticker_sentiment_score": "0.331411",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "3 High-Yielding Dividend Stocks Near Their 52-Week Lows",
            "url": "https://www.fool.com/investing/2023/10/24/3-high-yielding-dividend-stocks-near-their-52-week/",
            "time_published": "20231024T114500",
            "authors": [
                "David Jagielski"
            ],
            "summary": "Due to their declining share prices, Johnson & Johnson, Bank of America, and Target all yield more than 3% right now.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.54554"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.976913"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.118579,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "TGT",
                    "relevance_score": "0.321673",
                    "ticker_sentiment_score": "0.210712",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.321673",
                    "ticker_sentiment_score": "0.01945",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.321673",
                    "ticker_sentiment_score": "0.209912",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.055109",
                    "ticker_sentiment_score": "0.011995",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "The Best Stocks to Invest $5,000 In Right Now",
            "url": "https://www.fool.com/investing/2023/10/24/the-best-stocks-to-invest-5000-in-right-now/",
            "time_published": "20231024T093000",
            "authors": [
                "Adria Cimino"
            ],
            "summary": "Today, the following three healthcare players look like fantastic bargains.",
            "banner_image": "https://media.ycharts.com/charts/9580ab8fffe7217f39b1987355fdd495.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.972476"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.316726"
                }
            ],
            "overall_sentiment_score": 0.323116,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.102668",
                    "ticker_sentiment_score": "0.183773",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "VRTX",
                    "relevance_score": "0.102668",
                    "ticker_sentiment_score": "0.214111",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MRNA",
                    "relevance_score": "0.203643",
                    "ticker_sentiment_score": "0.121416",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.102668",
                    "ticker_sentiment_score": "0.175114",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "2 Historically Cheap Dow Dividend Kings That Are Ripe for the Picking",
            "url": "https://www.fool.com/investing/2023/10/24/2-cheap-dow-dividend-kings-are-ripe-for-picking/",
            "time_published": "20231024T092100",
            "authors": [
                "Sean Williams"
            ],
            "summary": "These inexpensive Dow components have achieved royalty status among income stocks -- more than 60 consecutive years of dividend increases.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F751877%2Fnyse-wall-street-trading-new-york-financial-stock-market-getty.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.87644"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.769861"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.228638,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.038223",
                    "ticker_sentiment_score": "0.004947",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TWOHD",
                    "relevance_score": "0.038223",
                    "ticker_sentiment_score": "0.270018",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.333757",
                    "ticker_sentiment_score": "0.353798",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.038223",
                    "ticker_sentiment_score": "0.200047",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.076358",
                    "ticker_sentiment_score": "-0.041088",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.298567",
                    "ticker_sentiment_score": "0.116827",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.038223",
                    "ticker_sentiment_score": "0.201042",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.038223",
                    "ticker_sentiment_score": "0.004947",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Idorsia announces financial results for the first nine months of 2023 - adapting the company to create sustainable value",
            "url": "https://www.globenewswire.com/news-release/2023/10/24/2765251/0/en/Idorsia-announces-financial-results-for-the-first-nine-months-of-2023-adapting-the-company-to-create-sustainable-value.html",
            "time_published": "20231024T050000",
            "authors": [
                "Idorsia Pharmaceuticals Ltd"
            ],
            "summary": "Ad hoc announcement pursuant to Art. 53 LR ...",
            "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/2b5c6373-4972-498a-b81c-ac336e21be66",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.147568,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "CVS",
                    "relevance_score": "0.023146",
                    "ticker_sentiment_score": "0.051334",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SOLTF",
                    "relevance_score": "0.261361",
                    "ticker_sentiment_score": "0.044993",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IDRSF",
                    "relevance_score": "0.283148",
                    "ticker_sentiment_score": "0.156458",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.011574",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NBIX",
                    "relevance_score": "0.011574",
                    "ticker_sentiment_score": "0.105523",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Phase 3 MARIPOSA-2 Study Shows RYBREVANT®  ( amivantamab-vmjw )  Plus Chemotherapy Given with or without Lazertinib Reduced Risk of Disease Progression or Death by 56 and 52 Percent Respectively in Patients with EGFR-Mutated Non-Small Cell Lung Cancer who Progressed on or after Osimertinib",
            "url": "https://www.prnewswire.com/news-releases/phase-3-mariposa-2-study-shows-rybrevant-amivantamab-vmjw-plus-chemotherapy-given-with-or-without-lazertinib-reduced-risk-of-disease-progression-or-death-by-56-and-52-percent-respectively-in-patients-with-egfr-mutated-non-small-301964621.html",
            "time_published": "20231023T144400",
            "authors": [
                "Janssen Pharmaceutical Companies of Johnson & Johnson"
            ],
            "summary": "Phase 3 MARIPOSA-2 Study Shows RYBREVANT® ( amivantamab-vmjw ) Plus Chemotherapy Given with or without ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/622202/Janssen_Biotech_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": -0.016917,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.058",
                    "ticker_sentiment_score": "0.020062",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Charles River  ( CRL )  Offers Access to Preclinical Cancer Research",
            "url": "https://www.zacks.com/stock/news/2170290/charles-river-crl-offers-access-to-preclinical-cancer-research",
            "time_published": "20231023T141000",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Charles River (CRL) contributes to 84 percent of the FDA-approved cancer medicines and provides partners with 16 oncology prospects.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/ca/2974.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.160598,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "CRL",
                    "relevance_score": "0.115232",
                    "ticker_sentiment_score": "-0.165166",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.172097",
                    "ticker_sentiment_score": "0.121222",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.172097",
                    "ticker_sentiment_score": "0.118379",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johnson & Johnson  ( JNJ )  Is a Trending Stock: Facts to Know Before Betting on It",
            "url": "https://www.zacks.com/stock/news/2170161/johnson-johnson-jnj-is-a-trending-stock-facts-to-know-before-betting-on-it",
            "time_published": "20231023T130010",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default96.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.54554"
                }
            ],
            "overall_sentiment_score": 0.219855,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.47672",
                    "ticker_sentiment_score": "0.133307",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "New Phase 3 TREMFYA®  ( guselkumab )  Results in Ulcerative Colitis Show a 77 Percent Overall Clinical Response Rate and Early Symptom Improvement",
            "url": "https://www.prnewswire.com/news-releases/new-phase-3-tremfya-guselkumab-results-in-ulcerative-colitis-show-a-77-percent-overall-clinical-response-rate-and-early-symptom-improvement-301963553.html",
            "time_published": "20231023T113100",
            "authors": [
                "Janssen Pharmaceutical Companies of Johnson & Johnson"
            ],
            "summary": "New Phase 3 TREMFYA® ( guselkumab ) Results in Ulcerative Colitis Show a 77 Percent Overall Clinical Response ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/1006365/Janssen_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": -0.043506,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.215149",
                    "ticker_sentiment_score": "0.01562",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "The 3 Safest Warren Buffett Stocks to Buy and Hold for the Next 20 Years",
            "url": "https://www.fool.com/investing/2023/10/23/the-3-safest-warren-buffett-stocks-to-buy-and-hold/",
            "time_published": "20231023T105000",
            "authors": [
                "Keith Speights"
            ],
            "summary": "These stocks are less risky than most.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999696"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.220733,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "META",
                    "relevance_score": "0.06623",
                    "ticker_sentiment_score": "0.105469",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.06623",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.132004",
                    "ticker_sentiment_score": "0.09359",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.06623",
                    "ticker_sentiment_score": "0.105469",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TMO",
                    "relevance_score": "0.06623",
                    "ticker_sentiment_score": "0.105469",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AXP",
                    "relevance_score": "0.06623",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSBHF",
                    "relevance_score": "0.545493",
                    "ticker_sentiment_score": "0.404096",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "MKL",
                    "relevance_score": "0.439243",
                    "ticker_sentiment_score": "0.310775",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "AbbVie  ( ABBV )  to Report Q3 Earnings: What's in the Cards?",
            "url": "https://www.zacks.com/stock/news/2170056/abbvie-abbv-to-report-q3-earnings-whats-in-the-cards",
            "time_published": "20231023T083200",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "AbbVie's (ABBV) Q3 performance will likely reflect its newer immunotherapy drugs trying to compensate for declining Humira sales following the loss of U.S. exclusivity.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/36/1919.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999992"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.202745,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "SSNLF",
                    "relevance_score": "0.043264",
                    "ticker_sentiment_score": "0.029734",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.412523",
                    "ticker_sentiment_score": "0.324419",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.2138",
                    "ticker_sentiment_score": "0.05686",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.2138",
                    "ticker_sentiment_score": "-0.004984",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.043264",
                    "ticker_sentiment_score": "0.115711",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Down in the Double Digits, These 2 Classic Warren Buffett Stocks Make Great Buys Now",
            "url": "https://www.fool.com/investing/2023/10/22/down-double-digits-these-buffett-stocks-are-buys/",
            "time_published": "20231022T105000",
            "authors": [
                "Adria Cimino"
            ],
            "summary": "These players could deliver top returns over the long haul.",
            "banner_image": "https://media.ycharts.com/charts/646704df6df1248cf3e6f53093aef562.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.495866"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.857896"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.394919,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.106305",
                    "ticker_sentiment_score": "0.180269",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.452384",
                    "ticker_sentiment_score": "0.476119",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.053271",
                    "ticker_sentiment_score": "0.169715",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.106305",
                    "ticker_sentiment_score": "0.015372",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "3 Foundational Blue Chip Dow Dividend Stocks for Building Generational Wealth",
            "url": "https://www.fool.com/investing/2023/10/22/3-foundational-blue-chip-dow-dividend-stocks/",
            "time_published": "20231022T090300",
            "authors": [
                "Daniel Foelber"
            ],
            "summary": "Dow stocks can provide the confidence needed to hold through periods of volatility.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F749878%2Fgettyimages-600148200.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.99977"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.972476"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": 0.229856,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "CVX",
                    "relevance_score": "0.414559",
                    "ticker_sentiment_score": "0.210604",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.039548",
                    "ticker_sentiment_score": "-0.007966",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.157227",
                    "ticker_sentiment_score": "0.098489",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.039548",
                    "ticker_sentiment_score": "-0.007966",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XOM",
                    "relevance_score": "0.039548",
                    "ticker_sentiment_score": "0.171857",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.195814",
                    "ticker_sentiment_score": "0.065699",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HD",
                    "relevance_score": "0.414559",
                    "ticker_sentiment_score": "0.343295",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Final Multivariate Analysis from the Phase 3 MAGNITUDE Study Shows Trend Toward Improvement in Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer with BRCA Alterations Treated with Niraparib and Abiraterone Acetate Plus Prednisone",
            "url": "https://www.prnewswire.com/news-releases/final-multivariate-analysis-from-the-phase-3-magnitude-study-shows-trend-toward-improvement-in-overall-survival-in-patients-with-metastatic-castration-resistant-prostate-cancer-with-brca-alterations-treated-with-niraparib-and-abir-301963785.html",
            "time_published": "20231022T063000",
            "authors": [
                "Janssen Pharmaceutical Companies of Johnson & Johnson"
            ],
            "summary": "Final Multivariate Analysis from the Phase 3 MAGNITUDE Study Shows Trend Toward Improvement in Overall Survival ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/622202/Janssen_Biotech_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": -0.055604,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.085411",
                    "ticker_sentiment_score": "0.023147",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "New Data from Phase 3 PAPILLON Study Show RYBREVANT®  ( amivantamab-vmjw )  Plus Chemotherapy Resulted in 60 Percent Reduction in Risk of Disease Progression or Death in Patients with Previously Untreated EGFR Exon 20 Insertion Mutation-Positive Non-Small Cell Lung Cancer",
            "url": "https://www.prnewswire.com/news-releases/new-data-from-phase-3-papillon-study-show-rybrevant-amivantamab-vmjw-plus-chemotherapy-resulted-in-60-percent-reduction-in-risk-of-disease-progression-or-death-in-patients-with-previously-untreated-egfr-exon-20-insertion-mutati-301963753.html",
            "time_published": "20231021T143000",
            "authors": [
                "Janssen Pharmaceutical Companies of Johnson & Johnson"
            ],
            "summary": "New Data from Phase 3 PAPILLON Study Show RYBREVANT® ( amivantamab-vmjw ) Plus Chemotherapy Resulted in ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/622202/Janssen_Biotech_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": 0.0,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.073418",
                    "ticker_sentiment_score": "0.020485",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JWCTF",
                    "relevance_score": "0.010503",
                    "ticker_sentiment_score": "0.057474",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "2 Warren Buffett Dividend Stocks to Buy and Hold Forever",
            "url": "https://www.fool.com/investing/2023/10/21/2-warren-buffett-dividend-stocks-to-buy-and-hold/",
            "time_published": "20231021T140700",
            "authors": [
                "Prosper Junior Bakiny"
            ],
            "summary": "Most people have come across these companies' services.",
            "banner_image": "https://media.ycharts.com/charts/5fb63464fc1d8ee2513c437bc63058a4.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.265109,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MA",
                    "relevance_score": "0.054857",
                    "ticker_sentiment_score": "0.041005",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "V",
                    "relevance_score": "0.269181",
                    "ticker_sentiment_score": "0.273944",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.417995",
                    "ticker_sentiment_score": "0.316087",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Bull Market or Recession? 2 Resilient Index Funds That Are Proven Moneymakers to Buy Now and Hold Forever  ( No Matter What Comes Next ) ",
            "url": "https://www.fool.com/investing/2023/10/21/bull-market-or-recession-2-index-funds-to-buy-now/",
            "time_published": "20231021T110700",
            "authors": [
                "Trevor Jennewine"
            ],
            "summary": "Through economic booms and recessions, bull markets and bear markets, these resilient index funds have consistently made money for patient investors.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Economy - Fiscal",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999756"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.139933,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.044222",
                    "ticker_sentiment_score": "-0.181439",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.088309",
                    "ticker_sentiment_score": "-0.192141",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "HCSG",
                    "relevance_score": "0.044222",
                    "ticker_sentiment_score": "0.029705",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.044222",
                    "ticker_sentiment_score": "-0.181439",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.044222",
                    "ticker_sentiment_score": "-0.181439",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "These 2 Dow Stocks Moved Markets This Week",
            "url": "https://www.fool.com/investing/2023/10/21/these-2-dow-stocks-moved-markets-this-week/",
            "time_published": "20231021T102700",
            "authors": [
                "Dan Caplinger"
            ],
            "summary": "Bulls and bears alike looked closely at these two companies.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.858979"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.744043"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.196733,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.282234",
                    "ticker_sentiment_score": "0.238385",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TRMNF",
                    "relevance_score": "0.057628",
                    "ticker_sentiment_score": "0.110052",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AWON",
                    "relevance_score": "0.057628",
                    "ticker_sentiment_score": "-0.052162",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.171688",
                    "ticker_sentiment_score": "0.075518",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.436947",
                    "ticker_sentiment_score": "0.298936",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Intuitive Surgical's Revenue Dipped: Is It Time to Sell?",
            "url": "https://www.fool.com/investing/2023/10/21/intuitive-surgicals-revenue-dipped-is-it-time-to-s/",
            "time_published": "20231021T092700",
            "authors": [
                "Cory Renauer"
            ],
            "summary": "A stagnating top line isn't what investors want to see, but things might not be as bad as the surgical robot specialist's stock price performance would suggest.",
            "banner_image": "https://media.ycharts.com/charts/09f0b390f8557b76ff486827a070b862.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.891286"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.15853,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MDT",
                    "relevance_score": "0.274628",
                    "ticker_sentiment_score": "0.082722",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ISRG",
                    "relevance_score": "0.326643",
                    "ticker_sentiment_score": "0.297294",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.111747",
                    "ticker_sentiment_score": "0.027716",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Results from Phase 2 THOR-2 Study Show Improved Rates of Recurrence-Free Survival in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer with Select Fibroblast Growth Factor Receptor Alterations Treated with BALVERSA®  ( erdafitinib )  Versus Chemotherapy",
            "url": "https://www.prnewswire.com/news-releases/results-from-phase-2-thor-2-study-show-improved-rates-of-recurrence-free-survival-in-patients-with-high-risk-non-muscle-invasive-bladder-cancer-with-select-fibroblast-growth-factor-receptor-alterations-treated-with-balversa-erda-301963725.html",
            "time_published": "20231021T065800",
            "authors": [
                "Janssen Pharmaceutical Companies of Johnson & Johnson"
            ],
            "summary": "Results from Phase 2 THOR-2 Study Show Improved Rates of Recurrence-Free Survival in Patients with High-Risk Non ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/622202/Janssen_Biotech_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": -0.074457,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.099418",
                    "ticker_sentiment_score": "0.010968",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Stocks Struggle As Yields Soar; Tesla Tumbles: Weekly Review",
            "url": "https://www.investors.com/news/stock-market-struggles-as-treasury-yields-soar-tesla-nvidia-among-notable-losers/",
            "time_published": "20231020T154900",
            "authors": [
                "IBD STAFF",
                "Investor's Business Daily"
            ],
            "summary": "Stock Market Struggles As Treasury Yields Soar. Tesla, Nvidia ... Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2019/02/Stock-UpDownArrows-04-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.154552,
            "overall_sentiment_label": "Somewhat-Bearish",
            "ticker_sentiment": [
                {
                    "ticker": "ENPH",
                    "relevance_score": "0.044469",
                    "ticker_sentiment_score": "-0.304019",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "UAL",
                    "relevance_score": "0.044469",
                    "ticker_sentiment_score": "-0.263305",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "VMW",
                    "relevance_score": "0.088799",
                    "ticker_sentiment_score": "-0.101013",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AVGO",
                    "relevance_score": "0.044469",
                    "ticker_sentiment_score": "-0.09585",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TEX",
                    "relevance_score": "0.11087",
                    "ticker_sentiment_score": "-0.277675",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.044469",
                    "ticker_sentiment_score": "-0.064247",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SLB",
                    "relevance_score": "0.044469",
                    "ticker_sentiment_score": "0.163964",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SKXJF",
                    "relevance_score": "0.022243",
                    "ticker_sentiment_score": "-0.342954",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "DSKYF",
                    "relevance_score": "0.022243",
                    "ticker_sentiment_score": "-0.342954",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "STT",
                    "relevance_score": "0.044469",
                    "ticker_sentiment_score": "-0.079928",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABT",
                    "relevance_score": "0.044469",
                    "ticker_sentiment_score": "-0.064247",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.132855",
                    "ticker_sentiment_score": "-0.15922",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "UNP",
                    "relevance_score": "0.06666",
                    "ticker_sentiment_score": "-0.28162",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "LRCX",
                    "relevance_score": "0.044469",
                    "ticker_sentiment_score": "-0.048687",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.088799",
                    "ticker_sentiment_score": "0.032981",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.044469",
                    "ticker_sentiment_score": "0.069336",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IBKR",
                    "relevance_score": "0.044469",
                    "ticker_sentiment_score": "-0.068991",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.088799",
                    "ticker_sentiment_score": "-0.160615",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "TSM",
                    "relevance_score": "0.044469",
                    "ticker_sentiment_score": "-0.048687",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FSLR",
                    "relevance_score": "0.044469",
                    "ticker_sentiment_score": "-0.304019",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "LMT",
                    "relevance_score": "0.06666",
                    "ticker_sentiment_score": "-0.106722",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SEDG",
                    "relevance_score": "0.06666",
                    "ticker_sentiment_score": "-0.310714",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.044469",
                    "ticker_sentiment_score": "-0.359384",
                    "ticker_sentiment_label": "Bearish"
                },
                {
                    "ticker": "CAT",
                    "relevance_score": "0.044469",
                    "ticker_sentiment_score": "-0.219468",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.06666",
                    "ticker_sentiment_score": "0.117914",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AXP",
                    "relevance_score": "0.044469",
                    "ticker_sentiment_score": "0.347311",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SCHW",
                    "relevance_score": "0.06666",
                    "ticker_sentiment_score": "-0.070334",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ISRG",
                    "relevance_score": "0.044469",
                    "ticker_sentiment_score": "-0.263305",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Janssen Announces TREMFYA®  ( guselkumab )  Demonstrates Significant Skin Clearance in First-of-its-Kind Prospective, Large-Scale Study Dedicated to People of Color Living with Moderate to Severe Plaque Psoriasis",
            "url": "https://www.prnewswire.com/news-releases/janssen-announces-tremfya-guselkumab-demonstrates-significant-skin-clearance-in-first-of-its-kind-prospective-large-scale-study-dedicated-to-people-of-color-living-with-moderate-to-severe-plaque-psoriasis-301963282.html",
            "time_published": "20231020T142500",
            "authors": [
                "Janssen Pharmaceutical Companies of Johnson & Johnson"
            ],
            "summary": "Janssen Announces TREMFYA® ( guselkumab ) Demonstrates Significant Skin Clearance in First-of-its-Kind ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/2252793/Janssen_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": 0.045716,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.108222",
                    "ticker_sentiment_score": "0.006817",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "CVS Health pulls some cough-and-cold treatments with ingredient deemed ineffective by doctors",
            "url": "https://apnews.com/article/cvs-health-cold-medications-phenylephrine-c8953a17b8e404cfe9e4a37d76993dc4",
            "time_published": "20231020T142400",
            "authors": [
                "TOM MURPHY"
            ],
            "summary": "CVS pulls some cough, cold medicines containing phenylephrine off shelves The Associated Press ...",
            "banner_image": "https://dims.apnews.com/dims4/default/13114a5/2147483647/strip/true/crop/6908x4601+0+2/resize/599x399!/quality/90/?url=https%3A%2F%2Fassets.apnews.com%2Fbd%2F36%2F7f8d661e992d3aed5c9ebe63456c%2F7ee9b928a8a4419896e88c65af621d04",
            "source": "Associated Press",
            "category_within_source": "Markets",
            "source_domain": "apnews.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.106867,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "CVS",
                    "relevance_score": "0.445569",
                    "ticker_sentiment_score": "0.174389",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.117486",
                    "ticker_sentiment_score": "-0.078822",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Medical device makers see limited hit from weight-loss drugs",
            "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/medical-device-makers-see-limited-hit-weight-loss-drugs-2023-10-20/",
            "time_published": "20231020T141800",
            "authors": [
                "Reuters"
            ],
            "summary": "[1/2] Boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, is seen at a Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023. REUTERS/George Frey/File Photo Acquire Licensing Rights",
            "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/V6WKJ3BLKRML3BRCVWOIWT5H3M.jpg",
            "source": "Reuters",
            "category_within_source": "Business",
            "source_domain": "www.reuters.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.011811,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "ISRG",
                    "relevance_score": "0.078611",
                    "ticker_sentiment_score": "0.005137",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.078611",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.156461",
                    "ticker_sentiment_score": "-0.029172",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "First pill for dengue shows promise in human challenge trial",
            "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/first-pill-dengue-shows-promise-human-challenge-trial-2023-10-20/",
            "time_published": "20231020T081100",
            "authors": [
                "Jennifer Rigby"
            ],
            "summary": "[1/2] An assistant holds a test tube with an Aedes aegypti mosquito at the CNEA ( National Atomic Energy Commission ) , in Ezeiza, in the outskirts of Buenos Aires, Argentina April 12, 2023. REUTERS/Agustin Marcarian/File Photo Acquire Licensing Rights",
            "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/JPYRWVWGNBJDPDJJKTUFIEABKA.jpg",
            "source": "Reuters",
            "category_within_source": "Business",
            "source_domain": "www.reuters.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.091692,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.078354",
                    "ticker_sentiment_score": "0.013549",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Striving Together For A Thriving Industry, International Biopharma Industry Week Shanghai 2023 Opens",
            "url": "https://www.prnewswire.com/apac/news-releases/striving-together-for-a-thriving-industry-international-biopharma-industry-week-shanghai-2023-opens-301962953.html",
            "time_published": "20231020T072900",
            "authors": [
                "Shanghai Biomedical Industry Promotion Center"
            ],
            "summary": "SHANGHAI, Oct. 20, 2023 /PRNewswire/ -- On October 16th, the inaugural ceremony of the 2023 International Biopharma Industry Week Shanghai ( IBIWS 2023 ) unfolded at the Zhangjiang Science Hall in Shanghai.",
            "banner_image": "https://mma.prnewswire.com/media/2251946/1.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Blockchain",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.384066,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "GAHC",
                    "relevance_score": "0.019364",
                    "ticker_sentiment_score": "0.031713",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.019364",
                    "ticker_sentiment_score": "0.190474",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.019364",
                    "ticker_sentiment_score": "0.190474",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BSX",
                    "relevance_score": "0.019364",
                    "ticker_sentiment_score": "0.190474",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.019364",
                    "ticker_sentiment_score": "0.190474",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.019364",
                    "ticker_sentiment_score": "0.190474",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "StockNews.com Downgrades Johnson & Johnson  ( NYSE:JNJ )  to Buy",
            "url": "https://www.defenseworld.net/2023/10/20/stocknews-com-downgrades-johnson-johnson-nysejnj-to-buy.html",
            "time_published": "20231020T071042",
            "authors": [
                "Defense World Staff"
            ],
            "summary": "Johnson & Johnson ( NYSE:JNJ - Get Free Report ) was downgraded by equities research analysts at StockNews.com from a \"strong-buy\" rating to a \"buy\" rating in a research note issued on Wednesday.",
            "banner_image": "https://www.marketbeat.com/logos/johnson--johnson-logo.png?v=20221020135923",
            "source": "Stocknews.com",
            "category_within_source": "n/a",
            "source_domain": "www.defenseworld.net",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.961735"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.284244,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JPM",
                    "relevance_score": "0.043342",
                    "ticker_sentiment_score": "0.07623",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BCS",
                    "relevance_score": "0.043342",
                    "ticker_sentiment_score": "0.07623",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.722944",
                    "ticker_sentiment_score": "0.433559",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "KENVUE DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/kenvue-deadline-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-in-kenvue-to-contact-him-directly-to-discuss-their-options-301962696.html",
            "time_published": "20231020T004500",
            "authors": [],
            "summary": "KENVUE DEADLINE ALERT: Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.769861"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.495866"
                }
            ],
            "overall_sentiment_score": 0.156899,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.600121",
                    "ticker_sentiment_score": "0.021496",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GCT",
                    "relevance_score": "0.061003",
                    "ticker_sentiment_score": "0.208112",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.061003",
                    "ticker_sentiment_score": "0.093005",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Myopia Market to Grow at a Substantial Growth Rate During the Study Period  ( 2019-2032 ) , Predicts DelveInsight | Leading Companies - Nevakar, Vyluma, Bausch & Lomb, Sydnexis, Ocumension, ORA, LENZ Therapeutics",
            "url": "https://www.prnewswire.com/news-releases/myopia-market-to-grow-at-a-substantial-growth-rate-during-the-study-period-20192032-predicts-delveinsight--leading-companies---nevakar-vyluma-bausch--lomb-sydnexis-ocumension-ora-lenz-therapeutics-301961706.html",
            "time_published": "20231019T210100",
            "authors": [
                "LLP",
                "DelveInsight Business Research"
            ],
            "summary": "Myopia Market to Grow at a Substantial Growth Rate During the Study Period ( 2019-2032 ) , Predicts DelveInsight ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.187486,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ALC",
                    "relevance_score": "0.025406",
                    "ticker_sentiment_score": "0.183471",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BHC",
                    "relevance_score": "0.025406",
                    "ticker_sentiment_score": "0.183471",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "EYEN",
                    "relevance_score": "0.025406",
                    "ticker_sentiment_score": "0.001821",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNPHF",
                    "relevance_score": "0.025406",
                    "ticker_sentiment_score": "0.001821",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.050786",
                    "ticker_sentiment_score": "0.160348",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Invitae Appoints Dr. David Sholehvar as Chief Operating Officer",
            "url": "https://www.prnewswire.com/news-releases/invitae-appoints-dr-david-sholehvar-as-chief-operating-officer-301962415.html",
            "time_published": "20231019T203000",
            "authors": [
                "Invitae Corporation"
            ],
            "summary": "SAN FRANCISCO, Oct. 19, 2023 /PRNewswire/ -- ( NYSE: NVTA ) , a leading medical genetics company, today announced the appointment of veteran healthcare leader David Sholehvar, M.D., as chief operating officer, effective November 13, 2023.",
            "banner_image": "https://mma.prnewswire.com/media/268592/invitae_corporation_logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.967645"
                }
            ],
            "overall_sentiment_score": 0.236927,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "III",
                    "relevance_score": "0.046907",
                    "ticker_sentiment_score": "0.006971",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NEO",
                    "relevance_score": "0.046907",
                    "ticker_sentiment_score": "0.069965",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVTA",
                    "relevance_score": "0.555553",
                    "ticker_sentiment_score": "0.393547",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "DGX",
                    "relevance_score": "0.046907",
                    "ticker_sentiment_score": "0.006971",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.140076",
                    "ticker_sentiment_score": "0.008823",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kenvue Inc. - KVUE - Kenvue  ( NYSE:KVUE ) ",
            "url": "https://www.benzinga.com/pressreleases/23/10/g35338096/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-kenvue-inc-kvue",
            "time_published": "20231019T192006",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "NEW YORK, Oct. 19, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Kenvue Inc. ( \"Kenvue\" or the \"Company\" ) KVUE. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.77141"
                }
            ],
            "overall_sentiment_score": 0.021762,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.691995",
                    "ticker_sentiment_score": "0.011422",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.115787",
                    "ticker_sentiment_score": "0.021477",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Check Out What Whales Are Doing With JNJ - Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/markets/options/23/10/35336744/check-out-what-whales-are-doing-with-jnj",
            "time_published": "20231019T180141",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson JNJ we detected 13 strange trades. If we consider the specifics of each trade, it is accurate to state that 38% of the investors opened trades with ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.092407,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "BCS",
                    "relevance_score": "0.127456",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.800656",
                    "ticker_sentiment_score": "0.201565",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Global Atherosclerosis Drugs Market Is Projected To Reach $54.8 Billion In 2027 With A CAGR Of 3% As Per The Business Research Company's Atherosclerosis Drugs Global Market Report 2023",
            "url": "https://www.benzinga.com/pressreleases/23/10/g35333824/global-atherosclerosis-drugs-market-is-projected-to-reach-54-8-billion-in-2027-with-a-cagr-of-3-as",
            "time_published": "20231019T154500",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "LONDON, Oct. 19, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Atherosclerosis Drugs Global Market Report 2023, the global atherosclerosis drugs market is poised for significant growth in 2023, with a projected value of $48.72 billion, marking a steady Compound Annual Growth ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.244776,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "NVS",
                    "relevance_score": "0.062271",
                    "ticker_sentiment_score": "0.168113",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.062271",
                    "ticker_sentiment_score": "0.072345",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAYZF",
                    "relevance_score": "0.062271",
                    "ticker_sentiment_score": "0.072345",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.062271",
                    "ticker_sentiment_score": "0.072345",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.062271",
                    "ticker_sentiment_score": "0.072345",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Kenvue Inc.  ( KVUE )  - Kenvue  ( NYSE:KVUE ) ",
            "url": "https://www.benzinga.com/pressreleases/23/10/g35332113/glancy-prongay-murray-llp-reminds-investors-of-looming-deadline-in-the-class-action-lawsuit-agains",
            "time_published": "20231019T150000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "LOS ANGELES, Oct. 19, 2023 ( GLOBE NEWSWIRE ) -- Glancy Prongay & Murray LLP ( \"GPM\" ) reminds investors of the upcoming December 8, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Kenvue Inc. ( \"Kenvue\" or the ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.890401"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.858979"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.021733,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.612343",
                    "ticker_sentiment_score": "0.039842",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.062597",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.062597",
                    "ticker_sentiment_score": "0.086023",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Stock Market Erases Gains And Here Comes Powell; Tesla Stock Has This Problem",
            "url": "https://www.investors.com/market-trend/stock-market-today/stock-market-erases-gains-here-comes-powell-teslas-chart-becomes-deformed/",
            "time_published": "20231019T144700",
            "authors": [
                "JUAN CARLOS ARANCIBIA",
                "Investor's Business Daily"
            ],
            "summary": "Stock Market Erases Gains And Here Comes Powell. Tesla Stock ... Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2022/06/Stock-jeromepowell2022-03-gov.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.795202"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.055338,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.175009",
                    "ticker_sentiment_score": "0.326468",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.175009",
                    "ticker_sentiment_score": "-0.021979",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BX",
                    "relevance_score": "0.1172",
                    "ticker_sentiment_score": "-0.076821",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.1172",
                    "ticker_sentiment_score": "-0.089813",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.175009",
                    "ticker_sentiment_score": "0.012121",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LVS",
                    "relevance_score": "0.1172",
                    "ticker_sentiment_score": "0.244611",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.1172",
                    "ticker_sentiment_score": "-0.089813",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.1172",
                    "ticker_sentiment_score": "-0.089813",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Is Johnson & Johnson Still a Good Dividend Stock to Buy?",
            "url": "https://www.fool.com/investing/2023/10/19/is-johnson-johnson-still-a-good-dividend-stock-to/",
            "time_published": "20231019T105300",
            "authors": [
                "Cory Renauer"
            ],
            "summary": "Investors wonder if the healthcare giant can keep raising its payout now that it no longer sells the consumer health brands that made it famous.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F751378%2Finvestment-presentation2-getty.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.929393"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.986413"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.236748,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.24847",
                    "ticker_sentiment_score": "0.133909",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.063091",
                    "ticker_sentiment_score": "-0.073147",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.365166",
                    "ticker_sentiment_score": "0.307675",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Legal tech teams turn to AI to advance business goals",
            "url": "https://www.ft.com/content/9a117ac7-29ae-43fe-b840-a04005b98799",
            "time_published": "20231019T030041",
            "authors": [
                "Tom Saunders"
            ],
            "summary": "Our case studies highlight how the latest tools are helping speed up legal work ...",
            "banner_image": "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2F2b522128-177d-4e59-92b1-c6a29aa5e895.jpg?source=next-article&fit=scale-down&quality=highest&width=700&dpr=1",
            "source": "Financial Times",
            "category_within_source": "Companies",
            "source_domain": "www.ft.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.250548,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "INTA",
                    "relevance_score": "0.021369",
                    "ticker_sentiment_score": "0.023011",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.064047",
                    "ticker_sentiment_score": "0.121116",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TRI",
                    "relevance_score": "0.064047",
                    "ticker_sentiment_score": "0.098192",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DSSMY",
                    "relevance_score": "0.021369",
                    "ticker_sentiment_score": "0.121192",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.021369",
                    "ticker_sentiment_score": "0.072416",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Why Johnson & Johnson Stock Flopped Today",
            "url": "https://www.fool.com/investing/2023/10/18/why-johnson-johnson-stock-flopped-today/",
            "time_published": "20231018T214646",
            "authors": [
                "Eric Volkman"
            ],
            "summary": "Perhaps those third-quarter results weren't as impressive as they first appeared to be.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.153837,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.133841",
                    "ticker_sentiment_score": "0.057223",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.133841",
                    "ticker_sentiment_score": "-0.030552",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.76191",
                    "ticker_sentiment_score": "0.302456",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Positive Outlook On Johnson & Johnson's Partner Legend Biotech: Analyst Confident On Blood Cancer Drug - Legend Biotech  ( NASDAQ:LEGN ) ",
            "url": "https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35314510/positive-outlook-on-johnson-johnsons-partner-legend-biotech-analyst-confident-on-bl",
            "time_published": "20231018T184406",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Legend Biotech Corporation's LEGN partner, Johnson & Johnson JNJ, reported Q3 Carvykti revenues of $152 million, up 30% sequentially.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/18/legn.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.258632,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.288893",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LEGN",
                    "relevance_score": "0.421485",
                    "ticker_sentiment_score": "0.195274",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "The Virology Testing Market Is Expected To Grow At A CAGR Of More Than 9% With Growing Viral Infections Cases As Per The Business Research Company's Virology Testing Global Market Report 2023",
            "url": "https://www.benzinga.com/pressreleases/23/10/g35312142/the-virology-testing-market-is-expected-to-grow-at-a-cagr-of-more-than-9-with-growing-viral-infect",
            "time_published": "20231018T153000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "LONDON, Oct. 18, 2023 ( GLOBE NEWSWIRE ) -- The global virology testing market is experiencing significant growth, and the latest market report for 2023 by The Business Research Company reveals an industry poised for substantial expansion.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.26177,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.065327",
                    "ticker_sentiment_score": "0.115639",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TMO",
                    "relevance_score": "0.065327",
                    "ticker_sentiment_score": "0.115639",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "JNJ Beats Q3 Earnings Estimates, Raises View: ETFs in Focus",
            "url": "https://www.zacks.com/stock/news/2168098/jnj-beats-q3-earnings-estimates-raises-view-etfs-in-focus",
            "time_published": "20231018T140500",
            "authors": [
                "Sweta Killa"
            ],
            "summary": "The world's biggest healthcare products maker continued with its long streak of earnings beat and lifted the full year outlook.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/7d/1177.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999682"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.938238"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.240634,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.143987",
                    "ticker_sentiment_score": "0.150058",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.04823",
                    "ticker_sentiment_score": "0.288117",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.454714",
                    "ticker_sentiment_score": "0.370588",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "1 Warren Buffett Stock to Buy Hand Over Fist Right Now",
            "url": "https://www.fool.com/investing/2023/10/18/1-warren-buffett-stock-to-buy-hand-over-fist-right/",
            "time_published": "20231018T133000",
            "authors": [
                "George Budwell"
            ],
            "summary": "This blue-chip healthcare stock is a solid pick for investors in uncertain times.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F751287%2Fgrowth.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.413559"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.650727"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.223467,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.130926",
                    "ticker_sentiment_score": "0.15186",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.130926",
                    "ticker_sentiment_score": "-0.010115",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Is American Century U.S. Quality Value ETF  ( VALQ )  a Strong ETF Right Now?",
            "url": "https://www.zacks.com/stock/news/2167684/is-american-century-us-quality-value-etf-valq-a-strong-etf-right-now",
            "time_published": "20231018T102006",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Smart Beta ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default44.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.289018,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.114682",
                    "ticker_sentiment_score": "0.04541",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GILD",
                    "relevance_score": "0.114682",
                    "ticker_sentiment_score": "0.04541",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.114682",
                    "ticker_sentiment_score": "0.04541",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Is the \"New\" Johnson & Johnson Stock a Buy With Its Improved Profit Outlook?",
            "url": "https://www.fool.com/investing/2023/10/18/is-the-new-johnson-johnson-stock-a-buy-with-its-im/",
            "time_published": "20231018T095100",
            "authors": [
                "Keith Speights"
            ],
            "summary": "Some things are different about J&J. But other things remain the same as they've been for a long time.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.316726"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.95493"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.229228,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.225425",
                    "ticker_sentiment_score": "0.259152",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.057079",
                    "ticker_sentiment_score": "-0.039002",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.569063",
                    "ticker_sentiment_score": "0.373567",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Johnson & Johnson's Sharper Focus Is Already Paying Dividends for Investors",
            "url": "https://www.fool.com/investing/2023/10/17/johnson-johnsons-sharper-focus-is-already-paying-d/",
            "time_published": "20231017T200000",
            "authors": [
                "Matthew DiLallo"
            ],
            "summary": "The healthcare behemoth reported strong earnings after separating its consumer health division.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F751288%2Fjnj_sankey_q32023.png&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999892"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.42835,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.47452",
                    "ticker_sentiment_score": "0.55085",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.366061",
                    "ticker_sentiment_score": "0.528137",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Back for Another Round: Rate Hike Fears Grow After Strong Retail Sales Sends Yields Spinning Higher - Bank of America  ( NYSE:BAC ) , American Airlines Group  ( NASDAQ:AAL ) ",
            "url": "https://www.benzinga.com/markets/23/10/35295882/back-for-another-round-rate-hike-fears-grow-after-strong-retail-sales-sends-yields-spinning-higher",
            "time_published": "20231017T183803",
            "authors": [
                "Schwab Center for Financial Research"
            ],
            "summary": "( Tuesday market open ) Early earnings results continued to impress but major indexes flagged in premarket trading Tuesday as Treasury yields swung higher after unexpectedly strong September U.S. Retail Sales raised concerns about another possible rate hike.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/17/shutterstock_732185581.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.838487"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999999"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999992"
                },
                {
                    "topic": "Economy - Macro",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.05773,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.109789",
                    "ticker_sentiment_score": "0.035084",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WHR",
                    "relevance_score": "0.0367",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UAL",
                    "relevance_score": "0.0367",
                    "ticker_sentiment_score": "-0.055195",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.091579",
                    "ticker_sentiment_score": "0.070621",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.0367",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VZ",
                    "relevance_score": "0.0367",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GM",
                    "relevance_score": "0.0367",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.0367",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.055025",
                    "ticker_sentiment_score": "0.056",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TXN",
                    "relevance_score": "0.0367",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAL",
                    "relevance_score": "0.073321",
                    "ticker_sentiment_score": "-0.049662",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.073321",
                    "ticker_sentiment_score": "0.125822",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TD",
                    "relevance_score": "0.109789",
                    "ticker_sentiment_score": "-0.019899",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LMT",
                    "relevance_score": "0.055025",
                    "ticker_sentiment_score": "0.131341",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.109789",
                    "ticker_sentiment_score": "0.001097",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RF",
                    "relevance_score": "0.0367",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNP",
                    "relevance_score": "0.073321",
                    "ticker_sentiment_score": "-0.049662",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "V",
                    "relevance_score": "0.0367",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.0367",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AXP",
                    "relevance_score": "0.0367",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SCHW",
                    "relevance_score": "0.055025",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PM",
                    "relevance_score": "0.0367",
                    "ticker_sentiment_score": "-0.026276",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GE",
                    "relevance_score": "0.0367",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johnson & Johnson's Q3 2023: $21.3B Rise In Sales, 'Sharpened Focus' On Innovation & Biotech Solutions - Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/markets/cannabis/23/10/35295397/johnson-johnsons-q3-2023-21-3b-rise-in-sales-sharpened-focus-on-innovation-biotech-solutions",
            "time_published": "20231017T182846",
            "authors": [
                "Lara Goldstein"
            ],
            "summary": "Healthcare company Johnson & Johnson ( J&J ) JNJ shared its financial outcomes for the third quarter of 2023, reflecting: Total reported sales of $21,351 million, a 6.8% increase compared to the same period in 2022.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/17/company_earnings_commons_-_pexels.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.380922,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.252987",
                    "ticker_sentiment_score": "0.424436",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Johnson & Johnson's Q3 2023: $21.3B Rise In Sales, 'Sharpened Focus' On Innovation & Biotech Solutions - Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/markets/cannabis/23/10/35295397/johnson-johnsons-q3-2023-21-3b-in-sales-sharpened-focus-on-innovation-biotech-solutions",
            "time_published": "20231017T182844",
            "authors": [
                "Lara Goldstein"
            ],
            "summary": "Healthcare company Johnson & Johnson ( J&J ) JNJ shared its financial outcomes for the third quarter of 2023, reflecting: Total reported sales of $21,351 million, a 6.8% increase compared to the same period in 2022.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/17/company_earnings_commons_-_pexels.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.380922,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.252987",
                    "ticker_sentiment_score": "0.424436",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "US Stock Futures Slide As Traders Look Past Positive Earnings News Flow; Analysts Predict Year-End Rally And Strong 2024 Ahead - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , United Airlines Holdings  ( NASDAQ:UAL ) , Lockheed Martin  ( NYSE:LMT ) , Bank of America  ( NYSE:BAC ) ",
            "url": "https://www.benzinga.com/23/10/35284350/us-stock-futures-slide-as-traders-look-past-positive-earnings-news-flow-analysts-predict-year-end-ra",
            "time_published": "20231017T174627",
            "authors": [
                "Shanthi Rexaline"
            ],
            "summary": "The market mood has turned somber on Tuesday, signaling that stocks could reverse some of the upside seen in the previous session. The bond yields have resumed their climb, with the 10-year U.S. Treasury note yield back above 4.7%, reflecting investor fears concerning further rate hikes.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/Stocks_Photo_by_Pixels_Hunter_on_Shutterstock_19.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.682689"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.99676"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.928139"
                }
            ],
            "overall_sentiment_score": 0.073847,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "UAL",
                    "relevance_score": "0.091684",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LMT",
                    "relevance_score": "0.091684",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.091684",
                    "ticker_sentiment_score": "0.022606",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.045918",
                    "ticker_sentiment_score": "0.198223",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ACI",
                    "relevance_score": "0.091684",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.091684",
                    "ticker_sentiment_score": "0.022606",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VSAT",
                    "relevance_score": "0.091684",
                    "ticker_sentiment_score": "0.208992",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BK",
                    "relevance_score": "0.091684",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.091684",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.045918",
                    "ticker_sentiment_score": "0.062917",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WT",
                    "relevance_score": "0.045918",
                    "ticker_sentiment_score": "0.084505",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johnson & Johnson  ( JNJ )  Q3 2023 Earnings Call Transcript",
            "url": "https://www.fool.com/earnings/call-transcripts/2023/10/17/johnson-johnson-jnj-q3-2023-earnings-call-transcri/",
            "time_published": "20231017T173022",
            "authors": [
                "Motley Fool Transcribing"
            ],
            "summary": "JNJ earnings call for the period ending September 30, 2023.",
            "banner_image": "https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999981"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.314238,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "GVHIB",
                    "relevance_score": "0.004444",
                    "ticker_sentiment_score": "0.139057",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BCS",
                    "relevance_score": "0.004444",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.004444",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.004444",
                    "ticker_sentiment_score": "0.107129",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.004444",
                    "ticker_sentiment_score": "0.113962",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.057724",
                    "ticker_sentiment_score": "0.126025",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.031102",
                    "ticker_sentiment_score": "0.093173",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AWON",
                    "relevance_score": "0.004444",
                    "ticker_sentiment_score": "0.101192",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.004444",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johnson & Johnson Was Saved By Its Focus On MedTech And Innovative Medicine - Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/23/10/35294426/johnson-johnson-was-saved-by-its-focus-on-medtech-and-innovative-medicine",
            "time_published": "20231017T171616",
            "authors": [
                "Upwallstreet"
            ],
            "summary": "Johnson & Johnson JNJ reported its third quarter results that topped Wall Street's expectations while also lifting its full year guidance fueled by a strong performance of its pharmaceutical and medical devices businesses.",
            "banner_image": "https://cdn.benzinga.com/files/medical-banner-with-doctor-wearing-goggles.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.947132"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.495866"
                }
            ],
            "overall_sentiment_score": 0.079845,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.088147",
                    "ticker_sentiment_score": "-0.048514",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.21803",
                    "ticker_sentiment_score": "0.080228",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.21803",
                    "ticker_sentiment_score": "-0.077784",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.342093",
                    "ticker_sentiment_score": "-0.007579",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "J&J  ( JNJ )  Beats Q3 Earnings & Sales Estimates Post Spin-Off",
            "url": "https://www.zacks.com/stock/news/2167442/jj-jnj-beats-q3-earnings-sales-estimates-post-spin-off",
            "time_published": "20231017T163200",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "J&J (JNJ) beats estimates for third-quarter earnings and sales. It raises full-year sales and earnings guidance.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/6c/385.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.94762"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999965"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.360215"
                }
            ],
            "overall_sentiment_score": 0.148882,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.14947",
                    "ticker_sentiment_score": "0.058046",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AUPH",
                    "relevance_score": "0.14947",
                    "ticker_sentiment_score": "0.089732",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MEIP",
                    "relevance_score": "0.060085",
                    "ticker_sentiment_score": "0.066999",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.090021",
                    "ticker_sentiment_score": "0.057932",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Baby Care Products Market to Touch USD 163.4 billion by 2031, Recording a CAGR of 6.2% | Report by Transparency Market Research",
            "url": "https://www.benzinga.com/pressreleases/23/10/g35291856/baby-care-products-market-to-touch-usd-163-4-billion-by-2031-recording-a-cagr-of-6-2-report-by-tra",
            "time_published": "20231017T153000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "Wilmington, Delaware, United States, Oct. 17, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global baby care products market is projected to flourish at a CAGR of 6.2% from 2021 to 2031. As per the report published by TMR, a valuation of US$ 163.4 billion is anticipated for ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.411007,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KMB",
                    "relevance_score": "0.047465",
                    "ticker_sentiment_score": "0.231866",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.047465",
                    "ticker_sentiment_score": "0.231866",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.047465",
                    "ticker_sentiment_score": "0.231866",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "STERIS'  ( STE )  Improved Volume, New Buyouts Drive Growth",
            "url": "https://www.zacks.com/stock/news/2167341/steris-ste-improved-volume-new-buyouts-drive-growth",
            "time_published": "20231017T151700",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "On the capital equipment side for STERIS (STE), the easing of supply-chain issues and reduced lead times are boosting shipments.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/4c/2710.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.9545"
                }
            ],
            "overall_sentiment_score": 0.285607,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KMB",
                    "relevance_score": "0.060694",
                    "ticker_sentiment_score": "0.074052",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "STE",
                    "relevance_score": "0.553595",
                    "ticker_sentiment_score": "0.389146",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "BSX",
                    "relevance_score": "0.060694",
                    "ticker_sentiment_score": "0.074052",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.060694",
                    "ticker_sentiment_score": "0.074052",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CAH",
                    "relevance_score": "0.180685",
                    "ticker_sentiment_score": "0.077305",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ALGN",
                    "relevance_score": "0.121037",
                    "ticker_sentiment_score": "0.062323",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HAE",
                    "relevance_score": "0.180685",
                    "ticker_sentiment_score": "0.101069",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ECL",
                    "relevance_score": "0.060694",
                    "ticker_sentiment_score": "0.074052",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Dow Jones Flat As Hot Data, Yields Weigh In; Tesla Falls On Fresh Recall",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-falls-as-hot-data-yields-spook-stocks-tesla-falls-on-fresh-recall/",
            "time_published": "20231017T151600",
            "authors": [
                "VIDYA RAMAKRISHNAN",
                "Investor's Business Daily"
            ],
            "summary": "Dow Jones Flat As Hot Data, Yields Weigh In. Tesla Falls On Fresh ... Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2016/06/ECON03_retail_061716_adobe.jpeg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999491"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999483"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.166667"
                }
            ],
            "overall_sentiment_score": 0.057734,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "UAL",
                    "relevance_score": "0.104683",
                    "ticker_sentiment_score": "0.132669",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VMW",
                    "relevance_score": "0.104683",
                    "ticker_sentiment_score": "0.058252",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CHH",
                    "relevance_score": "0.104683",
                    "ticker_sentiment_score": "0.160923",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "FRO",
                    "relevance_score": "0.104683",
                    "ticker_sentiment_score": "0.125072",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IBKR",
                    "relevance_score": "0.104683",
                    "ticker_sentiment_score": "0.132669",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AVGO",
                    "relevance_score": "0.104683",
                    "ticker_sentiment_score": "0.058252",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.104683",
                    "ticker_sentiment_score": "0.180514",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.104683",
                    "ticker_sentiment_score": "0.131785",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GSHD",
                    "relevance_score": "0.104683",
                    "ticker_sentiment_score": "0.125072",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.104683",
                    "ticker_sentiment_score": "-0.05719",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LMT",
                    "relevance_score": "0.104683",
                    "ticker_sentiment_score": "-0.005626",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.257805",
                    "ticker_sentiment_score": "-0.075043",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LBRT",
                    "relevance_score": "0.104683",
                    "ticker_sentiment_score": "0.125072",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Economic News Is More Important Than Earnings Right Now",
            "url": "https://realmoney.thestreet.com/investing/economic-news-is-more-important-than-earnings-right-now-16135714",
            "time_published": "20231017T151000",
            "authors": [
                "James \"Rev Shark\" DePorre"
            ],
            "summary": "Retail sales numbers were much higher than expected, and all six of the major earnings reports this morning beat on both revenues and EPS. That sounds like a catalyst for a positive market reaction, but what we are seeing is some very strong rotation out of the big-cap technology names and into ...",
            "banner_image": "http://s.thestreet.com/files/tsc/v2008/photos/contrib/uploads/64c5278a-ef5d-11e9-848d-857b1f6a04de.jpg",
            "source": "The Street",
            "category_within_source": "GoogleRSS",
            "source_domain": "realmoney.thestreet.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.714479"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.176295,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ACMR",
                    "relevance_score": "0.279015",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.279015",
                    "ticker_sentiment_score": "0.481203",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "RELY",
                    "relevance_score": "0.279015",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.279015",
                    "ticker_sentiment_score": "0.481203",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Retail Sales Increased More Than Expected",
            "url": "https://www.zacks.com/stock/news/2167321/retail-sales-increased-more-than-expected",
            "time_published": "20231017T145400",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "This morning we see new Retail Sales numbers for September, and they have come in hotter than expected: headline +0.7% month over month is 50 basis points ( bps ) higher than expected, though down 10 bps from the upwardly revised +0.8% in August.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/92/476.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.918141"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.173399,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BAC",
                    "relevance_score": "0.156461",
                    "ticker_sentiment_score": "0.145925",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.156461",
                    "ticker_sentiment_score": "0.211613",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.156461",
                    "ticker_sentiment_score": "0.155728",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "This 'Boring' Market Is Our Key To 10% Dividend Payouts",
            "url": "https://www.forbes.com/sites/michaelfoster/2023/10/17/this-boring-market-is-our-key-to-10-dividend-payouts/",
            "time_published": "20231017T143500",
            "authors": [
                "Michael Foster"
            ],
            "summary": "The \"boring\" truth is that what we've been seeing is nothing more than a transition from a panicked market to a more normal one.",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/65295bb345ea73cf6ecdaaa8/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
            "source": "Forbes",
            "category_within_source": "Markets",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.684621"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Economy - Macro",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.103817,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.085476",
                    "ticker_sentiment_score": "0.073844",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.085476",
                    "ticker_sentiment_score": "0.073844",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.0428",
                    "ticker_sentiment_score": "0.070217",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.085476",
                    "ticker_sentiment_score": "0.073844",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Retail Sales Hotter at +0.7%; JNJ, BAC, GS All Beat in Q3",
            "url": "https://www.zacks.com/stock/news/2167302/retail-sales-hotter-at-07-jnj-bac-gs-all-beat-in-q3",
            "time_published": "20231017T143200",
            "authors": [
                "Mark Vickery"
            ],
            "summary": "Retail Sales infer a consumer willing to spend, and the outlook for Q3 GDP is likely up somewhat on this news.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/ab/505.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.918141"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.838487"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.163949,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BAC",
                    "relevance_score": "0.147818",
                    "ticker_sentiment_score": "0.149788",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.220141",
                    "ticker_sentiment_score": "0.197845",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.147818",
                    "ticker_sentiment_score": "0.149788",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johnson & Johnson lifts profit outlook on strong demand for top-seller Stelara",
            "url": "https://www.foxbusiness.com/markets/johnson-johnson-lifts-profit-outlook-strong-demand-top-seller-stelara",
            "time_published": "20231017T140450",
            "authors": [
                "Reuters"
            ],
            "summary": "Johnson & Johnson raised its 2023 profit forecast in its first earnings report since spinning off its consumer health business, with the company's fortunes now tied more closely to sales of blockbusters like its arthritis drug Stelara. The company's shares were up about 2% in premarket trading on ...",
            "banner_image": "https://cf-images.us-east-1.prod.boltdns.net/v1/static/854081161001/c757b7f7-5a24-4e53-86bd-eaafafd5dd2c/8d4419ea-3121-4536-ac3a-ad66e049ed58/1280x720/match/image.jpg",
            "source": "Fox Business News",
            "category_within_source": "n/a",
            "source_domain": "www.foxbusiness.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.495866"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.224422,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "GS",
                    "relevance_score": "0.07913",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.07913",
                    "ticker_sentiment_score": "0.059833",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.234307",
                    "ticker_sentiment_score": "0.137139",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johnson & Johnson Is Falling, but This Tech Stock Is Really Getting Hit Hard",
            "url": "https://www.fool.com/investing/2023/10/17/johnson-johnson-is-falling-but-this-tech-stock-is/",
            "time_published": "20231017T140022",
            "authors": [
                "Dan Caplinger"
            ],
            "summary": "Earnings season is starting to ramp up.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.904684"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.09105,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "VMW",
                    "relevance_score": "0.272788",
                    "ticker_sentiment_score": "0.028618",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AVGO",
                    "relevance_score": "0.138464",
                    "ticker_sentiment_score": "0.040791",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.399204",
                    "ticker_sentiment_score": "0.251898",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Top 10 things to watch in the stock market Tuesday",
            "url": "https://www.cnbc.com/2023/10/17/top-10-things-to-watch-in-the-stock-market-tuesday.html",
            "time_published": "20231017T131108",
            "authors": [
                "Jeff Marks"
            ],
            "summary": "U.S. stocks are set to open lower on Tuesday as bond yields rise.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/107305168-1695391812680-gettyimages-1695425858-aca0db9d-1d95-4527-96d5-ebd4634e0c63.jpeg?v=1697548268&w=1920&h=1080",
            "source": "CNBC",
            "category_within_source": "Top News",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999499"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.891286"
                }
            ],
            "overall_sentiment_score": 0.170587,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.121037",
                    "ticker_sentiment_score": "0.099945",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.121037",
                    "ticker_sentiment_score": "0.144598",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DLTR",
                    "relevance_score": "0.121037",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.180685",
                    "ticker_sentiment_score": "0.026503",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.121037",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.180685",
                    "ticker_sentiment_score": "-0.008753",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TCTZF",
                    "relevance_score": "0.060694",
                    "ticker_sentiment_score": "0.088002",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LIN",
                    "relevance_score": "0.121037",
                    "ticker_sentiment_score": "0.239303",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LMT",
                    "relevance_score": "0.121037",
                    "ticker_sentiment_score": "0.070446",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "APD",
                    "relevance_score": "0.121037",
                    "ticker_sentiment_score": "0.239303",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "EBAY",
                    "relevance_score": "0.060694",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ETSY",
                    "relevance_score": "0.121037",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.180685",
                    "ticker_sentiment_score": "0.244074",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "W",
                    "relevance_score": "0.121037",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.121037",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CART",
                    "relevance_score": "0.121037",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PANW",
                    "relevance_score": "0.121037",
                    "ticker_sentiment_score": "-0.082887",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "J&J Raises Outlook As Health Bellwether Tries To Reinvent Itself",
            "url": "https://www.investors.com/news/technology/jnj-stock-johnson-johnson-earnings-q3-2023/",
            "time_published": "20231017T130500",
            "authors": [
                "Investor's Business Daily",
                "ALLISON GATLIN"
            ],
            "summary": "JNJ Stock: Health Care Bellwether Boosts Outlook As It Refocuses ... Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2021/01/Stock-JohnsonAndJohnson-syringe-shut.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.682689"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.918141"
                }
            ],
            "overall_sentiment_score": 0.327439,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.303175",
                    "ticker_sentiment_score": "0.368734",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "MRNA",
                    "relevance_score": "0.154455",
                    "ticker_sentiment_score": "0.018124",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.154455",
                    "ticker_sentiment_score": "0.018124",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BNTX",
                    "relevance_score": "0.154455",
                    "ticker_sentiment_score": "0.018124",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.880871",
                    "ticker_sentiment_score": "0.573042",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Stock market today: Wall Street inches back as war in the Middle East hangs over markets",
            "url": "https://apnews.com/article/stock-markets-earnings-china-war-69e60cda4b5adde06417e5822870837d",
            "time_published": "20231017T121400",
            "authors": [
                "MATT OTT",
                "ELAINE KURTENBACH"
            ],
            "summary": "Wall Street pointed toward losses early Tuesday as corporate earnings roll in and worries about war in the Middle East hang over markets. Futures for the S&P 500 and Dow industrials slipped 0.2% before the bell. In addition to another heavy slate of quarterly earnings, the U.S. will release ...",
            "banner_image": "https://dims.apnews.com/dims4/default/46893e0/2147483647/strip/true/crop/4162x2772+0+1/resize/599x399!/quality/90/?url=https%3A%2F%2Fassets.apnews.com%2Fb2%2F8b%2F9730f2c49f858bb9797944f27631%2Fa09381e771a34a2c80cdd8bac55fb3b7",
            "source": "Associated Press",
            "category_within_source": "Markets",
            "source_domain": "apnews.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.769861"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": -0.143879,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "WH",
                    "relevance_score": "0.06211",
                    "ticker_sentiment_score": "-0.13005",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CHH",
                    "relevance_score": "0.06211",
                    "ticker_sentiment_score": "-0.13005",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.06211",
                    "ticker_sentiment_score": "0.164097",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.06211",
                    "ticker_sentiment_score": "0.170637",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.06211",
                    "ticker_sentiment_score": "0.164097",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "FOREX:JPY",
                    "relevance_score": "0.123844",
                    "ticker_sentiment_score": "-0.156444",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "FOREX:EUR",
                    "relevance_score": "0.06211",
                    "ticker_sentiment_score": "-0.136057",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:USD",
                    "relevance_score": "0.06211",
                    "ticker_sentiment_score": "-0.136057",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "The daily business briefing: October 17, 2023",
            "url": "https://theweek.com/business/the-daily-business-briefing-october-17-2023",
            "time_published": "20231017T115616",
            "authors": [
                "The Week US",
                "Harold Maass"
            ],
            "summary": "2. Lululemon shares jump after joining S&P 500 3. Stock futures struggle as earnings season picks up 4. China tells banks to ease municipal debt burdens 5. Survey says shoppers expect to spend more this year",
            "banner_image": "https://cdn.mos.cms.futurecdn.net/xHpwKWhfea6hE9SwMmaAmG-415-80.jpg",
            "source": "The Week News",
            "category_within_source": "n/a",
            "source_domain": "theweek.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.904684"
                }
            ],
            "overall_sentiment_score": -0.021761,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "BAC",
                    "relevance_score": "0.033236",
                    "ticker_sentiment_score": "0.028903",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.033236",
                    "ticker_sentiment_score": "0.028903",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.033236",
                    "ticker_sentiment_score": "0.028903",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.033236",
                    "ticker_sentiment_score": "0.028903",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOX",
                    "relevance_score": "0.033236",
                    "ticker_sentiment_score": "0.052537",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.099476",
                    "ticker_sentiment_score": "0.018281",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FRNWF",
                    "relevance_score": "0.033236",
                    "ticker_sentiment_score": "0.055383",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LULU",
                    "relevance_score": "0.033236",
                    "ticker_sentiment_score": "0.060135",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LMT",
                    "relevance_score": "0.033236",
                    "ticker_sentiment_score": "0.028903",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RAD",
                    "relevance_score": "0.033236",
                    "ticker_sentiment_score": "-0.177258",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "XOM",
                    "relevance_score": "0.033236",
                    "ticker_sentiment_score": "-0.1139",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ATVI",
                    "relevance_score": "0.099476",
                    "ticker_sentiment_score": "0.072698",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SCHW",
                    "relevance_score": "0.033236",
                    "ticker_sentiment_score": "0.028903",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BIRK",
                    "relevance_score": "0.033236",
                    "ticker_sentiment_score": "-0.10993",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "New Johnson & Johnson's Q3 Earnings Beat Street View, Raises Annual Outlook - Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/general/biotech/23/10/35283724/new-johnson-johnsons-q3-earnings-beat-street-view-raises-annual-outlook",
            "time_published": "20231017T115326",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Johnson & Johnson JNJ has reported Q3 FY23 adjusted earnings of $2.66 per share, up 19.3% Y/Y and beating the consensus of $2.51. Sales increased 6.8% to $21.35 billion, beating the consensus of $21.04 billion, with operational growth of 7.5 and adjusted operational growth of 6.4%.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/17/jnjioffice3.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.222662,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.345674",
                    "ticker_sentiment_score": "0.518292",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.82082",
                    "ticker_sentiment_score": "0.504831",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Johnson & Johnson  ( JNJ )  Q3 Earnings and Revenues Surpass Estimates",
            "url": "https://www.zacks.com/stock/news/2166934/johnson-johnson-jnj-q3-earnings-and-revenues-surpass-estimates",
            "time_published": "20231017T114002",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Johnson & Johnson (JNJ) delivered earnings and revenue surprises of 5.56% and 1.67%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default138.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999997"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                }
            ],
            "overall_sentiment_score": 0.150803,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "PFE",
                    "relevance_score": "0.136888",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.395012",
                    "ticker_sentiment_score": "0.1105",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Tupperware Brands Announces CEO Transition and Board Refreshment - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/tupperware-brands-announces-ceo-transition-and-board-refreshment-301958827.html",
            "time_published": "20231017T113000",
            "authors": [],
            "summary": "Tupperware Brands Announces CEO Transition and Board Refreshment PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                }
            ],
            "overall_sentiment_score": 0.276926,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "META",
                    "relevance_score": "0.028937",
                    "ticker_sentiment_score": "0.192135",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.028937",
                    "ticker_sentiment_score": "0.010123",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RAD",
                    "relevance_score": "0.028937",
                    "ticker_sentiment_score": "-0.006524",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSMRF",
                    "relevance_score": "0.028937",
                    "ticker_sentiment_score": "0.023681",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HLX",
                    "relevance_score": "0.028937",
                    "ticker_sentiment_score": "0.033406",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "EVRG",
                    "relevance_score": "0.028937",
                    "ticker_sentiment_score": "-0.006524",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.028937",
                    "ticker_sentiment_score": "0.023681",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "EWCZ",
                    "relevance_score": "0.028937",
                    "ticker_sentiment_score": "0.010123",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WEWOW",
                    "relevance_score": "0.028937",
                    "ticker_sentiment_score": "-0.006524",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ICNB",
                    "relevance_score": "0.028937",
                    "ticker_sentiment_score": "0.310522",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NUS",
                    "relevance_score": "0.028937",
                    "ticker_sentiment_score": "0.023681",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TUP",
                    "relevance_score": "0.228341",
                    "ticker_sentiment_score": "0.225119",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Invest in millennials and these 'one-in-a-lifetime opportunity' stocks, says this fund manager",
            "url": "https://www.marketwatch.com/story/invest-in-millennials-and-these-one-in-a-lifetime-opportunity-stocks-says-this-fund-manager-cc5420c4",
            "time_published": "20231017T105200",
            "authors": [
                "Barbara Kollmeyer"
            ],
            "summary": "Our call of the day offers bargains among energy and stocks catering to future millennial spending.",
            "banner_image": "https://images.mktw.net/im-869859?width=700&height=479",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.989041"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.614606"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.112337,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "OXY",
                    "relevance_score": "0.082111",
                    "ticker_sentiment_score": "0.183155",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.082111",
                    "ticker_sentiment_score": "0.043497",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "COP",
                    "relevance_score": "0.082111",
                    "ticker_sentiment_score": "0.183155",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.082111",
                    "ticker_sentiment_score": "0.043497",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AXP",
                    "relevance_score": "0.082111",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BK",
                    "relevance_score": "0.082111",
                    "ticker_sentiment_score": "0.043497",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UHAL",
                    "relevance_score": "0.082111",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IDIG",
                    "relevance_score": "0.04111",
                    "ticker_sentiment_score": "0.061061",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.122894",
                    "ticker_sentiment_score": "0.038629",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CRYPTO:BTC",
                    "relevance_score": "0.04111",
                    "ticker_sentiment_score": "0.153649",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Johnson & Johnson beats on earnings and hikes outlook as medtech, pharmaceutical sales surge",
            "url": "https://www.cnbc.com/2023/10/17/johnson-johnson-jnj-q3-earnings-report-2023.html",
            "time_published": "20231017T102515",
            "authors": [
                "Annika Kim Constantino"
            ],
            "summary": "It marks J&J's first quarterly results since the company completed the separation from its consumer health spinoff Kenvue in August.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/106974803-1636726862899-gettyimages-1164570932-AFP_1JU2A3.jpeg?v=1697538315&w=1920&h=1080",
            "source": "CNBC",
            "category_within_source": "Business",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.947132"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.112428,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.255641",
                    "ticker_sentiment_score": "-0.151979",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.129516",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "J&J raises annual profit forecast on anti-inflammatory drug demand",
            "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/jj-raises-annual-profit-forecast-strong-cancer-drug-demand-2023-10-17/",
            "time_published": "20231017T102457",
            "authors": [
                "Reuters"
            ],
            "summary": "The logo of Johnson & Johnson is seen on a Brussels' office of the company in Diegem, Belgium September 21, 2023. REUTERS/Yves Herman/File Photo Acquire Licensing Rights",
            "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/XJJTNMLU6FPZLDD3S7GYM3JVWU.jpg",
            "source": "Reuters",
            "category_within_source": "Business",
            "source_domain": "www.reuters.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.340601,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.591019",
                    "ticker_sentiment_score": "0.385262",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Genmab Announces Net Sales of DARZALEX®  ( daratumumab )  for Third Quarter of 2023",
            "url": "https://www.globenewswire.com/news-release/2023/10/17/2761310/0/en/Genmab-Announces-Net-Sales-of-DARZALEX-daratumumab-for-Third-Quarter-of-2023.html",
            "time_published": "20231017T102200",
            "authors": [
                "Genmab A/S"
            ],
            "summary": "Company Announcement ...",
            "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.050362,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "GMAB",
                    "relevance_score": "0.665529",
                    "ticker_sentiment_score": "0.093273",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.127795",
                    "ticker_sentiment_score": "0.011568",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Morning Bid: Banks, Biden visit buoy markets",
            "url": "https://www.reuters.com/markets/us/global-markets-view-usa-2023-10-17/",
            "time_published": "20231017T100100",
            "authors": [
                "Reuters"
            ],
            "summary": "Traders work on the floor of the New York Stock Exchange ( NYSE ) in New York City, U.S., August 15, 2023. REUTERS/Brendan McDermid/File Photo Acquire Licensing Rights A look at the day ahead in U.S. and global markets from Mike Dolan",
            "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/UQEJIZSJ4FLI7JVPW2KKX7XCDY.jpg",
            "source": "Reuters",
            "category_within_source": "Markets",
            "source_domain": "www.reuters.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.972756"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.682689"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.2"
                }
            ],
            "overall_sentiment_score": 0.028984,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "UAL",
                    "relevance_score": "0.04794",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LMT",
                    "relevance_score": "0.04794",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "C",
                    "relevance_score": "0.04794",
                    "ticker_sentiment_score": "0.128815",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.095707",
                    "ticker_sentiment_score": "0.088196",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OMC",
                    "relevance_score": "0.04794",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.04794",
                    "ticker_sentiment_score": "0.128815",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.04794",
                    "ticker_sentiment_score": "0.128815",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.04794",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BK",
                    "relevance_score": "0.095707",
                    "ticker_sentiment_score": "0.088196",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PLD",
                    "relevance_score": "0.04794",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SCHW",
                    "relevance_score": "0.04794",
                    "ticker_sentiment_score": "0.325955",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.095707",
                    "ticker_sentiment_score": "0.088196",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:GBP",
                    "relevance_score": "0.04794",
                    "ticker_sentiment_score": "0.099001",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:USD",
                    "relevance_score": "0.04794",
                    "ticker_sentiment_score": "0.147003",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "S&P 500 futures drift as Goldman Sachs and Bank of America earnings awaited",
            "url": "https://www.marketwatch.com/story/s-p-500-futures-drift-as-goldman-sachs-and-bank-of-america-earnings-awaited-dfd86d7b",
            "time_published": "20231017T085100",
            "authors": [
                "Jamie Chisholm"
            ],
            "summary": "U.S. stock futures show Wall Street holding most of the rally from the start of the week as investors display less anxiety about geopolitical risk.",
            "banner_image": "https://images.mktw.net/im-869445/social",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.682689"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.150372,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "IBKR",
                    "relevance_score": "0.154951",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LMT",
                    "relevance_score": "0.154951",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "C",
                    "relevance_score": "0.154951",
                    "ticker_sentiment_score": "0.060631",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.154951",
                    "ticker_sentiment_score": "0.060631",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OMC",
                    "relevance_score": "0.154951",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.154951",
                    "ticker_sentiment_score": "0.060631",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.154951",
                    "ticker_sentiment_score": "0.060631",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.154951",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HRGLF",
                    "relevance_score": "0.077845",
                    "ticker_sentiment_score": "0.207393",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.154951",
                    "ticker_sentiment_score": "0.060631",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Bank of America, Johnson & Johnson And 3 Stocks To Watch Heading Into Tuesday - Bank of America  ( NYSE:BAC ) , Goldman Sachs Gr  ( NYSE:GS ) ",
            "url": "https://www.benzinga.com/news/earnings/23/10/35280111/bank-of-america-johnson-johnson-and-3-stocks-to-watch-heading-into-tuesday",
            "time_published": "20231017T074554",
            "authors": [
                "Lisa Levin"
            ],
            "summary": "With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Johnson & Johnson JNJ to report quarterly earnings at $2.51 per share on revenue of $21.04 billion before the opening bell.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/17/image12.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.413559"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.928769"
                }
            ],
            "overall_sentiment_score": 0.09356,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "XXII",
                    "relevance_score": "0.501398",
                    "ticker_sentiment_score": "-0.487426",
                    "ticker_sentiment_label": "Bearish"
                },
                {
                    "ticker": "NTCT",
                    "relevance_score": "0.501398",
                    "ticker_sentiment_score": "-0.314589",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.501398",
                    "ticker_sentiment_score": "0.320601",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.501398",
                    "ticker_sentiment_score": "0.559502",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.501398",
                    "ticker_sentiment_score": "0.559502",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Johnson & Johnson earnings: What to expect",
            "url": "https://www.marketwatch.com/story/johnson-johnson-earnings-what-to-expect-ee9e4a13",
            "time_published": "20231017T071300",
            "authors": [
                "Ciara Linnane"
            ],
            "summary": "Drug and medtech company is posting third-quarter earnings before the bell on Tuesday.",
            "banner_image": "https://images.mktw.net/im-757874/social",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.938793"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.109174,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.463792",
                    "ticker_sentiment_score": "0.36223",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.122894",
                    "ticker_sentiment_score": "0.046716",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.357293",
                    "ticker_sentiment_score": "0.303784",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Asia stocks rise on earnings hopes; keep wary eye on Middle east tensions",
            "url": "https://www.moneycontrol.com/news/business/markets/asia-stocks-rise-on-earnings-hopes-keep-wary-eye-on-middle-east-tensions-11544961.html",
            "time_published": "20231017T041226",
            "authors": [],
            "summary": "MSCI's broadest index of Asia-Pacific shares outside Japan advanced 0.4%. Tokyo's Nikkei rose 1%.",
            "banner_image": "https://images.moneycontrol.com/static-mcnews/2019/07/Asian-Markets.jpg?impolicy=website&width=168&height=118",
            "source": "Money Control",
            "category_within_source": "Markets",
            "source_domain": "www.moneycontrol.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.682689"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.818451"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": -0.024554,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "BLK",
                    "relevance_score": "0.075635",
                    "ticker_sentiment_score": "0.187947",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.075635",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.075635",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.075635",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.075635",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.075635",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CTRYF",
                    "relevance_score": "0.075635",
                    "ticker_sentiment_score": "-0.092025",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.075635",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:AUD",
                    "relevance_score": "0.075635",
                    "ticker_sentiment_score": "-0.134356",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:JPY",
                    "relevance_score": "0.075635",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:EUR",
                    "relevance_score": "0.075635",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:USD",
                    "relevance_score": "0.22421",
                    "ticker_sentiment_score": "-0.298006",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "CRYPTO:BTC",
                    "relevance_score": "0.075635",
                    "ticker_sentiment_score": "0.187947",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Asia stocks rise on earnings hopes; keep wary eye on Mideast tensions",
            "url": "https://www.reuters.com/markets/global-markets-wrapup-1-2023-10-17/",
            "time_published": "20231017T033239",
            "authors": [
                "Selena Li"
            ],
            "summary": "Asia stocks rise on earnings hopes. keep wary eye on Mideast tensions ...",
            "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/3YNMXI5NLZJHPH242XBLXFFGBA.jpg",
            "source": "Reuters",
            "category_within_source": "Markets",
            "source_domain": "www.reuters.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.682689"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.891286"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": -0.024458,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "BLK",
                    "relevance_score": "0.068306",
                    "ticker_sentiment_score": "0.185568",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.068306",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.068306",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.068306",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.068306",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.068306",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CTRYF",
                    "relevance_score": "0.068306",
                    "ticker_sentiment_score": "-0.090961",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.068306",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:AUD",
                    "relevance_score": "0.068306",
                    "ticker_sentiment_score": "-0.132693",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:JPY",
                    "relevance_score": "0.068306",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:EUR",
                    "relevance_score": "0.068306",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:USD",
                    "relevance_score": "0.202932",
                    "ticker_sentiment_score": "-0.273762",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "CRYPTO:BTC",
                    "relevance_score": "0.068306",
                    "ticker_sentiment_score": "0.185568",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Bitcoin, Ethereum, Dogecoin Spike As False BlackRock ETF Rumor Sparks $104M Shorts Liquidation: Analyst Says 'Real Tweet Would Do So Much More' - BlackRock  ( NYSE:BLK ) ",
            "url": "https://www.benzinga.com/markets/cryptocurrency/23/10/35279325/bitcoin-ethereum-dogecoin-spike-as-false-blackrock-etf-rumor-sparks-104m-shorts-liquidatio",
            "time_published": "20231017T023952",
            "authors": [
                "Mehab Qureshi"
            ],
            "summary": "Major cryptocurrencies experienced a significant surge on Monday evening, triggered by a false rumor on X, claiming that the Securities and Exchange Commission ( SEC ) had approved BlackRock's BLK spot bitcoin ETF application.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/Bitcoin_9.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.995921"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Blockchain",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.159981,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BLK",
                    "relevance_score": "0.196344",
                    "ticker_sentiment_score": "0.050249",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.066047",
                    "ticker_sentiment_score": "0.079114",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.066047",
                    "ticker_sentiment_score": "0.079114",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.066047",
                    "ticker_sentiment_score": "0.079114",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.066047",
                    "ticker_sentiment_score": "0.079114",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CRYPTO:BTC",
                    "relevance_score": "0.592742",
                    "ticker_sentiment_score": "0.12254",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Wall Street ends up on earnings optimism; eyes remain on Middle East",
            "url": "https://www.moneycontrol.com/news/business/markets/wall-street-ends-up-on-earnings-optimism-eyes-remain-on-middle-east-11543891.html",
            "time_published": "20231017T004845",
            "authors": [],
            "summary": "Market participants were monitoring the Israeli war in Gaza, but appeared to be taking more of a risk-on stance on Monday, with safe-haven gold prices down.",
            "banner_image": "https://images.moneycontrol.com/static-mcnews/2021/01/Wall-Street_reuters.jpg?impolicy=website&width=168&height=118",
            "source": "Money Control",
            "category_within_source": "Markets",
            "source_domain": "www.moneycontrol.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.682689"
                }
            ],
            "overall_sentiment_score": 0.07683,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.078354",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LULU",
                    "relevance_score": "0.078354",
                    "ticker_sentiment_score": "0.178924",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.078354",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.078354",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.078354",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.078354",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ATVI",
                    "relevance_score": "0.078354",
                    "ticker_sentiment_score": "0.178924",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SCHW",
                    "relevance_score": "0.078354",
                    "ticker_sentiment_score": "0.173357",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LPLA",
                    "relevance_score": "0.078354",
                    "ticker_sentiment_score": "0.150332",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.078354",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Markets Pop on Bargain Hunting, Stronger Economy",
            "url": "https://www.zacks.com/stock/news/2166817/markets-pop-on-bargain-hunting-stronger-economy",
            "time_published": "20231016T224200",
            "authors": [
                "Zacks Investment Research"
            ],
            "summary": "The small-cap Russell 2000, still under water over the past month, led the way higher today.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/81/48849.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.977154"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": 0.148243,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "UAL",
                    "relevance_score": "0.174587",
                    "ticker_sentiment_score": "0.036241",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LMT",
                    "relevance_score": "0.174587",
                    "ticker_sentiment_score": "0.036241",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.174587",
                    "ticker_sentiment_score": "0.036241",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ETSY",
                    "relevance_score": "0.174587",
                    "ticker_sentiment_score": "0.101763",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.174587",
                    "ticker_sentiment_score": "0.036241",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.174587",
                    "ticker_sentiment_score": "0.036241",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MRNA",
                    "relevance_score": "0.174587",
                    "ticker_sentiment_score": "0.101763",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.174587",
                    "ticker_sentiment_score": "0.101763",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Futures: Market Rally Snaps Back With Big Gains",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-rallies-market-rally-snaps-back-netflix-nvidia-tesla-in-focus/",
            "time_published": "20231016T211100",
            "authors": [
                "Investor's Business Daily",
                "SCOTT LEHTONEN"
            ],
            "summary": "Dow Jones Rallies 300 Points As Market Rally Snaps Back. Netflix ... Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2019/10/stock-wall-street-flags-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.769861"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.148112,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.069194",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.069194",
                    "ticker_sentiment_score": "0.12351",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.137868",
                    "ticker_sentiment_score": "0.030835",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.171851",
                    "ticker_sentiment_score": "-0.125093",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ANET",
                    "relevance_score": "0.069194",
                    "ticker_sentiment_score": "0.184966",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.069194",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.103628",
                    "ticker_sentiment_score": "0.109286",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.069194",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.069194",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.137868",
                    "ticker_sentiment_score": "0.047306",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LULU",
                    "relevance_score": "0.069194",
                    "ticker_sentiment_score": "0.184966",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LMT",
                    "relevance_score": "0.069194",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.171851",
                    "ticker_sentiment_score": "0.106864",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Large Granular Lymphocyte Leukemia Market is Projected to Grow During the Study Period  ( 2019-2032 ) , Assesses DelveInsight | Key Companies - Bristol Myers Squibb, Innate Pharma, Kymera Therapeutics, EUSA Pharma, Abcuro, Dren Bio, Novotech",
            "url": "https://www.prnewswire.com/news-releases/large-granular-lymphocyte-leukemia-market-is-projected-to-grow-during-the-study-period-20192032-assesses-delveinsight--key-companies---bristol-myers-squibb-innate-pharma-kymera-therapeutics-eusa-pharma-abcuro-dren-bio-n-301957023.html",
            "time_published": "20231016T210100",
            "authors": [
                "LLP",
                "DelveInsight Business Research"
            ],
            "summary": "Large Granular Lymphocyte Leukemia Market is Projected to Grow During the Study Period ( 2019-2032 ) , Assesses ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.069381,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "IPHA",
                    "relevance_score": "0.025845",
                    "ticker_sentiment_score": "0.095897",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.025845",
                    "ticker_sentiment_score": "-0.032245",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.051663",
                    "ticker_sentiment_score": "-0.028928",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LVTX",
                    "relevance_score": "0.025845",
                    "ticker_sentiment_score": "-0.026539",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.025845",
                    "ticker_sentiment_score": "-0.026539",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KYMR",
                    "relevance_score": "0.025845",
                    "ticker_sentiment_score": "0.095897",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TGTX",
                    "relevance_score": "0.025845",
                    "ticker_sentiment_score": "-0.026539",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.077426",
                    "ticker_sentiment_score": "-0.029504",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ONCT",
                    "relevance_score": "0.025845",
                    "ticker_sentiment_score": "-0.026539",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "APVO",
                    "relevance_score": "0.025845",
                    "ticker_sentiment_score": "-0.023726",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NRIX",
                    "relevance_score": "0.025845",
                    "ticker_sentiment_score": "-0.026539",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "INCY",
                    "relevance_score": "0.025845",
                    "ticker_sentiment_score": "-0.026539",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GILD",
                    "relevance_score": "0.051663",
                    "ticker_sentiment_score": "-0.028928",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "APRE",
                    "relevance_score": "0.025845",
                    "ticker_sentiment_score": "-0.026539",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BIIB",
                    "relevance_score": "0.025845",
                    "ticker_sentiment_score": "-0.023726",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.025845",
                    "ticker_sentiment_score": "-0.023726",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johnson & Johnson's Earnings Will Offer a Look at the Company Without Kenvue",
            "url": "https://www.barrons.com/articles/johnson-jnj-earnings-stock-price-20d516cc",
            "time_published": "20231016T210000",
            "authors": [
                "Josh Nathan-Kazis"
            ],
            "summary": "Johnson & Johnson's Earnings Are Coming. They'll Be the First ... ...",
            "banner_image": "https://images.barrons.com/im-17614305/social",
            "source": "Barrons",
            "category_within_source": "n/a",
            "source_domain": "www.barrons.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.0,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.769861",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "4 Hot Penny Stocks To Watch With The Stock Market Up Today",
            "url": "https://pennystocks.com/featured/2023/10/16/4-hot-penny-stocks-to-watch-with-the-stock-market-up-today/",
            "time_published": "20231016T174327",
            "authors": [
                "J. Phillip"
            ],
            "summary": "Whether you're trading penny stocks or stocks over $100, it's hard to miss that the stock market is up today. That's in stark contrast to last week, when markets appeared to be heading toward another downtrend.",
            "banner_image": "https://pennystocks.com/wp-content/uploads/2022/07/best-penny-stocks-to-watch-right-now.jpg",
            "source": "PennyStocks.com",
            "category_within_source": "n/a",
            "source_domain": "pennystocks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.187232,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.039811",
                    "ticker_sentiment_score": "0.14224",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.039811",
                    "ticker_sentiment_score": "0.14224",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MNTS",
                    "relevance_score": "0.158259",
                    "ticker_sentiment_score": "0.259889",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.039811",
                    "ticker_sentiment_score": "0.14224",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.039811",
                    "ticker_sentiment_score": "0.14224",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.039811",
                    "ticker_sentiment_score": "0.14224",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SCHW",
                    "relevance_score": "0.039811",
                    "ticker_sentiment_score": "0.14224",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPCE",
                    "relevance_score": "0.119038",
                    "ticker_sentiment_score": "0.100293",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SAVE",
                    "relevance_score": "0.039811",
                    "ticker_sentiment_score": "0.168359",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "FUBO",
                    "relevance_score": "0.158259",
                    "ticker_sentiment_score": "0.10182",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Pendulum Swings: Markets Recover Slightly After Friday's Anxious Trading, but Middle East Worries Dominate - Apple  ( NASDAQ:AAPL ) , American Airlines Group  ( NASDAQ:AAL ) ",
            "url": "https://www.benzinga.com/markets/23/10/35272437/pendulum-swings-markets-recover-slightly-after-fridays-anxious-trading-but-middle-east-worries-domin",
            "time_published": "20231016T170715",
            "authors": [
                "Schwab Center for Financial Research"
            ],
            "summary": "( Monday market open ) Last week gave us a taste of earnings. The meal starts tomorrow and picks up steam as banks, airlines, and health care companies report. And the main course might be Wednesday afternoon when Netflix NFLX and Tesla TSLA open their books.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/16/shutterstock_534464629_6.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.972193"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999995"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999989"
                },
                {
                    "topic": "Economy - Macro",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": -0.067779,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.090679",
                    "ticker_sentiment_score": "0.006231",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UAL",
                    "relevance_score": "0.0726",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.036338",
                    "ticker_sentiment_score": "0.036461",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "C",
                    "relevance_score": "0.036338",
                    "ticker_sentiment_score": "-0.081306",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NTRS",
                    "relevance_score": "0.036338",
                    "ticker_sentiment_score": "-0.117215",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.090679",
                    "ticker_sentiment_score": "-0.024393",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.054483",
                    "ticker_sentiment_score": "-0.082244",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.0726",
                    "ticker_sentiment_score": "-0.081525",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.0726",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ZIONL",
                    "relevance_score": "0.018173",
                    "ticker_sentiment_score": "-0.106918",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAL",
                    "relevance_score": "0.0726",
                    "ticker_sentiment_score": "-0.016156",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.0726",
                    "ticker_sentiment_score": "-0.087575",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LMT",
                    "relevance_score": "0.036338",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.108712",
                    "ticker_sentiment_score": "0.019806",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RF",
                    "relevance_score": "0.0726",
                    "ticker_sentiment_score": "-0.106746",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.054483",
                    "ticker_sentiment_score": "-0.031027",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNP",
                    "relevance_score": "0.054483",
                    "ticker_sentiment_score": "-0.015988",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.036338",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AXP",
                    "relevance_score": "0.036338",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CME",
                    "relevance_score": "0.036338",
                    "ticker_sentiment_score": "0.050374",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PM",
                    "relevance_score": "0.036338",
                    "ticker_sentiment_score": "-0.026246",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:USD",
                    "relevance_score": "0.0726",
                    "ticker_sentiment_score": "-0.064009",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Monday's Market Minute: This Week's Focus: Earnings & Consumer Spending - Bank of America  ( NYSE:BAC ) , American Express  ( NYSE:AXP ) ",
            "url": "https://www.benzinga.com/news/earnings/23/10/35272066/mondays-market-minute-this-weeks-focus-earnings-consumer-spending",
            "time_published": "20231016T164605",
            "authors": [
                "Schwab Network"
            ],
            "summary": "The focus for investors and traders will shift from inflation after the higher-than-expected figures last week to earnings and consumer spending habits.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/16/shutterstock_1978695896_13.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": -0.037954,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.246582",
                    "ticker_sentiment_score": "0.172999",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "UAL",
                    "relevance_score": "0.246582",
                    "ticker_sentiment_score": "0.172999",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LMT",
                    "relevance_score": "0.246582",
                    "ticker_sentiment_score": "0.172999",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "C",
                    "relevance_score": "0.246582",
                    "ticker_sentiment_score": "0.172999",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.246582",
                    "ticker_sentiment_score": "0.172999",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.246582",
                    "ticker_sentiment_score": "0.172999",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.246582",
                    "ticker_sentiment_score": "0.172999",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.246582",
                    "ticker_sentiment_score": "0.172999",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.246582",
                    "ticker_sentiment_score": "0.172999",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AXP",
                    "relevance_score": "0.246582",
                    "ticker_sentiment_score": "0.172999",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.246582",
                    "ticker_sentiment_score": "0.172999",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Wall Street Waits for Big Earnings Results",
            "url": "https://www.zacks.com/stock/news/2166555/wall-street-waits-for-big-earnings-results",
            "time_published": "20231016T145700",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "It's a busy trading week ahead, with Q3 earnings season heating up and more economic data being released a couple weeks ahead of the next Federal Open Market Committee ( FOMC ) meeting, which decides on interest rates.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/98/601.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.13292,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "SCHW",
                    "relevance_score": "0.210274",
                    "ticker_sentiment_score": "0.161935",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LMT",
                    "relevance_score": "0.210274",
                    "ticker_sentiment_score": "0.043266",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.210274",
                    "ticker_sentiment_score": "0.043266",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.210274",
                    "ticker_sentiment_score": "0.043266",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.210274",
                    "ticker_sentiment_score": "0.043266",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Empire State Less Bad than Expected; SCHW Mixed in Q3",
            "url": "https://www.zacks.com/stock/news/2166539/empire-state-less-bad-than-expected-schw-mixed-in-q3",
            "time_published": "20231016T142700",
            "authors": [
                "Mark Vickery"
            ],
            "summary": "We've only seen four months in positive territory on Empire State manufacturing year to date, the highest being +10.8 in April.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/ac/1026.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.132866,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "SCHW",
                    "relevance_score": "0.204936",
                    "ticker_sentiment_score": "0.158778",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LMT",
                    "relevance_score": "0.204936",
                    "ticker_sentiment_score": "0.042404",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.204936",
                    "ticker_sentiment_score": "0.042404",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.204936",
                    "ticker_sentiment_score": "0.042404",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.204936",
                    "ticker_sentiment_score": "0.042404",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "White River Bancshares Co. Earns $639,000, or $0.64 Per Diluted Share, in Third Quarter 2023; Highlighted by Double Digit Loan and Deposit Growth Year-Over-year",
            "url": "https://www.globenewswire.com/news-release/2023/10/16/2760706/0/en/White-River-Bancshares-Co-Earns-639-000-or-0-64-Per-Diluted-Share-in-Third-Quarter-2023-Highlighted-by-Double-Digit-Loan-and-Deposit-Growth-Year-Over-year.html",
            "time_published": "20231016T130000",
            "authors": [
                "White River Bancshares"
            ],
            "summary": "FAYETTEVILLE, Ark., Oct. 16, 2023 ( GLOBE NEWSWIRE ) -- White River Bancshares Company ( OTCQX: WRIV ) , ( the \"Company\" ) the holding company for Signature Bank of Arkansas ( the \"Bank\" ) , today reported net income of $639,000, or $0.64 per diluted share, in the third quarter of 2023, compared ...",
            "banner_image": "https://ml.globenewswire.com/Resource/Download/59f98c26-e808-41b4-b248-610c5133e898",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999998"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.576289"
                }
            ],
            "overall_sentiment_score": 0.208887,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KO",
                    "relevance_score": "0.016271",
                    "ticker_sentiment_score": "0.116446",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SBNY",
                    "relevance_score": "0.065017",
                    "ticker_sentiment_score": "0.102122",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSN",
                    "relevance_score": "0.016271",
                    "ticker_sentiment_score": "0.116446",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.016271",
                    "ticker_sentiment_score": "0.116446",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.016271",
                    "ticker_sentiment_score": "0.116446",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.016271",
                    "ticker_sentiment_score": "0.116446",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Innovation Takes Center Stage: Florida's Life Sciences Leaders Shine at BioFlorida Conference",
            "url": "https://www.prnewswire.com/news-releases/innovation-takes-center-stage-floridas-life-sciences-leaders-shine-at-bioflorida-conference-301957464.html",
            "time_published": "20231016T123800",
            "authors": [
                "BioFlorida"
            ],
            "summary": "The Annual Conference Fuels Growth with a Focus on Elevating Florida's Position on the Global Stage",
            "banner_image": "https://mma.prnewswire.com/media/2247700/BioFlorida_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.34544,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "CVKD",
                    "relevance_score": "0.057147",
                    "ticker_sentiment_score": "0.07",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.028592",
                    "ticker_sentiment_score": "0.198867",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GLOB",
                    "relevance_score": "0.028592",
                    "ticker_sentiment_score": "0.166429",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SZCRF",
                    "relevance_score": "0.014298",
                    "ticker_sentiment_score": "0.050969",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CPRX",
                    "relevance_score": "0.042876",
                    "ticker_sentiment_score": "0.32357",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.028592",
                    "ticker_sentiment_score": "0.198867",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "HRZN",
                    "relevance_score": "0.028592",
                    "ticker_sentiment_score": "0.134959",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "4 Dividend Stocks Yielding 4% or More to Buy Without Hesitation",
            "url": "https://www.fool.com/investing/2023/10/16/4-dividend-stocks-yield-4-buy-without-hesitation/",
            "time_published": "20231016T121200",
            "authors": [
                "Matthew DiLallo"
            ],
            "summary": "These stocks offer attractive payouts that should rise in the future.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.99793"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.343006,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.222022",
                    "ticker_sentiment_score": "0.326257",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "STAG",
                    "relevance_score": "0.134339",
                    "ticker_sentiment_score": "0.23903",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SO",
                    "relevance_score": "0.178459",
                    "ticker_sentiment_score": "0.232696",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.089797",
                    "ticker_sentiment_score": "0.199687",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "The daily business briefing: October 16, 2023",
            "url": "https://theweek.com/business/the-daily-business-briefing-october-16-2023",
            "time_published": "20231016T120957",
            "authors": [
                "The Week US",
                "Harold Maass"
            ],
            "summary": "2. Taylor Swift's concert movie breaks records 3. Dow, S&P edge higher ahead of wave of earnings 5. Pfizer cuts forecast for Covid vaccine, therapy sales A free daily digest of the biggest news stories of the day - and the best features from our website Thank you for signing up to TheWeek.",
            "banner_image": "https://cdn.mos.cms.futurecdn.net/YSghz4sVxEeV4uzDD3m96B-415-80.jpg",
            "source": "The Week News",
            "category_within_source": "n/a",
            "source_domain": "theweek.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.451494"
                }
            ],
            "overall_sentiment_score": -0.009662,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.033282",
                    "ticker_sentiment_score": "0.008567",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.033282",
                    "ticker_sentiment_score": "0.089797",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.033282",
                    "ticker_sentiment_score": "0.008567",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.033282",
                    "ticker_sentiment_score": "0.008567",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.033282",
                    "ticker_sentiment_score": "0.008567",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NYT",
                    "relevance_score": "0.033282",
                    "ticker_sentiment_score": "-0.13329",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOX",
                    "relevance_score": "0.033282",
                    "ticker_sentiment_score": "0.052548",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.099614",
                    "ticker_sentiment_score": "-0.026246",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.033282",
                    "ticker_sentiment_score": "0.008567",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BNTX",
                    "relevance_score": "0.099614",
                    "ticker_sentiment_score": "-0.004384",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.033282",
                    "ticker_sentiment_score": "0.089797",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FRNWF",
                    "relevance_score": "0.033282",
                    "ticker_sentiment_score": "0.055395",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.066506",
                    "ticker_sentiment_score": "0.023091",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RAD",
                    "relevance_score": "0.099614",
                    "ticker_sentiment_score": "-0.148968",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.066506",
                    "ticker_sentiment_score": "0.003023",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XOM",
                    "relevance_score": "0.033282",
                    "ticker_sentiment_score": "-0.113922",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ATVI",
                    "relevance_score": "0.033282",
                    "ticker_sentiment_score": "0.090704",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BIRK",
                    "relevance_score": "0.033282",
                    "ticker_sentiment_score": "-0.109932",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "TREMFYA®  ( guselkumab )  Maintains Key Efficacy Endpoints Through Three Years for Adults with Moderately to Severely Active Crohn's Disease in a Phase 2 Study",
            "url": "https://markets.businessinsider.com/news/stocks/tremfya-guselkumab-maintains-key-efficacy-endpoints-through-three-years-for-adults-with-moderately-to-severely-active-crohn-s-disease-in-a-phase-2-study-1032708159",
            "time_published": "20231016T120100",
            "authors": [
                "markets.businessinsider.com"
            ],
            "summary": "TREMFYA® (guselkumab) Maintains Key Efficacy Endpoints Through Three Years for Adults with Moderately to Severely Active Crohn's Disease in a Phase 2 Study ...",
            "banner_image": "https://mma.prnewswire.com/media/1006365/Janssen_Logo.jpg",
            "source": "Business Insider",
            "category_within_source": "RSS",
            "source_domain": "markets.businessinsider.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.038824,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.130217",
                    "ticker_sentiment_score": "0.10974",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Janssen Aims to Define New Standards of Care in the Treatment of Solid Tumor Cancers with Transformative Data Planned for Presentation at ESMO",
            "url": "https://markets.businessinsider.com/news/stocks/janssen-aims-to-define-new-standards-of-care-in-the-treatment-of-solid-tumor-cancers-with-transformative-data-planned-for-presentation-at-esmo-1032708126",
            "time_published": "20231016T120000",
            "authors": [
                "markets.businessinsider.com"
            ],
            "summary": "Janssen Aims to Define New Standards of Care in the Treatment of Solid Tumor Cancers with Transformative Data Planned for Presentation at ...",
            "banner_image": "https://c212.net/c/img/favicon.png?sn=AQ31152&sd=2023-10-16",
            "source": "Business Insider",
            "category_within_source": "RSS",
            "source_domain": "markets.businessinsider.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.057784,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.028109",
                    "ticker_sentiment_score": "-0.050847",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Janssen to Highlight Latest Research from Nipocalimab Clinical Development Program to Address Unmet Need in Myasthenia Gravis at AANEM 2023 Meeting",
            "url": "https://www.prnewswire.com/news-releases/janssen-to-highlight-latest-research-from-nipocalimab-clinical-development-program-to-address-unmet-need-in-myasthenia-gravis-at-aanem-2023-meeting-301957084.html",
            "time_published": "20231016T120000",
            "authors": [
                "Janssen Pharmaceutical Companies of Johnson & Johnson"
            ],
            "summary": "Janssen to Highlight Latest Research from Nipocalimab Clinical Development Program to Address Unmet Need in ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/2193913/jsn_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": -0.014468,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.185917",
                    "ticker_sentiment_score": "-0.009305",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "TSX futures kick off week on copper boost, Middle East conflict weighs",
            "url": "https://www.reuters.com/markets/tsx-futures-kick-off-week-copper-boost-middle-east-conflict-weighs-2023-10-16/",
            "time_published": "20231016T114900",
            "authors": [
                "Reuters"
            ],
            "summary": "The Art Deco facade of the original Toronto Stock Exchange building is seen on Bay Street in Toronto, Ontario, Canada January 23, 2019. REUTERS/Chris Helgren/File Photo Acquire Licensing Rights",
            "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/STWPE5MPBNIFROJQ5NZIJRD6X4.jpg",
            "source": "Reuters",
            "category_within_source": "Markets",
            "source_domain": "www.reuters.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.839681"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": -0.021632,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.110973",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LTKBF",
                    "relevance_score": "0.110973",
                    "ticker_sentiment_score": "0.24409",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.110973",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.110973",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.110973",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.110973",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.110973",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "US Stocks On Track For A Strong Start To Week, Buoyed By Earnings Optimism: Analyst Flags 13-14% Upside As Bull Market Enters Its Second Year - Netflix  ( NASDAQ:NFLX ) , Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , NVIDIA  ( NASDAQ:NVDA ) , Tesla  ( NASDAQ:TSLA ) ",
            "url": "https://www.benzinga.com/news/earnings/23/10/35263899/us-stocks-on-track-for-a-strong-start-to-week-buoyed-by-earnings-optimism-analyst-flags-13-14-upsid",
            "time_published": "20231016T113407",
            "authors": [
                "Shanthi Rexaline"
            ],
            "summary": "Earnings optimism has kept sentiment buoyant, with the stock futures pointing to a higher opening on Monday. The third-quarter earnings season starts in earnest this week, with some blue chip companies, including Tesla, Inc. TSLA, Netflix, Inc.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/Stocks_Photo_by_Jirapong_Manustrong_on_Shutterstock_28.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.682689"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999499"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.928139"
                }
            ],
            "overall_sentiment_score": 0.052859,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.100308",
                    "ticker_sentiment_score": "0.179311",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.100308",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SSTK",
                    "relevance_score": "0.050254",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.149966",
                    "ticker_sentiment_score": "0.132041",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.100308",
                    "ticker_sentiment_score": "0.179311",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.100308",
                    "ticker_sentiment_score": "0.179311",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SCHW",
                    "relevance_score": "0.100308",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LPLA",
                    "relevance_score": "0.050254",
                    "ticker_sentiment_score": "0.219344",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVAX",
                    "relevance_score": "0.100308",
                    "ticker_sentiment_score": "-0.084608",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.050254",
                    "ticker_sentiment_score": "0.14925",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Is iShares Core Dividend Growth ETF  ( DGRO )  a Strong ETF Right Now?",
            "url": "https://www.zacks.com/stock/news/2166224/is-ishares-core-dividend-growth-etf-dgro-a-strong-etf-right-now",
            "time_published": "20231016T102006",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Smart Beta ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default267.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999986"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.300328,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BLK",
                    "relevance_score": "0.057767",
                    "ticker_sentiment_score": "0.101971",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.115232",
                    "ticker_sentiment_score": "0.06109",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MORN",
                    "relevance_score": "0.115232",
                    "ticker_sentiment_score": "0.179932",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.115232",
                    "ticker_sentiment_score": "0.06109",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.115232",
                    "ticker_sentiment_score": "0.06109",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Infinium Global Research Forecasts Robust Growth in Ophthalmic Surgical Technologies Market: Anticipates USD 2487.63 Million Value by 2030 with a Notable CAGR of 5.25%",
            "url": "https://www.prnewswire.com/news-releases/infinium-global-research-forecasts-robust-growth-in-ophthalmic-surgical-technologies-market-anticipates-usd-2487-63-million-value-by-2030-with-a-notable-cagr-of-5-25-301957269.html",
            "time_published": "20231016T100000",
            "authors": [
                "Infinium Global Research"
            ],
            "summary": "Infinium Global Research Forecasts Robust Growth in Ophthalmic Surgical Technologies Market: Anticipates USD ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/2244132/Infinium_Global_Research_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.219009,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "SNPHF",
                    "relevance_score": "0.04882",
                    "ticker_sentiment_score": "0.092574",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.04882",
                    "ticker_sentiment_score": "0.092574",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "STAA",
                    "relevance_score": "0.04882",
                    "ticker_sentiment_score": "0.092574",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ALC",
                    "relevance_score": "0.04882",
                    "ticker_sentiment_score": "0.092574",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "III",
                    "relevance_score": "0.04882",
                    "ticker_sentiment_score": "0.167968",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GKOS",
                    "relevance_score": "0.04882",
                    "ticker_sentiment_score": "0.092574",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.04882",
                    "ticker_sentiment_score": "0.092574",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TOPCF",
                    "relevance_score": "0.04882",
                    "ticker_sentiment_score": "0.092574",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Futures up ahead of earnings and data, Middle East tensions weigh",
            "url": "https://www.reuters.com/markets/us/futures-up-ahead-earnings-data-middle-east-tensions-weigh-2023-10-16/",
            "time_published": "20231016T095600",
            "authors": [
                "Reuters"
            ],
            "summary": "Traders work on the floor of the New York Stock Exchange ( NYSE ) in New York City, U.S., September 28, 2023. REUTERS/Brendan McDermid/File Photo Acquire Licensing Rights",
            "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/32DHT533XJKJDP3XVC5KVAMRUY.jpg",
            "source": "Reuters",
            "category_within_source": "Markets",
            "source_domain": "www.reuters.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.614606"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": -0.044985,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.085324",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.085324",
                    "ticker_sentiment_score": "-0.185896",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.085324",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.085324",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.085324",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.085324",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SCHW",
                    "relevance_score": "0.085324",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.085324",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.085324",
                    "ticker_sentiment_score": "-0.295459",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "TECHNICOLOR CREATIVE STUDIOS STRENGTHENS ITS LEADERSHIP STRUCTURE",
            "url": "https://www.benzinga.com/pressreleases/23/10/g35258709/technicolor-creative-studios-strengthens-its-leadership-structure",
            "time_published": "20231016T060426",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "Paris ( France ) , October 16, 2023 - Technicolor Creative Studios ( TCS ) announces the evolution of its Executive Committee with: The appointment of Michael Masset as Chief People Officer The extension of Stéphanie Fougou's portfolio of responsibilities with the inclusion of the ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.406678,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MAT",
                    "relevance_score": "0.033751",
                    "ticker_sentiment_score": "0.106387",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ACRFF",
                    "relevance_score": "0.033751",
                    "ticker_sentiment_score": "0.125389",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VLOUF",
                    "relevance_score": "0.033751",
                    "ticker_sentiment_score": "0.125389",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CLPIF",
                    "relevance_score": "0.033751",
                    "ticker_sentiment_score": "0.112199",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DXBGY",
                    "relevance_score": "0.033751",
                    "ticker_sentiment_score": "0.073653",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.033751",
                    "ticker_sentiment_score": "0.106387",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XOM",
                    "relevance_score": "0.033751",
                    "ticker_sentiment_score": "0.106387",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HPQ",
                    "relevance_score": "0.033751",
                    "ticker_sentiment_score": "0.106387",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FDX",
                    "relevance_score": "0.033751",
                    "ticker_sentiment_score": "0.106387",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CREAF",
                    "relevance_score": "0.033751",
                    "ticker_sentiment_score": "0.219281",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "TECHNICOLOR CREATIVE STUDIOS STRENGTHENS ITS LEADERSHIP STRUCTURE",
            "url": "https://www.globenewswire.com/news-release/2023/10/16/2760308/0/en/TECHNICOLOR-CREATIVE-STUDIOS-STRENGTHENS-ITS-LEADERSHIP-STRUCTURE.html",
            "time_published": "20231016T060400",
            "authors": [
                "Technicolor Creative Studios"
            ],
            "summary": "PRESS RELEASE ...",
            "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/b42a1545-5237-4d78-a9db-63a0b497f310",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.400658,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MAT",
                    "relevance_score": "0.033656",
                    "ticker_sentiment_score": "0.106346",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ACRFF",
                    "relevance_score": "0.033656",
                    "ticker_sentiment_score": "0.125349",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VLOUF",
                    "relevance_score": "0.033656",
                    "ticker_sentiment_score": "0.125349",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CLPIF",
                    "relevance_score": "0.033656",
                    "ticker_sentiment_score": "0.112156",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DXBGY",
                    "relevance_score": "0.033656",
                    "ticker_sentiment_score": "0.073622",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.033656",
                    "ticker_sentiment_score": "0.106346",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XOM",
                    "relevance_score": "0.033656",
                    "ticker_sentiment_score": "0.106346",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HPQ",
                    "relevance_score": "0.033656",
                    "ticker_sentiment_score": "0.106346",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FDX",
                    "relevance_score": "0.033656",
                    "ticker_sentiment_score": "0.106346",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CREAF",
                    "relevance_score": "0.033656",
                    "ticker_sentiment_score": "0.292162",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Wall Street's Q3 expectations have been all over the place. Now, a swing to profit growth is 'likely' - with a bigger rebound next year",
            "url": "https://www.marketwatch.com/story/wall-streets-q3-expectations-have-been-all-over-the-place-now-a-swing-to-profit-growth-is-likely-with-a-bigger-rebound-next-year-d12282de",
            "time_published": "20231015T143100",
            "authors": [
                "Bill Peters"
            ],
            "summary": "One analyst who tracks the ebbs and flows of earnings data says at least a slight profit gain for the third quarter is more likely.",
            "banner_image": "https://images.mktw.net/im-868495/social",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999326"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                }
            ],
            "overall_sentiment_score": 0.178294,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.153797",
                    "ticker_sentiment_score": "0.142829",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UAL",
                    "relevance_score": "0.102888",
                    "ticker_sentiment_score": "-0.066278",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "C",
                    "relevance_score": "0.153797",
                    "ticker_sentiment_score": "-0.016073",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.204072",
                    "ticker_sentiment_score": "0.116921",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.153797",
                    "ticker_sentiment_score": "0.079337",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.102888",
                    "ticker_sentiment_score": "-0.066278",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAL",
                    "relevance_score": "0.102888",
                    "ticker_sentiment_score": "-0.066278",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.102888",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DAL",
                    "relevance_score": "0.102888",
                    "ticker_sentiment_score": "0.157606",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "DFS",
                    "relevance_score": "0.102888",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.153797",
                    "ticker_sentiment_score": "0.142074",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "T",
                    "relevance_score": "0.051551",
                    "ticker_sentiment_score": "-0.060909",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.102888",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AXP",
                    "relevance_score": "0.102888",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Why You Should Invest In Healthcare Stocks",
            "url": "https://www.kiplinger.com/investing/healthcare-stocks/why-you-should-invest-in-healthcare-stocks",
            "time_published": "20231015T140059",
            "authors": [
                "James K. Glassman"
            ],
            "summary": "Healthcare stocks have had a rough few years. So why invest in them? First, I'm a contrarian. I like what's down. Second, healthcare is a booming industry, accounting for 18% of gross domestic product ( GDP ) in 2021, up from 12% in 1991. Third, the sector adds stability to any portfolio.",
            "banner_image": "https://cdn.mos.cms.futurecdn.net/KKJr2NN3xukR5Kxuhz2vrY-415-80.jpg",
            "source": "Kiplinger",
            "category_within_source": "n/a",
            "source_domain": "www.kiplinger.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.99737"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.183015,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "SYK",
                    "relevance_score": "0.099752",
                    "ticker_sentiment_score": "0.18093",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ILMN",
                    "relevance_score": "0.066598",
                    "ticker_sentiment_score": "0.119713",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HCA",
                    "relevance_score": "0.099752",
                    "ticker_sentiment_score": "0.087475",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.066598",
                    "ticker_sentiment_score": "0.0641",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.066598",
                    "ticker_sentiment_score": "-0.162455",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.033328",
                    "ticker_sentiment_score": "0.12656",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.099752",
                    "ticker_sentiment_score": "-0.01214",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.099752",
                    "ticker_sentiment_score": "0.276915",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "DHR",
                    "relevance_score": "0.066598",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.132733",
                    "ticker_sentiment_score": "0.109596",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.033328",
                    "ticker_sentiment_score": "-0.068677",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WST",
                    "relevance_score": "0.066598",
                    "ticker_sentiment_score": "0.068343",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AUGX",
                    "relevance_score": "0.099752",
                    "ticker_sentiment_score": "-0.041137",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ISRG",
                    "relevance_score": "0.066598",
                    "ticker_sentiment_score": "0.068343",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "3 Dividend Growth Stocks You Can Buy and Hold Forever",
            "url": "https://www.fool.com/investing/2023/10/14/3-dividend-growth-stocks-you-can-buy-and-hold-fore/",
            "time_published": "20231014T105200",
            "authors": [
                "Keith Speights",
                "and Prosper Junior Bakiny",
                "David Jagielski"
            ],
            "summary": "Investors can sit back and let the dividends flow in with these great stocks.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.803643"
                }
            ],
            "overall_sentiment_score": 0.201977,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.353338",
                    "ticker_sentiment_score": "0.11404",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.278561",
                    "ticker_sentiment_score": "0.130001",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.316337",
                    "ticker_sentiment_score": "0.229411",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Kenvue Inc.: Please contact the Portnoy Law Firm to recover your losses; December 8, 2023 deadline - Kenvue  ( NYSE:KVUE ) ",
            "url": "https://www.benzinga.com/pressreleases/23/10/g35251596/kenvue-inc-please-contact-the-portnoy-law-firm-to-recover-your-losses-december-8-2023-deadline",
            "time_published": "20231014T014246",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "Investors can contact the law firm at no cost to learn more about recovering their losses",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.890401"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.796627"
                }
            ],
            "overall_sentiment_score": -0.026674,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.450165",
                    "ticker_sentiment_score": "0.0091",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.079392",
                    "ticker_sentiment_score": "0.128105",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Brazil - Cosmetics Market size to increase by USD 4.72 billion between 2022 to 2027| Rise in sales of cosmetics ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/brazil---cosmetics-market-size-to-increase-by-usd-4-72-billion-between-2022-to-2027-rise-in-sales-of-cosmetics-through-e-commerce-channels-drives-the-market-growth---technavio-301955600.html",
            "time_published": "20231013T233500",
            "authors": [],
            "summary": "Brazil - Cosmetics Market size to increase by USD 4.72 billion between 2022 to 2027| Rise in sales of cosmetics ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.275801,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BDRFF",
                    "relevance_score": "0.056674",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KAOCF",
                    "relevance_score": "0.056674",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SSDOF",
                    "relevance_score": "0.056674",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.056674",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.056674",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UL",
                    "relevance_score": "0.056674",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HENKY",
                    "relevance_score": "0.056674",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMRSQ",
                    "relevance_score": "0.056674",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LRLCF",
                    "relevance_score": "0.056674",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "COTY",
                    "relevance_score": "0.056674",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "ENT Devices Market size to grow by USD 8.83 billion from 2022-2027| Market is fragmented by major companies like ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/ent-devices-market-size-to-grow-by-usd-8-83-billion-from-2022-2027-market-is-fragmented-by-major-companies-like-baxter-international-inc-siemens-healthineers-ag-johnson-and-johnson-and-much-more---technavio-301955602.html",
            "time_published": "20231013T231500",
            "authors": [],
            "summary": "ENT Devices Market size to grow by USD 8.83 billion from 2022-2027| Market is fragmented by major companies like ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.194001,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "SYK",
                    "relevance_score": "0.076358",
                    "ticker_sentiment_score": "0.059606",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CHEOF",
                    "relevance_score": "0.076358",
                    "ticker_sentiment_score": "0.059606",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.076358",
                    "ticker_sentiment_score": "0.059606",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HOCPF",
                    "relevance_score": "0.076358",
                    "ticker_sentiment_score": "0.059606",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SEMHF",
                    "relevance_score": "0.076358",
                    "ticker_sentiment_score": "0.059606",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OCPNF",
                    "relevance_score": "0.076358",
                    "ticker_sentiment_score": "0.059606",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CLPBY",
                    "relevance_score": "0.076358",
                    "ticker_sentiment_score": "0.059606",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNN",
                    "relevance_score": "0.076358",
                    "ticker_sentiment_score": "0.059606",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SONVF",
                    "relevance_score": "0.076358",
                    "ticker_sentiment_score": "0.059606",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DSSMY",
                    "relevance_score": "0.076358",
                    "ticker_sentiment_score": "0.059606",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WILLF",
                    "relevance_score": "0.076358",
                    "ticker_sentiment_score": "0.059606",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAX",
                    "relevance_score": "0.152018",
                    "ticker_sentiment_score": "0.065042",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.076358",
                    "ticker_sentiment_score": "0.059606",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Weekly Roundup",
            "url": "https://aap.thestreet.com/story/16135510/1/weekly-roundup.html",
            "time_published": "20231013T225600",
            "authors": [],
            "summary": "Before the week even started, we knew it had the potential to be volatile. We had just come off the September jobs report that surprised with its stunning strength, and we had the consumer and producer price index reports that would land, filling out the picture on inflation.",
            "banner_image": "https://s.thestreet.com/files/tsc/v2008/photos/contrib/uploads/91fbc74f-6a0d-11ee-9691-b5f85aa22ae6.png",
            "source": "The Street",
            "category_within_source": "GoogleRSS",
            "source_domain": "aap.thestreet.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.999973"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.142857"
                }
            ],
            "overall_sentiment_score": 0.161329,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "HRL",
                    "relevance_score": "0.003607",
                    "ticker_sentiment_score": "-0.019654",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDNDF",
                    "relevance_score": "0.021637",
                    "ticker_sentiment_score": "0.041278",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TRIN",
                    "relevance_score": "0.003607",
                    "ticker_sentiment_score": "0.054415",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ROAD",
                    "relevance_score": "0.010819",
                    "ticker_sentiment_score": "0.097441",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.007213",
                    "ticker_sentiment_score": "-0.057441",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ELV",
                    "relevance_score": "0.007213",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "STT",
                    "relevance_score": "0.003607",
                    "ticker_sentiment_score": "-0.019188",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VFC",
                    "relevance_score": "0.007213",
                    "ticker_sentiment_score": "-0.057441",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MA",
                    "relevance_score": "0.010819",
                    "ticker_sentiment_score": "0.061732",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SBUX",
                    "relevance_score": "0.003607",
                    "ticker_sentiment_score": "0.095943",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CHKP",
                    "relevance_score": "0.003607",
                    "ticker_sentiment_score": "0.016071",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IRBT",
                    "relevance_score": "0.003607",
                    "ticker_sentiment_score": "0.026473",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OLED",
                    "relevance_score": "0.043257",
                    "ticker_sentiment_score": "0.083718",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CMG",
                    "relevance_score": "0.014425",
                    "ticker_sentiment_score": "0.022535",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.003607",
                    "ticker_sentiment_score": "0.116333",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.010819",
                    "ticker_sentiment_score": "0.031519",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TOL",
                    "relevance_score": "0.003607",
                    "ticker_sentiment_score": "0.028174",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BCS",
                    "relevance_score": "0.007213",
                    "ticker_sentiment_score": "0.0984",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CNHI",
                    "relevance_score": "0.003607",
                    "ticker_sentiment_score": "0.09225",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ADBE",
                    "relevance_score": "0.007213",
                    "ticker_sentiment_score": "0.027385",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ATVI",
                    "relevance_score": "0.007213",
                    "ticker_sentiment_score": "0.056078",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SONO",
                    "relevance_score": "0.003607",
                    "ticker_sentiment_score": "0.116333",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMAT",
                    "relevance_score": "0.010819",
                    "ticker_sentiment_score": "0.141612",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CVS",
                    "relevance_score": "0.003607",
                    "ticker_sentiment_score": "-0.017149",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UAL",
                    "relevance_score": "0.007213",
                    "ticker_sentiment_score": "-0.057441",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "C",
                    "relevance_score": "0.007213",
                    "ticker_sentiment_score": "0.098766",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VZ",
                    "relevance_score": "0.003607",
                    "ticker_sentiment_score": "0.032316",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.014425",
                    "ticker_sentiment_score": "0.127871",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PPG",
                    "relevance_score": "0.007213",
                    "ticker_sentiment_score": "-0.010201",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BLDR",
                    "relevance_score": "0.003607",
                    "ticker_sentiment_score": "0.028174",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AXON",
                    "relevance_score": "0.014425",
                    "ticker_sentiment_score": "0.106253",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "URI",
                    "relevance_score": "0.007213",
                    "ticker_sentiment_score": "0.074835",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.021637",
                    "ticker_sentiment_score": "0.077273",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SSNLF",
                    "relevance_score": "0.007213",
                    "ticker_sentiment_score": "0.051416",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "COST",
                    "relevance_score": "0.014425",
                    "ticker_sentiment_score": "0.091194",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "QCOM",
                    "relevance_score": "0.039655",
                    "ticker_sentiment_score": "0.085261",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.003607",
                    "ticker_sentiment_score": "0.167311",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "UNP",
                    "relevance_score": "0.007213",
                    "ticker_sentiment_score": "-0.057441",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LRCX",
                    "relevance_score": "0.007213",
                    "ticker_sentiment_score": "-0.010201",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.025241",
                    "ticker_sentiment_score": "0.133748",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HUM",
                    "relevance_score": "0.003607",
                    "ticker_sentiment_score": "-0.017149",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.003607",
                    "ticker_sentiment_score": "0.061298",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.039655",
                    "ticker_sentiment_score": "0.114871",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "USEG",
                    "relevance_score": "0.003607",
                    "ticker_sentiment_score": "0.039252",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ICNB",
                    "relevance_score": "0.003607",
                    "ticker_sentiment_score": "0.177971",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "VMC",
                    "relevance_score": "0.018031",
                    "ticker_sentiment_score": "0.07327",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LMT",
                    "relevance_score": "0.014425",
                    "ticker_sentiment_score": "0.085763",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.007213",
                    "ticker_sentiment_score": "-0.057441",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AXP",
                    "relevance_score": "0.010819",
                    "ticker_sentiment_score": "0.059346",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PEP",
                    "relevance_score": "0.03245",
                    "ticker_sentiment_score": "0.0912",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.018031",
                    "ticker_sentiment_score": "0.025176",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:USD",
                    "relevance_score": "0.007213",
                    "ticker_sentiment_score": "0.078063",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Cramer's week ahead: Keep an eye on banks as earnings season kicks off",
            "url": "https://www.cnbc.com/2023/10/13/cramers-week-ahead-keep-an-eye-on-banks-as-earnings-season-kicks-off.html",
            "time_published": "20231013T222151",
            "authors": [
                "Julie Coleman"
            ],
            "summary": "CNBC's Jim Cramer on Friday told investors what to look out for next week, with numerous major names reporting earnings.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/106349607-1579721279110img_3326r.jpg?v=1697235711&w=1920&h=1080",
            "source": "CNBC",
            "category_within_source": "Top News",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.451494"
                }
            ],
            "overall_sentiment_score": 0.050563,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.097457",
                    "ticker_sentiment_score": "0.027333",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.097457",
                    "ticker_sentiment_score": "-0.095911",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UAL",
                    "relevance_score": "0.097457",
                    "ticker_sentiment_score": "0.111927",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.193465",
                    "ticker_sentiment_score": "0.021752",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.193465",
                    "ticker_sentiment_score": "0.171843",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.097457",
                    "ticker_sentiment_score": "0.111927",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SLB",
                    "relevance_score": "0.097457",
                    "ticker_sentiment_score": "0.099194",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.193465",
                    "ticker_sentiment_score": "0.021752",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LMT",
                    "relevance_score": "0.097457",
                    "ticker_sentiment_score": "0.111927",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.097457",
                    "ticker_sentiment_score": "0.027333",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNP",
                    "relevance_score": "0.097457",
                    "ticker_sentiment_score": "0.099194",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.193465",
                    "ticker_sentiment_score": "0.171843",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AXP",
                    "relevance_score": "0.097457",
                    "ticker_sentiment_score": "0.099194",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SCHW",
                    "relevance_score": "0.097457",
                    "ticker_sentiment_score": "-0.036334",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KEY",
                    "relevance_score": "0.097457",
                    "ticker_sentiment_score": "0.099194",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Facial Serum Market size is to grow by USD 466.23 million from 2022 to 2027 | The introduction of brands owned or ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/facial-serum-market-size-is-to-grow-by-usd-466-23-million-from-2022-to-2027--the-introduction-of-brands-owned-or-endorsed-by-celebrities-to-boost-market-growth---technavio-301955571.html",
            "time_published": "20231013T220000",
            "authors": [],
            "summary": "Facial Serum Market size is to grow by USD 466.23 million from 2022 to 2027 | The introduction of brands owned or ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.280639,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BDRFF",
                    "relevance_score": "0.064623",
                    "ticker_sentiment_score": "0.117452",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KAOCF",
                    "relevance_score": "0.064623",
                    "ticker_sentiment_score": "0.117452",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SSDOF",
                    "relevance_score": "0.064623",
                    "ticker_sentiment_score": "0.117452",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.064623",
                    "ticker_sentiment_score": "0.117452",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.064623",
                    "ticker_sentiment_score": "0.117452",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UL",
                    "relevance_score": "0.064623",
                    "ticker_sentiment_score": "0.117452",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LRLCF",
                    "relevance_score": "0.064623",
                    "ticker_sentiment_score": "0.117452",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "COTY",
                    "relevance_score": "0.064623",
                    "ticker_sentiment_score": "0.117452",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Investing Action Plan: A Change Of Season As Netflix, Tesla Face Tests",
            "url": "https://www.investors.com/research/investing-action-plan/investing-action-plan-a-change-of-season-as-netflix-tesla-face-tests/",
            "time_published": "20231013T214500",
            "authors": [
                "Investor's Business Daily",
                "IBD STAFF"
            ],
            "summary": "Investing Action Plan: A Change Of Season As Netflix, Tesla Face ... Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2020/09/Stock-fallleaves-02-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999701"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.142857"
                }
            ],
            "overall_sentiment_score": 0.08389,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.091597",
                    "ticker_sentiment_score": "0.091347",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UAL",
                    "relevance_score": "0.045874",
                    "ticker_sentiment_score": "0.089595",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ANET",
                    "relevance_score": "0.045874",
                    "ticker_sentiment_score": "0.032889",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AVGO",
                    "relevance_score": "0.068764",
                    "ticker_sentiment_score": "0.033399",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.045874",
                    "ticker_sentiment_score": "0.17754",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GM",
                    "relevance_score": "0.045874",
                    "ticker_sentiment_score": "0.080844",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.022947",
                    "ticker_sentiment_score": "0.01108",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.022947",
                    "ticker_sentiment_score": "-0.008963",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.045874",
                    "ticker_sentiment_score": "0.016984",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LVS",
                    "relevance_score": "0.045874",
                    "ticker_sentiment_score": "0.067379",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.045874",
                    "ticker_sentiment_score": "0.016984",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NTES",
                    "relevance_score": "0.068764",
                    "ticker_sentiment_score": "0.033399",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FITB",
                    "relevance_score": "0.045874",
                    "ticker_sentiment_score": "-0.009969",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "COST",
                    "relevance_score": "0.068764",
                    "ticker_sentiment_score": "0.033399",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LMT",
                    "relevance_score": "0.045874",
                    "ticker_sentiment_score": "0.020974",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.137018",
                    "ticker_sentiment_score": "-0.034349",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNP",
                    "relevance_score": "0.091597",
                    "ticker_sentiment_score": "0.012766",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.045874",
                    "ticker_sentiment_score": "0.016984",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LRCX",
                    "relevance_score": "0.045874",
                    "ticker_sentiment_score": "0.123449",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SCHW",
                    "relevance_score": "0.045874",
                    "ticker_sentiment_score": "0.067704",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FCX",
                    "relevance_score": "0.045874",
                    "ticker_sentiment_score": "-0.092",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "REGN",
                    "relevance_score": "0.045874",
                    "ticker_sentiment_score": "0.032889",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ISRG",
                    "relevance_score": "0.045874",
                    "ticker_sentiment_score": "0.101496",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "STLD",
                    "relevance_score": "0.045874",
                    "ticker_sentiment_score": "-0.122362",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Israel-Hamas War Shakes Middle East, Inflation Reawakens, Oil Surges: The Week In The Markets - United Airlines Holdings  ( NASDAQ:UAL ) , Johnson & Johnson  ( NYSE:JNJ ) , SLB  ( NYSE:SLB ) , Bank of New York Mellon  ( NYSE:BK ) ",
            "url": "https://www.benzinga.com/markets/equities/23/10/35248880/israel-hamas-war-shakes-middle-east-inflation-reawakens-oil-surges-the-week-in-the-markets",
            "time_published": "20231013T203331",
            "authors": [
                "Piero Cingari"
            ],
            "summary": "Global geopolitical developments and domestic economic data shaped investor sentiment throughout the week, sparking fresh concerns regarding the outlook for growth and inflation. The week commenced with the eruption of conflict in the Middle East involving Israel and the Palestinian militant ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/Wall_Street_subway_sign_2.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.972193"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.682689"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.166667"
                }
            ],
            "overall_sentiment_score": 0.028703,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "UAL",
                    "relevance_score": "0.095517",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.095517",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SLB",
                    "relevance_score": "0.047844",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BK",
                    "relevance_score": "0.095517",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PLD",
                    "relevance_score": "0.095517",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ELV",
                    "relevance_score": "0.095517",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DHR",
                    "relevance_score": "0.095517",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.047844",
                    "ticker_sentiment_score": "0.044356",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABT",
                    "relevance_score": "0.095517",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.095517",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "T",
                    "relevance_score": "0.047844",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BX",
                    "relevance_score": "0.095517",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNP",
                    "relevance_score": "0.095517",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LRCX",
                    "relevance_score": "0.095517",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CME",
                    "relevance_score": "0.047844",
                    "ticker_sentiment_score": "0.060192",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.095517",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IBKR",
                    "relevance_score": "0.095517",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.095517",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HON",
                    "relevance_score": "0.095517",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.095517",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.095517",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LMT",
                    "relevance_score": "0.095517",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.095517",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XOM",
                    "relevance_score": "0.047844",
                    "ticker_sentiment_score": "0.044356",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ATVI",
                    "relevance_score": "0.095517",
                    "ticker_sentiment_score": "0.047127",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AXP",
                    "relevance_score": "0.095517",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SCHW",
                    "relevance_score": "0.095517",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FCX",
                    "relevance_score": "0.095517",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PM",
                    "relevance_score": "0.095517",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Over Delivering: Big Banks Beat Expectations After Tough Quarter, but Market Eyes Middle East Warily - Abbott Laboratories  ( NYSE:ABT ) , American Airlines Group  ( NASDAQ:AAL ) ",
            "url": "https://www.benzinga.com/markets/23/10/35244544/over-delivering-big-banks-beat-expectations-after-tough-quarter-but-market-eyes-middle-east-warily",
            "time_published": "20231013T161933",
            "authors": [
                "Schwab Network"
            ],
            "summary": "( Friday market open ) Big bank earnings this morning threatened to take a back seat as geopolitical worries helped spark a rally in crude oil and sent more investors fleeing toward the perceived safety of fixed income. The benchmark 10-year U.S.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/13/shutterstock_1388100275_5.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.999855"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999999"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Economy - Macro",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": -0.014495,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.03786",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UAL",
                    "relevance_score": "0.075635",
                    "ticker_sentiment_score": "-0.022185",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "C",
                    "relevance_score": "0.075635",
                    "ticker_sentiment_score": "0.192842",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NTRS",
                    "relevance_score": "0.03786",
                    "ticker_sentiment_score": "-0.072356",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.03786",
                    "ticker_sentiment_score": "-0.072356",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.094464",
                    "ticker_sentiment_score": "0.120521",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.075635",
                    "ticker_sentiment_score": "-0.050747",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.075635",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAL",
                    "relevance_score": "0.075635",
                    "ticker_sentiment_score": "-0.032421",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.075635",
                    "ticker_sentiment_score": "-0.054847",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TD",
                    "relevance_score": "0.11324",
                    "ticker_sentiment_score": "-0.034147",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LMT",
                    "relevance_score": "0.03786",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.03786",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RF",
                    "relevance_score": "0.075635",
                    "ticker_sentiment_score": "-0.065115",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.075635",
                    "ticker_sentiment_score": "0.13564",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNP",
                    "relevance_score": "0.056763",
                    "ticker_sentiment_score": "-0.031996",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.03786",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AXP",
                    "relevance_score": "0.03786",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SCHW",
                    "relevance_score": "0.056763",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PM",
                    "relevance_score": "0.03786",
                    "ticker_sentiment_score": "-0.02637",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Growing Geriatric Population Fuels Ankylosing Spondylitis Market: Management of Pain and Mobility Gains Importance in Aging Demographics",
            "url": "https://www.prnewswire.com/news-releases/growing-geriatric-population-fuels-ankylosing-spondylitis-market-management-of-pain-and-mobility-gains-importance-in-aging-demographics-301956060.html",
            "time_published": "20231013T154500",
            "authors": [
                "Research and Markets"
            ],
            "summary": "Growing Geriatric Population Fuels Ankylosing Spondylitis Market: Management of Pain and Mobility Gains Importance ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.144187,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "AZN",
                    "relevance_score": "0.036643",
                    "ticker_sentiment_score": "0.067285",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.036643",
                    "ticker_sentiment_score": "0.067285",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VTRS",
                    "relevance_score": "0.036643",
                    "ticker_sentiment_score": "0.067285",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ALPMF",
                    "relevance_score": "0.036643",
                    "ticker_sentiment_score": "0.067285",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVS",
                    "relevance_score": "0.036643",
                    "ticker_sentiment_score": "0.067285",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.036643",
                    "ticker_sentiment_score": "0.067285",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GILD",
                    "relevance_score": "0.036643",
                    "ticker_sentiment_score": "0.067285",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "REGN",
                    "relevance_score": "0.036643",
                    "ticker_sentiment_score": "0.067285",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RXDX",
                    "relevance_score": "0.073209",
                    "ticker_sentiment_score": "0.139168",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.036643",
                    "ticker_sentiment_score": "0.067285",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.073209",
                    "ticker_sentiment_score": "0.08925",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.036643",
                    "ticker_sentiment_score": "0.067285",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "J&J  ( JNJ )  to Report Q3 Earnings, Its First After Unit Spin-Off",
            "url": "https://www.zacks.com/stock/news/2165582/jj-jnj-to-report-q3-earnings-its-first-after-unit-spin-off",
            "time_published": "20231013T134900",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "J&J's (JNJ) third-quarter results are the first quarterly update for the new company after the Consumer Health spin-off.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/ff/1612.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.99393"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999992"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.149943,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.130453",
                    "ticker_sentiment_score": "0.063321",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MRNA",
                    "relevance_score": "0.173333",
                    "ticker_sentiment_score": "-0.063835",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "REGN",
                    "relevance_score": "0.257442",
                    "ticker_sentiment_score": "0.135924",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.215702",
                    "ticker_sentiment_score": "0.094996",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.173333",
                    "ticker_sentiment_score": "0.080645",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "UM Commerce Hosts Grand Opening of \"Marva's,\" Industry-First 360 Commerce Experience - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/um-commerce-hosts-grand-opening-of-marvas-industry-first-360-commerce-experience-301956034.html",
            "time_published": "20231013T110300",
            "authors": [],
            "summary": "UM Commerce Hosts Grand Opening of \"Marva's,\" Industry-First 360 Commerce Experience PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.257672,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "SNEJF",
                    "relevance_score": "0.052226",
                    "ticker_sentiment_score": "0.187607",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MAT",
                    "relevance_score": "0.052226",
                    "ticker_sentiment_score": "0.187607",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SPOT",
                    "relevance_score": "0.052226",
                    "ticker_sentiment_score": "0.187607",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GPRO",
                    "relevance_score": "0.052226",
                    "ticker_sentiment_score": "0.187607",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.052226",
                    "ticker_sentiment_score": "0.187607",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AXP",
                    "relevance_score": "0.052226",
                    "ticker_sentiment_score": "0.187607",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ACN",
                    "relevance_score": "0.052226",
                    "ticker_sentiment_score": "0.187607",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Ophthalmology Devices Market size to grow by USD 19.93 billion from 2022 to 2027, North America to account for 41 ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/ophthalmology-devices-market-size-to-grow-by-usd-19-93-billion-from-2022-to-2027--north-america-to-account-for-41-of-market-growth--technavio-301955503.html",
            "time_published": "20231013T083500",
            "authors": [],
            "summary": "Ophthalmology Devices Market size to grow by USD 19.93 billion from 2022 to 2027, North America to account for 41 ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.230614,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "COO",
                    "relevance_score": "0.06179",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LNSR",
                    "relevance_score": "0.06179",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ESLOF",
                    "relevance_score": "0.06179",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.06179",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "STAA",
                    "relevance_score": "0.06179",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GKOS",
                    "relevance_score": "0.06179",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HOCPF",
                    "relevance_score": "0.06179",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DHR",
                    "relevance_score": "0.06179",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MTLZF",
                    "relevance_score": "0.06179",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ALC",
                    "relevance_score": "0.183895",
                    "ticker_sentiment_score": "0.172871",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "IRIX",
                    "relevance_score": "0.06179",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BHC",
                    "relevance_score": "0.06179",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TOPCF",
                    "relevance_score": "0.06179",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Take Five: War and peace of mind",
            "url": "https://www.reuters.com/business/take-five/global-markets-themes-graphic-pix-2023-10-13/",
            "time_published": "20231013T072000",
            "authors": [
                "Reuters"
            ],
            "summary": "LONDON Oct 13 ( Reuters ) - Geopolitics are at the forefront of everyone's minds after war broke out between Israel and Palestinian militant group Hamas, and the mood in markets is jittery at best.",
            "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/GGEZIRPNPNLVPNJHCXG4RG4UNY.jpg",
            "source": "Reuters",
            "category_within_source": "Business",
            "source_domain": "www.reuters.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.682689"
                },
                {
                    "topic": "Economy - Fiscal",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.918141"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.838487"
                }
            ],
            "overall_sentiment_score": 0.016985,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.048425",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMDUF",
                    "relevance_score": "0.048425",
                    "ticker_sentiment_score": "0.15788",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.048425",
                    "ticker_sentiment_score": "0.09006",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.048425",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.048425",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CTRYF",
                    "relevance_score": "0.048425",
                    "ticker_sentiment_score": "-0.206922",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.048425",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PM",
                    "relevance_score": "0.048425",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:PLN",
                    "relevance_score": "0.048425",
                    "ticker_sentiment_score": "-0.023059",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Peering Into Johnson & Johnson's Recent Short Interest - Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/short-sellers/23/10/35228760/peering-into-johnson-johnsons-recent-short-interest",
            "time_published": "20231012T194530",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Johnson & Johnson's JNJ short percent of float has fallen 32.85% since its last report. The company recently reported that it has 22.26 million shares sold short, which is 0.92% of all regular shares that are available for trading.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.365926"
                }
            ],
            "overall_sentiment_score": 0.237013,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.221819",
                    "ticker_sentiment_score": "0.081322",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Kenvue Inc.  ( KVUE )  Investors and Encourages Investors to Contact the Firm Before December 8, 2023 - Kenvue  ( NYSE:KVUE ) ",
            "url": "https://www.benzinga.com/pressreleases/23/10/g35228334/kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-on-behalf-of-kenv",
            "time_published": "20231012T192202",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "NEW YORK, Oct. 12, 2023 ( GLOBE NEWSWIRE ) -- The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.890401"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.045664,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.692465",
                    "ticker_sentiment_score": "0.053559",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.16171",
                    "ticker_sentiment_score": "0.052379",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Stellar Ventures and Cypress Growth Capital Commit to Fueling the Future of Robotics Software",
            "url": "https://www.prnewswire.com/news-releases/stellar-ventures-and-cypress-growth-capital-commit-to-fueling-the-future-of-robotics-software-301955366.html",
            "time_published": "20231012T183500",
            "authors": [
                "PickNik Robotics"
            ],
            "summary": "BOULDER, Colo., Oct. 12, 2023 /PRNewswire/ -- PickNik Robotics, \"The Unstructured Robotics Company,\" proudly announces a major milestone in its mission to bring robot arms out of factories and into our everyday lives.",
            "banner_image": "https://mma.prnewswire.com/media/2245906/PICKNIK_ROBOTICS.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.316726"
                }
            ],
            "overall_sentiment_score": 0.432262,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "SSNLF",
                    "relevance_score": "0.043658",
                    "ticker_sentiment_score": "0.235082",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.043658",
                    "ticker_sentiment_score": "0.235082",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AGTEF",
                    "relevance_score": "0.043658",
                    "ticker_sentiment_score": "0.235082",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.043658",
                    "ticker_sentiment_score": "0.235082",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "CPI Data Generates Calm Initial Reaction, But Some Troubling Trends Under the Surface - Citigroup  ( NYSE:C ) , Delta Air Lines  ( NYSE:DAL ) ",
            "url": "https://www.benzinga.com/markets/23/10/35223366/cpi-data-generates-calm-initial-reaction-but-some-troubling-trends-under-the-surface",
            "time_published": "20231012T152601",
            "authors": [
                "Schwab Center for Financial Research"
            ],
            "summary": "( Thursday market open ) An eagerly awaited report on U.S. consumer inflation didn't appear too frightening early Thursday, and major indexes initially appeared unhindered as the October rally rolled on.",
            "banner_image": "https://tickertapecdn.tdameritrade.com/assets/images/pages/md/chart-10-12.png",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.999989"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Economy - Macro",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.02411,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "BLK",
                    "relevance_score": "0.041682",
                    "ticker_sentiment_score": "0.09158",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.041682",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UAL",
                    "relevance_score": "0.041682",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "C",
                    "relevance_score": "0.083251",
                    "ticker_sentiment_score": "0.062279",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.083251",
                    "ticker_sentiment_score": "0.062279",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.041682",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.041682",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAL",
                    "relevance_score": "0.041682",
                    "ticker_sentiment_score": "-0.026632",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.041682",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LMT",
                    "relevance_score": "0.041682",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.041682",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.083251",
                    "ticker_sentiment_score": "0.062279",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNP",
                    "relevance_score": "0.041682",
                    "ticker_sentiment_score": "-0.026632",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.041682",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WBA",
                    "relevance_score": "0.041682",
                    "ticker_sentiment_score": "0.044686",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PM",
                    "relevance_score": "0.041682",
                    "ticker_sentiment_score": "-0.026632",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Dow ETF in Focus Ahead of Q3 Earnings",
            "url": "https://www.zacks.com/stock/news/2165006/dow-etf-in-focus-ahead-of-q3-earnings",
            "time_published": "20231012T151000",
            "authors": [
                "Sweta Killa"
            ],
            "summary": "With some of the blue-chip companies having reasonable chances of coming up with an earnings surprise, investors should closely monitor the movement of the Dow ETF and grab any opportunity that arises from a surge in any of the 30 stocks.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default161.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999174"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.108642,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "DOW",
                    "relevance_score": "0.136113",
                    "ticker_sentiment_score": "0.016715",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IBM",
                    "relevance_score": "0.180798",
                    "ticker_sentiment_score": "-0.00144",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "INTC",
                    "relevance_score": "0.136113",
                    "ticker_sentiment_score": "0.055477",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.180798",
                    "ticker_sentiment_score": "0.077339",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.136113",
                    "ticker_sentiment_score": "-0.013245",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.136113",
                    "ticker_sentiment_score": "0.031511",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "JNJ: Johnson & Johnson  ( JNJ )  vs. Madrigal Pharmaceuticals  ( MDGL ) : Which Pharma Stock Is a Worthier October Investment?",
            "url": "https://stocknews.com/news/jnj-mdgl-johnson-johnson-jnj-vs-madrigal-pharmaceuticals-mdgl-which-pharma/",
            "time_published": "20231012T114952",
            "authors": [
                "StockNews.com Staff"
            ],
            "summary": "JNJ: Johnson & Johnson ( JNJ ) vs. Madrigal Pharmaceuticals ... ...",
            "banner_image": "https://stocknews.com/wp-content/uploads/2022/04/Vs.-scaled.jpg",
            "source": "Stocknews.com",
            "category_within_source": "n/a",
            "source_domain": "stocknews.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.99994"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999987"
                }
            ],
            "overall_sentiment_score": 0.197165,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.155451",
                    "ticker_sentiment_score": "0.205032",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MDGL",
                    "relevance_score": "0.417008",
                    "ticker_sentiment_score": "0.100708",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.632922",
                    "ticker_sentiment_score": "0.16808",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Attention Medicare Recipients: You Could See Lower Costs for These 10 Drugs in the Not-Too-Distant Future",
            "url": "https://www.fool.com/retirement/2023/10/12/medicare-recipients-could-see-lower-costs-for-thes/",
            "time_published": "20231012T091500",
            "authors": [
                "Keith Speights"
            ],
            "summary": "Medicare will soon begin negotiations with drugmakers for the first time ever.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F750108%2Folder-couple-pill-bottle.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.127947,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "AZN",
                    "relevance_score": "0.08687",
                    "ticker_sentiment_score": "-0.129312",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.08687",
                    "ticker_sentiment_score": "-0.129312",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.08687",
                    "ticker_sentiment_score": "-0.129312",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Where can you find entertainment, beaches, jobs, low cost of living and more? Here are some of the best places to live in Florida.",
            "url": "https://www.marketwatch.com/story/where-can-you-find-entertainment-beaches-jobs-low-cost-of-living-and-more-here-are-some-of-the-best-places-to-live-in-florida-2638454c",
            "time_published": "20231012T090200",
            "authors": [
                "Livability"
            ],
            "summary": "You're never far from the water, blue skies and sunshine in Florida. These cities offer thriving economies, low cost of living and a healthy active lifestyle.",
            "banner_image": "https://images.mktw.net/im-425215?width=700&height=467",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.375762,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "RDW",
                    "relevance_score": "0.029025",
                    "ticker_sentiment_score": "0.149857",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BA",
                    "relevance_score": "0.029025",
                    "ticker_sentiment_score": "0.184363",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "DIS",
                    "relevance_score": "0.029025",
                    "ticker_sentiment_score": "0.007425",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.029025",
                    "ticker_sentiment_score": "0.149857",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PSFE",
                    "relevance_score": "0.029025",
                    "ticker_sentiment_score": "0.149857",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Alvotech Provides Update on Status of U.S. Biologics License Application for AVT04",
            "url": "https://www.globenewswire.com/news-release/2023/10/12/2758971/0/en/Alvotech-Provides-Update-on-Status-of-U-S-Biologics-License-Application-for-AVT04.html",
            "time_published": "20231012T080000",
            "authors": [
                "Alvotech"
            ],
            "summary": "Alvotech ( NASDAQ: ALVO ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that the US Food and Drug Administration ( FDA ) has issued a complete response letter ( CRL ) for Alvotech's Biologics License ...",
            "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/17a8091d-68a6-47c1-968e-fcced99f1d44",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.104414,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "ALVO",
                    "relevance_score": "0.591955",
                    "ticker_sentiment_score": "0.153319",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TEVA",
                    "relevance_score": "0.028695",
                    "ticker_sentiment_score": "0.060316",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KMDA",
                    "relevance_score": "0.028695",
                    "ticker_sentiment_score": "0.060316",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LTUS",
                    "relevance_score": "0.028695",
                    "ticker_sentiment_score": "0.060316",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.028695",
                    "ticker_sentiment_score": "0.032211",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Alvotech Provides Update on Status of U.S. Biologics License Application for AVT04",
            "url": "https://www.globenewswire.com/news-release/2023/10/12/2758972/0/en/Alvotech-Provides-Update-on-Status-of-U-S-Biologics-License-Application-for-AVT04.html",
            "time_published": "20231012T080000",
            "authors": [
                "Alvotech"
            ],
            "summary": "REYKJAVIK, Iceland, Oct. 12, 2023 ( GLOBE NEWSWIRE ) -- Alvotech ( NASDAQ: ALVO ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that the US Food and Drug Administration ( FDA ) has issued a complete ...",
            "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/17a8091d-68a6-47c1-968e-fcced99f1d44",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.111463,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "ALVO",
                    "relevance_score": "0.586931",
                    "ticker_sentiment_score": "0.162845",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TEVA",
                    "relevance_score": "0.028388",
                    "ticker_sentiment_score": "0.060221",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KMDA",
                    "relevance_score": "0.028388",
                    "ticker_sentiment_score": "0.060221",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LTUS",
                    "relevance_score": "0.028388",
                    "ticker_sentiment_score": "0.060221",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.028388",
                    "ticker_sentiment_score": "0.125175",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Healthcare Education Solutions Market size to grow by USD 5.30 billion from 2022 to 2027 | Market is fragmented due ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/healthcare-education-solutions-market-size-to-grow-by-usd-5-30-billion-from-2022-to-2027--market-is-fragmented-due-to-the-presence-of-prominent-companies-like-3m-co-bbraun-se-and-becton-dickinson-and-co-and-many-more-301952875.html",
            "time_published": "20231011T231500",
            "authors": [],
            "summary": "Healthcare Education Solutions Market size to grow by USD 5.30 billion from 2022 to 2027 | Market is fragmented due ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.327571,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ZBH",
                    "relevance_score": "0.140896",
                    "ticker_sentiment_score": "0.092834",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CAJFF",
                    "relevance_score": "0.070725",
                    "ticker_sentiment_score": "0.086725",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SMAWF",
                    "relevance_score": "0.070725",
                    "ticker_sentiment_score": "0.086725",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SYK",
                    "relevance_score": "0.070725",
                    "ticker_sentiment_score": "0.086725",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BSX",
                    "relevance_score": "0.070725",
                    "ticker_sentiment_score": "0.086725",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.070725",
                    "ticker_sentiment_score": "0.086725",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRKR",
                    "relevance_score": "0.070725",
                    "ticker_sentiment_score": "0.086725",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MMM",
                    "relevance_score": "0.070725",
                    "ticker_sentiment_score": "0.086725",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OCPNF",
                    "relevance_score": "0.070725",
                    "ticker_sentiment_score": "0.086725",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PHG",
                    "relevance_score": "0.070725",
                    "ticker_sentiment_score": "0.086725",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNN",
                    "relevance_score": "0.070725",
                    "ticker_sentiment_score": "0.086725",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DSSMY",
                    "relevance_score": "0.070725",
                    "ticker_sentiment_score": "0.086725",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BDX",
                    "relevance_score": "0.070725",
                    "ticker_sentiment_score": "0.086725",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TMO",
                    "relevance_score": "0.070725",
                    "ticker_sentiment_score": "0.086725",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FUJIF",
                    "relevance_score": "0.070725",
                    "ticker_sentiment_score": "0.086725",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.070725",
                    "ticker_sentiment_score": "0.086725",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GE",
                    "relevance_score": "0.070725",
                    "ticker_sentiment_score": "0.086725",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Birkenstock slides about 10% in stock market debut after opening at $41 per share",
            "url": "https://www.cnbc.com/2023/10/11/birkenstock-ipo-birk-starts-trading-on-the-nyse.html",
            "time_published": "20231011T173411",
            "authors": [
                "Gabrielle Fonrouge"
            ],
            "summary": "German shoe brand Birkenstock made its market debut Wednesday after pricing its IPO at $46.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/107315226-1697034572902-gettyimages-1719128571-AFP_33XZ6ZE.jpeg?v=1697045651&w=1920&h=1080",
            "source": "CNBC",
            "category_within_source": "Business",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.682689"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.990999"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.18349,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.062434",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DSSMY",
                    "relevance_score": "0.124486",
                    "ticker_sentiment_score": "0.117392",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ODD",
                    "relevance_score": "0.062434",
                    "ticker_sentiment_score": "0.078193",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.062434",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Here's Why You Should Invest in Boston Scientific  ( BSX )  Now",
            "url": "https://www.zacks.com/stock/news/2164426/heres-why-you-should-invest-in-boston-scientific-bsx-now",
            "time_published": "20231011T144700",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Investors are optimistic about Boston Scientific (BSX) on consistent growth and upbeat guidance.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/4c/2710.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.99915"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.242473,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "EW",
                    "relevance_score": "0.050044",
                    "ticker_sentiment_score": "0.070392",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNN",
                    "relevance_score": "0.050044",
                    "ticker_sentiment_score": "0.070392",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DSSMY",
                    "relevance_score": "0.050044",
                    "ticker_sentiment_score": "0.070392",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BSX",
                    "relevance_score": "0.293506",
                    "ticker_sentiment_score": "0.164302",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.050044",
                    "ticker_sentiment_score": "0.070392",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ALGN",
                    "relevance_score": "0.09989",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.050044",
                    "ticker_sentiment_score": "0.070392",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DVA",
                    "relevance_score": "0.198221",
                    "ticker_sentiment_score": "0.077786",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PXXXF",
                    "relevance_score": "0.050044",
                    "ticker_sentiment_score": "0.151212",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "QTRX",
                    "relevance_score": "0.09989",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "The 20 companies engineering students around the world most want to work for",
            "url": "https://africa.businessinsider.com/careers/the-20-companies-engineering-students-around-the-world-most-want-to-work-for/yr5x4mp",
            "time_published": "20231011T140320",
            "authors": [
                "Madison Hoff"
            ],
            "summary": "That's based on the World's Most Attractive Employers report for this year from employer-branding company Universum. The newly published engineering-student ranking from the report, along with the other global rankings part of it, are based on how students of different college and university ...",
            "banner_image": "https://ocdn.eu/pulscms-transforms/1/hNJktkuTURBXy9iZTgxOGRmMy1jYjllLTQ5Y2YtYjNjYy05Y2UyYjk2NTUwMDkuanBlZ5GTBc0DFs0Brg",
            "source": "Business Insider",
            "category_within_source": "GoogleRSS",
            "source_domain": "africa.businessinsider.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.171211,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BA",
                    "relevance_score": "0.299478",
                    "ticker_sentiment_score": "0.106751",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.299478",
                    "ticker_sentiment_score": "0.106751",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "The 20 companies engineering students around the world most want to work for",
            "url": "https://www.businessinsider.com/companies-engineering-students-around-world-want-to-work-for-2023-10",
            "time_published": "20231011T140300",
            "authors": [
                "Madison Hoff"
            ],
            "summary": "Companies engineering students around the world want to work for - Business Insider ...",
            "banner_image": null,
            "source": "Business Insider",
            "category_within_source": "GoogleRSS",
            "source_domain": "www.businessinsider.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.229597,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.195814",
                    "ticker_sentiment_score": "0.439345",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.543004",
                    "ticker_sentiment_score": "0.473985",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.195814",
                    "ticker_sentiment_score": "0.17187",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BA",
                    "relevance_score": "0.380012",
                    "ticker_sentiment_score": "0.226527",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.195814",
                    "ticker_sentiment_score": "0.075947",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "2 No-Brainer Dividend King Stocks to Buy Right Now",
            "url": "https://www.fool.com/investing/2023/10/11/2-no-brainer-dividend-king-stocks-to-buy-right-now/",
            "time_published": "20231011T124500",
            "authors": [
                "George Budwell"
            ],
            "summary": "These two blue-chip stocks should hold up well in a choppy market.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F750416%2Ftime-to-buy.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.495866"
                }
            ],
            "overall_sentiment_score": 0.383773,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KO",
                    "relevance_score": "0.319725",
                    "ticker_sentiment_score": "0.356695",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.195287",
                    "ticker_sentiment_score": "0.282736",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "FOREX:GBP",
                    "relevance_score": "0.065685",
                    "ticker_sentiment_score": "0.207583",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "3 Delaware Investments Mutual Funds for Solid Returns",
            "url": "https://www.zacks.com/stock/news/2164054/3-delaware-investments-mutual-funds-for-solid-returns",
            "time_published": "20231011T090900",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Invest in Delaware Investments mutual funds such as WLGYX, IDAAX and DDFAX for the opportunity to maximize your investment returns.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/d9/554.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999967"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.294286,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MCQEF",
                    "relevance_score": "0.069094",
                    "ticker_sentiment_score": "0.248564",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.069094",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XM",
                    "relevance_score": "0.069094",
                    "ticker_sentiment_score": "-0.01612",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.069094",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "V",
                    "relevance_score": "0.069094",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HES",
                    "relevance_score": "0.069094",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.069094",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johnson & Johnson  ( NYSE:JNJ )  Upgraded by StockNews.com to Strong-Buy",
            "url": "https://www.defenseworld.net/2023/10/11/johnson-johnson-nysejnj-upgraded-by-stocknews-com-to-strong-buy.html",
            "time_published": "20231011T080244",
            "authors": [
                "Defense World Staff"
            ],
            "summary": "Johnson & Johnson ( NYSE:JNJ ) Upgraded by StockNews.com to ... Defense World ...",
            "banner_image": "https://www.marketbeat.com/logos/johnson--johnson-logo.png?v=20221020135923",
            "source": "Stocknews.com",
            "category_within_source": "n/a",
            "source_domain": "www.defenseworld.net",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.846708"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.961735"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.30983,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MS",
                    "relevance_score": "0.040829",
                    "ticker_sentiment_score": "0.093661",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GILD",
                    "relevance_score": "0.040829",
                    "ticker_sentiment_score": "0.094895",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.717663",
                    "ticker_sentiment_score": "0.495744",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Sinus Dilation Devices Market Revenue to Cross USD 4.7 billion in 2031, Securing a 7.2% CAGR Says, Transparency Market Research",
            "url": "https://www.benzinga.com/pressreleases/23/10/g35183414/sinus-dilation-devices-market-revenue-to-cross-usd-4-7-billion-in-2031-securing-a-7-2-cagr-says-tr",
            "time_published": "20231011T072554",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "Wilmington, Delaware, United States, Oct. 11, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global sinus dilation devices market is anticipated to expand at a 7.2% CAGR from 2021 to 2031. The market for sinus dilation devices is expected to reach US$ 4.7 billion by 2031.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.294154,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "SNN",
                    "relevance_score": "0.045054",
                    "ticker_sentiment_score": "0.049951",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.089965",
                    "ticker_sentiment_score": "0.09324",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OCPNF",
                    "relevance_score": "0.045054",
                    "ticker_sentiment_score": "0.049951",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DSSMY",
                    "relevance_score": "0.045054",
                    "ticker_sentiment_score": "0.049951",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.045054",
                    "ticker_sentiment_score": "0.049951",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johnson & Johnson Upgraded to \"Strong-Buy\" Rating by StockNews.com",
            "url": "https://www.claytoncountyregister.com/news2/johnson-johnson-nysejnj-stock-rating-upgraded-by-stocknews-com/564546/",
            "time_published": "20231011T051209",
            "authors": [
                "Barret Loux"
            ],
            "summary": "Johnson & Johnson Upgraded to \"Strong-Buy\" Rating by StockNews ... Clayton County Register ...",
            "banner_image": "https://www.claytoncountyregister.com/wp-content/uploads/2023/07/mfrack_realistic_photo_of_German_stock_exchange_fd73ce83-c418-4c01-83ae-070526825e8c.jpeg",
            "source": "Stocknews.com",
            "category_within_source": "n/a",
            "source_domain": "www.claytoncountyregister.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.962106"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.795202"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.263318,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "WFC",
                    "relevance_score": "0.133841",
                    "ticker_sentiment_score": "0.059481",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.870696",
                    "ticker_sentiment_score": "0.434441",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Birkenstock expects to price IPO at $46 per share, toward midpoint of stated range",
            "url": "https://www.cnbc.com/2023/10/10/birkenstock-expects-to-price-ipo-at-46-per-share.html",
            "time_published": "20231010T205939",
            "authors": [
                "Leslie Picker",
                "Gabrielle Fonrouge"
            ],
            "summary": "German shoemaker Birkenstock is expected to price its IPO at $46 per share on Tuesday.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/107300018-1694612492332-gettyimages-1662222510-20090101230913-99-179166.jpeg?v=1696971579&w=1920&h=1080",
            "source": "CNBC",
            "category_within_source": "Business",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.87644"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.214548,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.101582",
                    "ticker_sentiment_score": "0.185764",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ODD",
                    "relevance_score": "0.101582",
                    "ticker_sentiment_score": "0.185764",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CROX",
                    "relevance_score": "0.101582",
                    "ticker_sentiment_score": "0.004316",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.101582",
                    "ticker_sentiment_score": "0.185764",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Johnson & Johnson Unusual Options Activity - Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/markets/options/23/10/35170396/johnson-johnson-unusual-options-activity",
            "time_published": "20231010T200053",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                }
            ],
            "overall_sentiment_score": 0.113402,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.749166",
                    "ticker_sentiment_score": "0.279992",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "As Middle East Conflict Continues, Yields Recede, Giving Stocks A Light Tailwind - Citigroup  ( NYSE:C ) , Delta Air Lines  ( NYSE:DAL ) ",
            "url": "https://www.benzinga.com/markets/23/10/35168047/as-middle-east-conflict-continues-yields-recede-giving-stocks-a-light-tailwind",
            "time_published": "20231010T172106",
            "authors": [
                "Schwab Center for Financial Research"
            ],
            "summary": "( Tuesday market open ) Back from their three-day holiday weekend, U.S. Treasury note yields slipped early Tuesday, initially providing traction for stocks in premarket trading before the market flattened ahead of the open.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/10/shutterstock_1928985866_7.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Economy - Fiscal",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.997405"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999756"
                },
                {
                    "topic": "Economy - Macro",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.028985,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "BLK",
                    "relevance_score": "0.042159",
                    "ticker_sentiment_score": "0.088752",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DMPZF",
                    "relevance_score": "0.021087",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UAL",
                    "relevance_score": "0.042159",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LMT",
                    "relevance_score": "0.042159",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "C",
                    "relevance_score": "0.084201",
                    "ticker_sentiment_score": "0.039851",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.084201",
                    "ticker_sentiment_score": "0.039851",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.084201",
                    "ticker_sentiment_score": "0.039851",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.042159",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WBA",
                    "relevance_score": "0.084201",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PEP",
                    "relevance_score": "0.021087",
                    "ticker_sentiment_score": "0.066519",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.042159",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DPZ",
                    "relevance_score": "0.063202",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:USD",
                    "relevance_score": "0.021087",
                    "ticker_sentiment_score": "0.034554",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Earnings Preview: Johnson & Johnson  ( JNJ )  Q3 Earnings Expected to Decline",
            "url": "https://www.zacks.com/stock/news/2163470/earnings-preview-johnson-johnson-jnj-q3-earnings-expected-to-decline",
            "time_published": "20231010T140016",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Johnson & Johnson (JNJ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default258.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.316726"
                }
            ],
            "overall_sentiment_score": 0.15492,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.295273",
                    "ticker_sentiment_score": "0.083135",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Russell Reynolds Associates, World 50 Group To Help Accelerate Executive Diversity With Third Cohort of \"Next Generation Director\" Development Program",
            "url": "https://www.prnewswire.com/news-releases/russell-reynolds-associates-world-50-group-to-help-accelerate-executive-diversity-with-third-cohort-of-next-generation-director-development-program-301951425.html",
            "time_published": "20231010T130000",
            "authors": [
                "Russell Reynolds Associates"
            ],
            "summary": "Russell Reynolds Associates, World 50 Group To Help Accelerate Executive Diversity With Third Cohort of \"Next ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/1502546/Russell_Reynolds_Associates_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.37705,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "SYF",
                    "relevance_score": "0.04161",
                    "ticker_sentiment_score": "0.089247",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SBUX",
                    "relevance_score": "0.04161",
                    "ticker_sentiment_score": "0.089247",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.04161",
                    "ticker_sentiment_score": "0.089247",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AXP",
                    "relevance_score": "0.04161",
                    "ticker_sentiment_score": "0.217634",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GILD",
                    "relevance_score": "0.04161",
                    "ticker_sentiment_score": "0.089247",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UBER",
                    "relevance_score": "0.04161",
                    "ticker_sentiment_score": "0.089247",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ATGE",
                    "relevance_score": "0.04161",
                    "ticker_sentiment_score": "0.217634",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BA",
                    "relevance_score": "0.04161",
                    "ticker_sentiment_score": "0.089247",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Society Pass Inc.  ( Nasdaq: SOPA )  Announces Plans to Spinout Two Profitable Business Units Into New Publicly-Traded Companies via Nasdaq IPOs in 2024",
            "url": "https://www.globenewswire.com/news-release/2023/10/10/2757479/0/en/Society-Pass-Inc-Nasdaq-SOPA-Announces-Plans-to-Spinout-Two-Profitable-Business-Units-Into-New-Publicly-Traded-Companies-via-Nasdaq-IPOs-in-2024.html",
            "time_published": "20231010T123000",
            "authors": [
                "Society Pass Incorporated"
            ],
            "summary": "NEW YORK, NY, Oct. 10, 2023 ( GLOBE NEWSWIRE ) -- via NewMediaWire - Society Pass Inc. ( Nasdaq: SOPA ) ( \"SoPa\" or the \"Company\" ) , Southeast Asia's ( \"SEA\" ) next generation, data-driven, loyalty, fintech and e-commerce ecosystem, announces that its Board of Directors, together with its ...",
            "banner_image": "https://ml.globenewswire.com/Resource/Download/af90c8eb-2176-4e65-8a4f-07e034f597c2",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.274762,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "META",
                    "relevance_score": "0.086245",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.057559",
                    "ticker_sentiment_score": "0.070955",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SOPA",
                    "relevance_score": "0.361155",
                    "ticker_sentiment_score": "0.326541",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "IBN Announces Latest Episode of The Bell2Bell Podcast featuring Rob Etherington, CEO of Clene Inc.",
            "url": "https://www.benzinga.com/pressreleases/23/10/g35160236/ibn-announces-latest-episode-of-the-bell2bell-podcast-featuring-rob-etherington-ceo-of-clene-inc",
            "time_published": "20231010T121700",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "LOS ANGELES, Oct. 10, 2023 ( GLOBE NEWSWIRE ) -- via IBN -- IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The Bell2Bell Podcast as part of its sustained effort to ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.77141"
                }
            ],
            "overall_sentiment_score": 0.202221,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "META",
                    "relevance_score": "0.028695",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DSSMY",
                    "relevance_score": "0.028695",
                    "ticker_sentiment_score": "0.020297",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CLNN",
                    "relevance_score": "0.307661",
                    "ticker_sentiment_score": "0.225737",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.028695",
                    "ticker_sentiment_score": "0.182241",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.028695",
                    "ticker_sentiment_score": "0.182241",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Should You Invest in the Fidelity MSCI Health Care Index ETF  ( FHLC ) ?",
            "url": "https://www.zacks.com/stock/news/2163168/should-you-invest-in-the-fidelity-msci-health-care-index-etf-fhlc",
            "time_published": "20231010T102006",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Sector ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default268.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.304478,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.12546",
                    "ticker_sentiment_score": "0.049458",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.12546",
                    "ticker_sentiment_score": "0.049458",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.12546",
                    "ticker_sentiment_score": "0.049458",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Should You Invest in the iShares U.S. Pharmaceuticals ETF  ( IHE ) ?",
            "url": "https://www.zacks.com/stock/news/2163169/should-you-invest-in-the-ishares-us-pharmaceuticals-etf-ihe",
            "time_published": "20231010T102005",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Sector ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default268.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.150003,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BLK",
                    "relevance_score": "0.06623",
                    "ticker_sentiment_score": "0.031033",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.132004",
                    "ticker_sentiment_score": "0.063692",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ZTS",
                    "relevance_score": "0.132004",
                    "ticker_sentiment_score": "0.063692",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.132004",
                    "ticker_sentiment_score": "0.043293",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.132004",
                    "ticker_sentiment_score": "0.063692",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Should iShares Core High Dividend ETF  ( HDV )  Be on Your Investing Radar?",
            "url": "https://www.zacks.com/stock/news/2163163/should-ishares-core-high-dividend-etf-hdv-be-on-your-investing-radar",
            "time_published": "20231010T102005",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Style Box ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default265.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.233966,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BLK",
                    "relevance_score": "0.061631",
                    "ticker_sentiment_score": "0.117025",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MORN",
                    "relevance_score": "0.122894",
                    "ticker_sentiment_score": "0.195175",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.122894",
                    "ticker_sentiment_score": "0.068464",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.122894",
                    "ticker_sentiment_score": "0.068464",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XOM",
                    "relevance_score": "0.122894",
                    "ticker_sentiment_score": "0.068464",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Is Vanguard High Dividend Yield ETF  ( VYM )  a Strong ETF Right Now?",
            "url": "https://www.zacks.com/stock/news/2163174/is-vanguard-high-dividend-yield-etf-vym-a-strong-etf-right-now",
            "time_published": "20231010T102005",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Smart Beta ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default323.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.236793,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JPM",
                    "relevance_score": "0.121037",
                    "ticker_sentiment_score": "0.061185",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.121037",
                    "ticker_sentiment_score": "0.061185",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XOM",
                    "relevance_score": "0.121037",
                    "ticker_sentiment_score": "0.061185",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Shake it off: Travis Kelce hip to Taylor Swift's lyrics as he slips free from injury, Rodgers insult",
            "url": "https://apnews.com/article/behind-call-kelce-rodgers-2f0725e098511f88ba36a25faa760503",
            "time_published": "20231010T100000",
            "authors": [
                "ARNIE MELENDREZ STAPLETON"
            ],
            "summary": "Need another sign that Travis Kelce and Taylor Swift are simply meant to be together or \"Tayvis\" or besties or whatever it is they are? How about this: the Kansas City Chiefs star tight end just spent Week 5 dealing with both a gnarly-looking sprained ankle and a needless dig from Aaron Rodgers ...",
            "banner_image": "https://dims.apnews.com/dims4/default/c9c4193/2147483647/strip/true/crop/7473x4978+0+2/resize/599x399!/quality/90/?url=https%3A%2F%2Fassets.apnews.com%2F7f%2F0a%2F5352319e1e6c19cd6fb6af628443%2Fd0c856f80c944957bd8293347447989d",
            "source": "Associated Press",
            "category_within_source": "Markets",
            "source_domain": "apnews.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.114076,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "PFE",
                    "relevance_score": "0.296463",
                    "ticker_sentiment_score": "0.167273",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.100941",
                    "ticker_sentiment_score": "-0.027953",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "New Equity Research Report Recommends 'Buy' Rating for Virtualware  ( EPA:MLVIR )  with €10 Price Target",
            "url": "https://www.globenewswire.com/news-release/2023/10/10/2757117/0/en/New-Equity-Research-Report-Recommends-Buy-Rating-for-Virtualware-EPA-MLVIR-with-10-Price-Target.html",
            "time_published": "20231010T054500",
            "authors": [
                "VIRTUALWARE 2007 SA"
            ],
            "summary": "New York and Bilbao, Spain, 10, October.- Litchfield Hills Research initiated coverage of Virtualware ( ENXTPA: MLVIR ) with a 'Buy' rating and €10 ( $10.56 ) price target, according to an equity research report published and distributed Monday.",
            "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/13948b91-ce96-426f-b8a7-b1586665fb52",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.684621"
                }
            ],
            "overall_sentiment_score": 0.178587,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "HTHIF",
                    "relevance_score": "0.047278",
                    "ticker_sentiment_score": "0.097811",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IBDSF",
                    "relevance_score": "0.047278",
                    "ticker_sentiment_score": "0.097811",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AOMFF",
                    "relevance_score": "0.047278",
                    "ticker_sentiment_score": "0.097811",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BIIB",
                    "relevance_score": "0.047278",
                    "ticker_sentiment_score": "0.097811",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.047278",
                    "ticker_sentiment_score": "0.097811",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "The Evolving Market Dynamics of Factor-based Bleeding Disorders: Hemophilia A, Hemophilia B, and Von Willebrand Disease | Key Analysis by DelveInsight",
            "url": "https://www.prnewswire.com/news-releases/the-evolving-market-dynamics-of-factor-based-bleeding-disorders-hemophilia-a-hemophilia-b-and-von-willebrand-disease--key-analysis-by-delveinsight-301950491.html",
            "time_published": "20231009T210100",
            "authors": [
                "LLP",
                "DelveInsight Business Research"
            ],
            "summary": "The Evolving Market Dynamics of Factor-based Bleeding Disorders: Hemophilia A, Hemophilia B, and Von Willebrand ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.009725,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "BGNE",
                    "relevance_score": "0.018173",
                    "ticker_sentiment_score": "0.026267",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BLUE",
                    "relevance_score": "0.036338",
                    "ticker_sentiment_score": "0.036038",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.036338",
                    "ticker_sentiment_score": "0.033442",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RSSS",
                    "relevance_score": "0.018173",
                    "ticker_sentiment_score": "0.124364",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VRTX",
                    "relevance_score": "0.036338",
                    "ticker_sentiment_score": "0.036038",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IONS",
                    "relevance_score": "0.018173",
                    "ticker_sentiment_score": "0.029703",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.036338",
                    "ticker_sentiment_score": "0.029364",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.036338",
                    "ticker_sentiment_score": "0.034129",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.054483",
                    "ticker_sentiment_score": "0.032874",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ACLX",
                    "relevance_score": "0.018173",
                    "ticker_sentiment_score": "0.026267",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AGIO",
                    "relevance_score": "0.018173",
                    "ticker_sentiment_score": "0.029703",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SLN",
                    "relevance_score": "0.018173",
                    "ticker_sentiment_score": "0.029703",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CRTHF",
                    "relevance_score": "0.018173",
                    "ticker_sentiment_score": "0.026267",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ALPN",
                    "relevance_score": "0.018173",
                    "ticker_sentiment_score": "0.033264",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "INCY",
                    "relevance_score": "0.018173",
                    "ticker_sentiment_score": "0.033264",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RIGL",
                    "relevance_score": "0.018173",
                    "ticker_sentiment_score": "0.033264",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "REGN",
                    "relevance_score": "0.036338",
                    "ticker_sentiment_score": "0.029364",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CCCC",
                    "relevance_score": "0.018173",
                    "ticker_sentiment_score": "0.026267",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.036338",
                    "ticker_sentiment_score": "0.047119",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Penny Stocks To Buy This Week? Analysts Like These 3",
            "url": "https://pennystocks.com/featured/2023/10/09/penny-stocks-to-buy-this-week-analysts-like-these-3/",
            "time_published": "20231009T200608",
            "authors": [
                "J. Samuel"
            ],
            "summary": "Penny Stocks: Using Analyst Sentiment and Research for Smart Trading Penny stocks are shares of small companies priced under $5 per share. While the potential returns can be alluring, penny stocks carry high risk. Thorough research is essential before trading.",
            "banner_image": null,
            "source": "PennyStocks.com",
            "category_within_source": "n/a",
            "source_domain": "pennystocks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.161647"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.138709,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MXCT",
                    "relevance_score": "0.125297",
                    "ticker_sentiment_score": "-0.013114",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SCLX",
                    "relevance_score": "0.156258",
                    "ticker_sentiment_score": "0.00943",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.031446",
                    "ticker_sentiment_score": "-0.001896",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.031446",
                    "ticker_sentiment_score": "-0.001896",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Looking At Johnson & Johnson's Recent Unusual Options Activity - Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/markets/options/23/10/35150435/looking-at-johnson-johnsons-recent-unusual-options-activity",
            "time_published": "20231009T190114",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson JNJ we detected 16 strange trades. If we consider the specifics of each trade, it is accurate to state that 37% of the investors opened trades with ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                }
            ],
            "overall_sentiment_score": 0.137597,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.677342",
                    "ticker_sentiment_score": "0.056099",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "J&J  ( JNJ )  Seeks EU Nod for Rybrevant for First-Line NSCLC",
            "url": "https://www.zacks.com/stock/news/2162746/jj-jnj-seeks-eu-nod-for-rybrevant-for-first-line-nsclc",
            "time_published": "20231009T151000",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "J&J (JNJ) files an application in Europe seeking expanded approval for Rybrevant as a first-line combination treatment in patients with advanced or metastatic EGFR exon 20 insertion mutation-positive NSCLC.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/52/873.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.890401"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.231883,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "CORT",
                    "relevance_score": "0.124486",
                    "ticker_sentiment_score": "0.060792",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AUPH",
                    "relevance_score": "0.304679",
                    "ticker_sentiment_score": "0.234426",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ALPN",
                    "relevance_score": "0.245959",
                    "ticker_sentiment_score": "0.195126",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.245959",
                    "ticker_sentiment_score": "-0.059285",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Janssen Highlights Latest Research for TREMFYA®  ( guselkumab )  and Investigational Targeted Oral Peptide JNJ-2113 in Moderate to Severe Plaque Psoriasis at the European Academy of Dermatology and Venereology  ( EADV )  Congress",
            "url": "https://www.prnewswire.com/news-releases/janssen-highlights-latest-research-for-tremfya-guselkumab-and-investigational-targeted-oral-peptide-jnj-2113-in-moderate-to-severe-plaque-psoriasis-at-the-european-academy-of-dermatology-and-venereology-eadv-congress-301949936.html",
            "time_published": "20231009T113100",
            "authors": [
                "Janssen Pharmaceutical Companies of Johnson & Johnson"
            ],
            "summary": "Janssen Highlights Latest Research for TREMFYA® ( guselkumab ) and Investigational Targeted Oral Peptide JNJ-2113 ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/1006365/Janssen_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": -0.007263,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "PTGX",
                    "relevance_score": "0.17991",
                    "ticker_sentiment_score": "0.123068",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.335845",
                    "ticker_sentiment_score": "0.046641",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Meet the 3 Dividend Kings Warren Buffett Is Betting $21 Billion On",
            "url": "https://www.fool.com/investing/2023/10/09/3-dividend-kings-warren-buffett-bet-21-billion-on/",
            "time_published": "20231009T092100",
            "authors": [
                "Sean Williams"
            ],
            "summary": "Three dividend stocks that have each increased their base annual payout for more than 60 years account for $21 billion of Berkshire Hathaway's $337 billion of invested assets.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F750048%2Fbuffett6-tmf.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.929393"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.890401"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.275186,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "CURN",
                    "relevance_score": "0.031654",
                    "ticker_sentiment_score": "-0.02116",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.337532",
                    "ticker_sentiment_score": "0.294014",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.031654",
                    "ticker_sentiment_score": "0.055431",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.031654",
                    "ticker_sentiment_score": "0.155834",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.157278",
                    "ticker_sentiment_score": "0.22646",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.157278",
                    "ticker_sentiment_score": "0.119051",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.031654",
                    "ticker_sentiment_score": "0.188243",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "J&J : Data Suggest Esketamine More Effective Than Typical Treatments In Major Depressive Disorder",
            "url": "https://markets.businessinsider.com/news/stocks/j-j-data-suggest-esketamine-more-effective-than-typical-treatments-in-major-depressive-disorder-1032686618",
            "time_published": "20231008T171842",
            "authors": [
                "markets.businessinsider.com"
            ],
            "summary": "( RTTNews ) - The new safety data from the ESCAPE-TRD Phase 3b study suggested Johnson & Johnson's Spravato or esketamine nasal spray was more tolerable and effective compared to quetiapine extended-release in adults with treatment-resistant major depressive disorder.",
            "banner_image": "https://markets.businessinsider.com/Images/FacebookIcon.jpg",
            "source": "Business Insider",
            "category_within_source": "RSS",
            "source_domain": "markets.businessinsider.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.024008,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.181137",
                    "ticker_sentiment_score": "-0.143264",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "My Top Under-Appreciated Dividend King to Buy in October",
            "url": "https://www.fool.com/investing/2023/10/08/my-top-under-appreciated-dividend-king-buy-october/",
            "time_published": "20231008T095700",
            "authors": [
                "Daniel Foelber"
            ],
            "summary": "This company is putting on a clinic on how to operate as a successful industrial conglomerate.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F749872%2Fsparks-fly-off-of-a-circular-saw-in-a-factory.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.938238"
                }
            ],
            "overall_sentiment_score": 0.307932,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "YUM",
                    "relevance_score": "0.117295",
                    "ticker_sentiment_score": "0.081526",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.039224",
                    "ticker_sentiment_score": "0.094794",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HON",
                    "relevance_score": "0.039224",
                    "ticker_sentiment_score": "0.136068",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.039224",
                    "ticker_sentiment_score": "0.094794",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.039224",
                    "ticker_sentiment_score": "0.094794",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSBHF",
                    "relevance_score": "0.039224",
                    "ticker_sentiment_score": "0.136068",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NKE",
                    "relevance_score": "0.039224",
                    "ticker_sentiment_score": "0.040328",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ITW",
                    "relevance_score": "0.508878",
                    "ticker_sentiment_score": "0.458503",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "GE",
                    "relevance_score": "0.039224",
                    "ticker_sentiment_score": "0.136068",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Could The Next Tech Unicorn Be Hiding In A Forest Of Patents?",
            "url": "https://www.forbes.com/sites/carolynschwaar/2023/10/07/could-the-next-tech-unicorn-be-hiding-in-a-forest-of-patents/",
            "time_published": "20231007T134346",
            "authors": [
                "Carolyn Schwaar"
            ],
            "summary": "As 3D printing continues to evolve as a manufacturing method, patent data provides valuable insight into the technological landscape and areas of innovation.",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/652157ad6369b876ad4a1fce/0x0.jpg?format=jpg&crop=2048,1153,x0,y101,safe&width=1200",
            "source": "Forbes",
            "category_within_source": "Business",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.169928,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ADSK",
                    "relevance_score": "0.037329",
                    "ticker_sentiment_score": "0.148082",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.037329",
                    "ticker_sentiment_score": "0.049634",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DM",
                    "relevance_score": "0.037329",
                    "ticker_sentiment_score": "0.049634",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SINT",
                    "relevance_score": "0.037329",
                    "ticker_sentiment_score": "0.060235",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MKFG",
                    "relevance_score": "0.037329",
                    "ticker_sentiment_score": "0.049634",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SSYS",
                    "relevance_score": "0.037329",
                    "ticker_sentiment_score": "0.049634",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GE",
                    "relevance_score": "0.037329",
                    "ticker_sentiment_score": "0.049634",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Malinda Williams, Founder of The Arise And Shine Women's Empowerment Brunch, celebrated 5 years of uplifting, uniting and inspiring black women",
            "url": "https://www.benzinga.com/pressreleases/23/10/n35134983/malinda-williams-founder-of-the-arise-and-shine-womens-empowerment-brunch-celebrated-5-years-of-up",
            "time_published": "20231007T004500",
            "authors": [
                "PRNewswire"
            ],
            "summary": "Williams also announced the launch of the Arise And Shine Foundation, a 501 ( c ) ( 3 ) that aims to advance the professional development of underserved and underrepresented women and girls. The E.S.T.E.A.M Project will be the pilot program under the new nonprofit.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.530581,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.044634",
                    "ticker_sentiment_score": "0.267963",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Kansas City Chiefs' Travis Kelce laughs off Aaron Rodgers' 'Mr. Pfizer' quip",
            "url": "https://www.cnn.com/2023/10/06/sport/travis-kelce-aaron-rodgers-nickname-swift-spt-intl/index.html",
            "time_published": "20231006T215800",
            "authors": [
                "Jacob Lev"
            ],
            "summary": "Travis Kelce has laughed off Aaron Rodgers' new nickname for the Kansas City Chiefs tight end after the injured New York Jets quarterback called him \"Mr. Pfizer\" during his weekly appearance on ESPN's \"The Pat McAfee Show.\"",
            "banner_image": "https://media.cnn.com/api/v1/images/stellar/prod/231005140840-05-taylor-swift-travis-kelce-split.jpg?c=16x9&q=h_720,w_1280,c_fill",
            "source": "CNN",
            "category_within_source": "Markets",
            "source_domain": "www.cnn.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.315412,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MET",
                    "relevance_score": "0.07423",
                    "ticker_sentiment_score": "-0.015248",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.485711",
                    "ticker_sentiment_score": "0.38099",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.147818",
                    "ticker_sentiment_score": "-0.080342",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "The Executive Leadership Council's Symposium and Recognition Gala Week Wraps Up with $1M Community Impact ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/the-executive-leadership-councils-symposium-and-recognition-gala-week-wraps-up-with-1m-community-impact-investment-301949944.html",
            "time_published": "20231006T204000",
            "authors": [],
            "summary": "The Executive Leadership Council's Symposium and Recognition Gala Week Wraps Up with $1M Community Impact ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                }
            ],
            "overall_sentiment_score": 0.322297,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BAC",
                    "relevance_score": "0.142565",
                    "ticker_sentiment_score": "0.130674",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.07157",
                    "ticker_sentiment_score": "0.055272",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.07157",
                    "ticker_sentiment_score": "0.055272",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XOM",
                    "relevance_score": "0.07157",
                    "ticker_sentiment_score": "0.055272",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HPQ",
                    "relevance_score": "0.07157",
                    "ticker_sentiment_score": "0.055272",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MCO",
                    "relevance_score": "0.07157",
                    "ticker_sentiment_score": "0.055272",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.07157",
                    "ticker_sentiment_score": "0.055272",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.07157",
                    "ticker_sentiment_score": "0.055272",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Will Johnson & Johnson  ( JNJ )  Beat Estimates Again in Its Next Earnings Report?",
            "url": "https://www.zacks.com/stock/news/2161719/will-johnson-johnson-jnj-beat-estimates-again-in-its-next-earnings-report",
            "time_published": "20231006T161011",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default304.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.99998"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.327439,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.396261",
                    "ticker_sentiment_score": "0.474656",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Johnson & Johnson Has Potential To Drive Its Pharma And MedTech Franchises, Says Bullish Analyst - Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35111380/johnson-johnson-has-potential-to-drive-its-pharma-and-medtech-franchises-says-bulli",
            "time_published": "20231005T164011",
            "authors": [
                "Priya Nigam"
            ],
            "summary": "Shares of Johnson & Johnson JNJ recovered slightly in early trading on Thursday, after tanking in the previous session. The company is \"uniquely positioned with Pharma and MedTech under one umbrella,\" according to RBC Capital Markets.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/05/johnsonandjohnson.turbaliska.shutterstock_1403911202.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.192158,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.973732",
                    "ticker_sentiment_score": "0.286539",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Stocks making the biggest moves midday: Rivian, Orchard Therapeutics, Lamb Weston and more",
            "url": "https://www.cnbc.com/2023/10/05/stocks-making-the-biggest-moves-midday-rivian-orchard-therapeutics-lamb-weston-and-more.html",
            "time_published": "20231005T163426",
            "authors": [
                "Lisa Kailai Han"
            ],
            "summary": "These are the stocks posting the largest moves in midday trading.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/101253784-142606586r.jpg?v=1696523666&w=1920&h=1080",
            "source": "CNBC",
            "category_within_source": "Market Insider",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.977154"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.684621"
                }
            ],
            "overall_sentiment_score": 0.189709,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "CARR",
                    "relevance_score": "0.060848",
                    "ticker_sentiment_score": "-0.124407",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ORTX",
                    "relevance_score": "0.060848",
                    "ticker_sentiment_score": "0.087002",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.060848",
                    "ticker_sentiment_score": "-0.124407",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDNDF",
                    "relevance_score": "0.060848",
                    "ticker_sentiment_score": "0.192338",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.060848",
                    "ticker_sentiment_score": "0.01708",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.060848",
                    "ticker_sentiment_score": "0.120012",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RIVN",
                    "relevance_score": "0.121343",
                    "ticker_sentiment_score": "0.043871",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KNBWF",
                    "relevance_score": "0.060848",
                    "ticker_sentiment_score": "0.087002",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LW",
                    "relevance_score": "0.121343",
                    "ticker_sentiment_score": "0.22248",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CLX",
                    "relevance_score": "0.060848",
                    "ticker_sentiment_score": "0.186009",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ARMK",
                    "relevance_score": "0.060848",
                    "ticker_sentiment_score": "-0.003034",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XOM",
                    "relevance_score": "0.060848",
                    "ticker_sentiment_score": "-0.141731",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.060848",
                    "ticker_sentiment_score": "0.120012",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "STZ",
                    "relevance_score": "0.060848",
                    "ticker_sentiment_score": "0.06409",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KYKOF",
                    "relevance_score": "0.060848",
                    "ticker_sentiment_score": "0.087002",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LOB",
                    "relevance_score": "0.121343",
                    "ticker_sentiment_score": "0.02017",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "3 Ways AI Can Help Healthcare Companies Grow",
            "url": "https://www.fool.com/investing/2023/10/05/3-ways-ai-can-help-healthcare-companies-grow/",
            "time_published": "20231005T120000",
            "authors": [
                "David Jagielski"
            ],
            "summary": "The hottest AI stocks are in tech right now, but the best opportunities ahead may be in healthcare.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.357144,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.154785",
                    "ticker_sentiment_score": "0.204034",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TDOC",
                    "relevance_score": "0.103554",
                    "ticker_sentiment_score": "0.121281",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.20537",
                    "ticker_sentiment_score": "0.312891",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "HCA",
                    "relevance_score": "0.051886",
                    "ticker_sentiment_score": "0.185956",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.154785",
                    "ticker_sentiment_score": "0.16921",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "2 Magnificent Dividend Kings to Buy Now",
            "url": "https://www.fool.com/investing/2023/10/05/2-magnificent-dividend-kings-to-buy-now/",
            "time_published": "20231005T100000",
            "authors": [
                "Adria Cimino"
            ],
            "summary": "These stocks offer you income no matter what the market is doing.",
            "banner_image": "https://media.ycharts.com/charts/49cee2af8a8aa6734c4be7160841217f.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.997405"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.99246"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.335081,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KO",
                    "relevance_score": "0.362505",
                    "ticker_sentiment_score": "0.427652",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.062597",
                    "ticker_sentiment_score": "-0.02804",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.124809",
                    "ticker_sentiment_score": "-0.032715",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Phase III studies to investigate survodutide for people living with obesity and overweight, with and without diabetes, cardiovascular disease and chronic kidney disease",
            "url": "https://www.globenewswire.com/news-release/2023/10/05/2755164/0/en/Phase-III-studies-to-investigate-survodutide-for-people-living-with-obesity-and-overweight-with-and-without-diabetes-cardiovascular-disease-and-chronic-kidney-disease.html",
            "time_published": "20231005T095300",
            "authors": [
                "Zealand Pharma"
            ],
            "summary": "Phase III studies to investigate survodutide for people living with obesity and overweight, with and without diabetes, cardiovascular disease and chronic kidney disease • SYNCHRONIZE-1 and SYNCHRONIZE-2 are global Phase III studies of survodutide ( BI 456906 ) in people living with obesity and ...",
            "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/8e5dac9c-86c4-4996-bce9-0f8ba208f970",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.026403,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "HLF",
                    "relevance_score": "0.027164",
                    "ticker_sentiment_score": "0.05734",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.027164",
                    "ticker_sentiment_score": "0.05734",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.027164",
                    "ticker_sentiment_score": "0.05734",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ZLDPF",
                    "relevance_score": "0.054297",
                    "ticker_sentiment_score": "0.086994",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "3 Historically Cheap Dow Stocks to Buy Hand Over Fist in October",
            "url": "https://www.fool.com/investing/2023/10/05/3-historically-cheap-dow-stocks-to-buy-in-october/",
            "time_published": "20231005T092100",
            "authors": [
                "Sean Williams"
            ],
            "summary": "These profitable, time-tested Dow Jones stocks are cheaper than they've been in at least a decade, if not well beyond.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F749618%2Fnyse-wall-street-trading-new-york-financial-stock-market-getty.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999996"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.714479"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.141321,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.031654",
                    "ticker_sentiment_score": "0.223138",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "VZ",
                    "relevance_score": "0.188193",
                    "ticker_sentiment_score": "0.033183",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HCSG",
                    "relevance_score": "0.126119",
                    "ticker_sentiment_score": "0.086394",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.188193",
                    "ticker_sentiment_score": "0.20772",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "WBA",
                    "relevance_score": "0.094762",
                    "ticker_sentiment_score": "-0.067757",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "India Baby Care Products Market size to grow by USD 15.69 billion from 2022 to 2027 | Market is fragmented due to the ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/india-baby-care-products-market-size-to-grow-by-usd-15-69-billion-from-2022-to-2027--market-is-fragmented-due-to-the-presence-of-prominent-companies-like-abbott-laboratories-artsana-spa-bio-veda-action-research-co-and-many-mo-301944281.html",
            "time_published": "20231004T230000",
            "authors": [],
            "summary": "India Baby Care Products Market size to grow by USD 15.69 billion from 2022 to 2027 | Market is fragmented due to the ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.287139,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KMB",
                    "relevance_score": "0.07446",
                    "ticker_sentiment_score": "0.089055",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MHCRF",
                    "relevance_score": "0.07446",
                    "ticker_sentiment_score": "0.089055",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABT",
                    "relevance_score": "0.07446",
                    "ticker_sentiment_score": "0.089055",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PIGEF",
                    "relevance_score": "0.07446",
                    "ticker_sentiment_score": "0.089055",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.07446",
                    "ticker_sentiment_score": "0.089055",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.07446",
                    "ticker_sentiment_score": "0.089055",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UL",
                    "relevance_score": "0.07446",
                    "ticker_sentiment_score": "0.089055",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PHG",
                    "relevance_score": "0.07446",
                    "ticker_sentiment_score": "0.089055",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Promaxo Receives Direct Investment from Surgical Robotics Industry Pioneer Fred Moll and Announces Appointment as Strategic Advisor",
            "url": "https://www.benzinga.com/pressreleases/23/10/g35092941/promaxo-receives-direct-investment-from-surgical-robotics-industry-pioneer-fred-moll-and-announces",
            "time_published": "20231004T160000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "OAKLAND, Calif., Oct. 04, 2023 ( GLOBE NEWSWIRE ) -- Promaxo, Inc. ( \"Promaxo\" or the \"Company\" ) , a medical imaging, robotics, and AI technology company, announced today that it has received a direct investment from Fred Moll, M.D., industry pioneer and leader in surgical robotics and ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Economy - Fiscal",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.229312,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ISRG",
                    "relevance_score": "0.172713",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PRCT",
                    "relevance_score": "0.172713",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SWAV",
                    "relevance_score": "0.172713",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.172713",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Medical Supplies Market Size is Projected to Hit USD 185.21 Billion, at a 4.5% CAGR by 2028 | Brandessence Market Research",
            "url": "https://www.prnewswire.com/news-releases/medical-supplies-market-size-is-projected-to-hit-usd-185-21-billion-at-a-4-5-cagr-by-2028--brandessence-market-research-301947208.html",
            "time_published": "20231004T151500",
            "authors": [
                "Brandessence Market Research and Consulting Private Limited"
            ],
            "summary": "Medical Supplies Market Size is Projected to Hit USD 185.21 Billion, at a 4.5% CAGR by 2028 | Brandessence Market ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/1392316/BEMR_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.28991,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LXRX",
                    "relevance_score": "0.067536",
                    "ticker_sentiment_score": "0.251231",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "INVA",
                    "relevance_score": "0.067536",
                    "ticker_sentiment_score": "0.167595",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BSX",
                    "relevance_score": "0.067536",
                    "ticker_sentiment_score": "-0.16357",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.067536",
                    "ticker_sentiment_score": "-0.16357",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "TMO",
                    "relevance_score": "0.067536",
                    "ticker_sentiment_score": "-0.16357",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "BAX",
                    "relevance_score": "0.067536",
                    "ticker_sentiment_score": "-0.16357",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.067536",
                    "ticker_sentiment_score": "-0.16357",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "MMM",
                    "relevance_score": "0.067536",
                    "ticker_sentiment_score": "-0.16357",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Showpad Recognized as a Leader in Sales Readiness Solutions",
            "url": "https://www.benzinga.com/pressreleases/23/10/g35091831/showpad-recognized-as-a-leader-in-sales-readiness-solutions",
            "time_published": "20231004T150509",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "Top-tier industry analyst firm recognizes Showpad as it:\"paves the way with a comprehensive solution and a focused market approach\" CHICAGO, Oct. 04, 2023 ( GLOBE NEWSWIRE ) -- Showpad, a global leader in sales enablement, has secured a coveted spot as a recognized leader in The Forrester Wave™: ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.214378"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.438513,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "CCEP",
                    "relevance_score": "0.058759",
                    "ticker_sentiment_score": "0.068072",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.058759",
                    "ticker_sentiment_score": "0.068072",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.058759",
                    "ticker_sentiment_score": "0.068072",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Jim Cramer's top 10 things to watch in the stock market Wednesday",
            "url": "https://www.cnbc.com/2023/10/04/jim-cramers-top-10-things-to-watch-in-the-stock-market-wednesday.html",
            "time_published": "20231004T131212",
            "authors": [
                "Jim Cramer"
            ],
            "summary": "Stock futures are up on light jobs data, but several headwinds keeping a lid on prices.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/107306729-16957419172023-09-26t152140z_1602763426_rc2eg3a3yuvw_rtrmadp_0_usa-stocks.jpeg?v=1696425132&w=1920&h=1080",
            "source": "CNBC",
            "category_within_source": "Top News",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.997902"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.360215"
                }
            ],
            "overall_sentiment_score": 0.019354,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "BLK",
                    "relevance_score": "0.122269",
                    "ticker_sentiment_score": "0.131755",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.182506",
                    "ticker_sentiment_score": "0.163269",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.299478",
                    "ticker_sentiment_score": "-0.223117",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "HAL",
                    "relevance_score": "0.122269",
                    "ticker_sentiment_score": "0.135998",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "C",
                    "relevance_score": "0.122269",
                    "ticker_sentiment_score": "-0.048044",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.061315",
                    "ticker_sentiment_score": "0.11",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "INTC",
                    "relevance_score": "0.299478",
                    "ticker_sentiment_score": "0.146776",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.061315",
                    "ticker_sentiment_score": "-0.058223",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.122269",
                    "ticker_sentiment_score": "-0.06858",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.122269",
                    "ticker_sentiment_score": "-0.06858",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MCO",
                    "relevance_score": "0.061315",
                    "ticker_sentiment_score": "-0.13571",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SQ",
                    "relevance_score": "0.122269",
                    "ticker_sentiment_score": "-0.199354",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Investors Heavily Search Johnson & Johnson  ( JNJ ) : Here is What You Need to Know",
            "url": "https://www.zacks.com/stock/news/2159912/investors-heavily-search-johnson-johnson-jnj-here-is-what-you-need-to-know",
            "time_published": "20231004T130010",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default265.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999999"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.54554"
                }
            ],
            "overall_sentiment_score": 0.235541,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.475838",
                    "ticker_sentiment_score": "0.129986",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Here's Why Kenvue Stock Is  ( Slightly )  Riskier Than It Seems",
            "url": "https://www.fool.com/investing/2023/10/04/heres-why-kenvue-stock-is-slightly-riskier-than-it/",
            "time_published": "20231004T123600",
            "authors": [
                "Alex Carchidi"
            ],
            "summary": "It's not about to crash, but eventually, it might struggle to thrive.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.538269"
                }
            ],
            "overall_sentiment_score": 0.087268,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.431371",
                    "ticker_sentiment_score": "0.149313",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CVS",
                    "relevance_score": "0.056808",
                    "ticker_sentiment_score": "0.14301",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "COST",
                    "relevance_score": "0.056808",
                    "ticker_sentiment_score": "0.14301",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.056808",
                    "ticker_sentiment_score": "0.006",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Esteemed Leader, Robert Pemberton, Joins Forces with Co-Founders Anthony Uzzo and Jim Gregory to Accelerate ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/esteemed-leader-robert-pemberton-joins-forces-with-co-founders-anthony-uzzo-and-jim-gregory-to-accelerate-service-insights-path-to-enable-digital-transformation-across-diverse-industries-301946103.html",
            "time_published": "20231004T120000",
            "authors": [],
            "summary": "Esteemed Leader, Robert Pemberton, Joins Forces with Co-Founders Anthony Uzzo and Jim Gregory to Accelerate ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.684621"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.564212,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ISRG",
                    "relevance_score": "0.045396",
                    "ticker_sentiment_score": "0.256005",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AGTEF",
                    "relevance_score": "0.045396",
                    "ticker_sentiment_score": "0.172068",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.045396",
                    "ticker_sentiment_score": "0.256005",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "You Can't Control Recessions, but You Can Control What You Do About Them",
            "url": "https://www.fool.com/investing/2023/10/04/you-cant-control-recessions-but-you-can-control-wh/",
            "time_published": "20231004T093200",
            "authors": [
                "Marc Rapport"
            ],
            "summary": "These strategies can help you weather the storms to come ... and they will come.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F749556%2Frecession-fear-economy.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.99737"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                }
            ],
            "overall_sentiment_score": 0.132831,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "DG",
                    "relevance_score": "0.057079",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.057079",
                    "ticker_sentiment_score": "0.160979",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NEM",
                    "relevance_score": "0.057079",
                    "ticker_sentiment_score": "0.358117",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.057079",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CL",
                    "relevance_score": "0.057079",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.057079",
                    "ticker_sentiment_score": "0.160979",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GTY",
                    "relevance_score": "0.057079",
                    "ticker_sentiment_score": "0.06003",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.057079",
                    "ticker_sentiment_score": "0.160979",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.057079",
                    "ticker_sentiment_score": "0.160979",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ED",
                    "relevance_score": "0.057079",
                    "ticker_sentiment_score": "0.094943",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "O",
                    "relevance_score": "0.057079",
                    "ticker_sentiment_score": "0.06003",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.057079",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Global South should learn from Big Pharma's bullying of South Africa",
            "url": "https://www.aljazeera.com/opinions/2023/10/4/global-south-should-learn-from-big-pharmas-bullying-of-south-africa",
            "time_published": "20231004T084241",
            "authors": [
                "Ray Mwareya"
            ],
            "summary": "The extortionate vaccine contracts Pretoria signed during the pandemic demonstrate why achieving pharmaceutical sovereignty should be a priority for all developing nations.",
            "banner_image": "https://www.aljazeera.com/wp-content/uploads/2021/12/2021-12-16T185808Z_56729251_RC2UFR99D011_RTRMADP_3_TRADE-WTO.jpg?resize=770%2C513&quality=80",
            "source": "Al Jareeza",
            "category_within_source": "n/a",
            "source_domain": "www.aljazeera.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.360215"
                }
            ],
            "overall_sentiment_score": 0.058231,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "AZN",
                    "relevance_score": "0.03798",
                    "ticker_sentiment_score": "-0.007817",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.075874",
                    "ticker_sentiment_score": "-0.004109",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BNTX",
                    "relevance_score": "0.03798",
                    "ticker_sentiment_score": "-0.007817",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.03798",
                    "ticker_sentiment_score": "0.000994",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Drugmakers Agree To Participate For Medicare Drug Price Negotiation With Biden Administration - Novo Nordisk  ( NYSE:NVO ) ",
            "url": "https://www.benzinga.com/general/biotech/23/10/35068559/drugmakers-agree-to-participate-for-medicare-drug-price-negotiation-with-biden-administration",
            "time_published": "20231003T173519",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "All ten manufacturers of the first drugs selected for Medicare price negotiations will be participating, the White House said, even though many of them are suing the administration to halt the process.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/03/pills-image_by_steve_buissinne_from_pixabay.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.08438,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "AZN",
                    "relevance_score": "0.262522",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.262522",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.262522",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.262522",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVS",
                    "relevance_score": "0.262522",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.262522",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.262522",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Drugmakers Agree To US Govt Price Talks Amid Pushback",
            "url": "https://www.barrons.com/news/drugmakers-agree-to-us-govt-price-talks-amid-pushback-c7eb4567",
            "time_published": "20231003T154800",
            "authors": [
                "Beiyi SEOW"
            ],
            "summary": "Drugmakers Agree To US Govt Price Talks Amid ...",
            "banner_image": "https://www.barrons.com/asset/external-media/afp/AFP2007430630409481451714611589397832456678---1.jpg",
            "source": "Barrons",
            "category_within_source": "n/a",
            "source_domain": "www.barrons.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.048405,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "AZN",
                    "relevance_score": "0.070725",
                    "ticker_sentiment_score": "0.148076",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.070725",
                    "ticker_sentiment_score": "-0.235822",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.070725",
                    "ticker_sentiment_score": "-0.029698",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Court tosses $223.8 million verdict against J&J in talc cancer case",
            "url": "https://www.reuters.com/markets/us/court-tosses-2238-million-verdict-against-jj-talc-cancer-case-2023-10-03/",
            "time_published": "20231003T145700",
            "authors": [
                "Brendan Pierson"
            ],
            "summary": "Oct 3 ( Reuters ) - A New Jersey appeals court on Tuesday threw out a $223.8 million verdict against Johnson & Johnson ( JNJ.N ) that a jury had awarded to four plaintiffs who claimed they developed cancer from being exposed to asbestos in the company's talc powder products.",
            "banner_image": "https://s3.amazonaws.com/arc-authors/reuters/75c45489-f2d2-466a-9429-aeeb9ef3b6f1.png",
            "source": "Reuters",
            "category_within_source": "Markets",
            "source_domain": "www.reuters.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.155816,
            "overall_sentiment_label": "Somewhat-Bearish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.118647",
                    "ticker_sentiment_score": "-0.032967",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Sanofi  ( SNY )  Inks Deal With J&J to Develop E. coli Vaccine",
            "url": "https://www.zacks.com/stock/news/2159363/sanofi-sny-inks-deal-with-jj-to-develop-e-coli-vaccine",
            "time_published": "20231003T144500",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Per the terms of the deal, Sanofi (SNY) and J&J will co-fund current and future R&D costs to develop a potential first-in-class vaccine against extraintestinal pathogenic E. coli.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/8d/2080.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.928139"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.126213,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "VAXX",
                    "relevance_score": "0.229149",
                    "ticker_sentiment_score": "0.08764",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ANVS",
                    "relevance_score": "0.229149",
                    "ticker_sentiment_score": "0.048782",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.153961",
                    "ticker_sentiment_score": "0.220831",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.562664",
                    "ticker_sentiment_score": "0.304949",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Top Stories Tuesday, Oct 3: 'Airbnb Has Foundational Cracks', Disney+ Follows Netflix On Subscription Sharing Crackdown, Microsoft's Nadella Criticizes Google's Exclusive Content Deals - Apple  ( NASDAQ:AAPL ) , ALX Oncology Holdings  ( NASDAQ:ALXO ) ",
            "url": "https://www.benzinga.com/news/23/10/35064552/airbnb-has-foundational-cracks-disney-follows-netflix-on-subscription-sharing-crackdown-microsofts-n",
            "time_published": "20231003T141120",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "In a significant development, Microsoft Corp's MSFT CEO, Satya Nadella, has voiced concerns over the competitive landscape of content acquisition essential for training artificial intelligence ( AI ) .",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/03/airbnbtoronto5.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.166667"
                }
            ],
            "overall_sentiment_score": 0.058194,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "TGT",
                    "relevance_score": "0.076236",
                    "ticker_sentiment_score": "0.263048",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.189076",
                    "ticker_sentiment_score": "0.273786",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.038162",
                    "ticker_sentiment_score": "0.139139",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPOT",
                    "relevance_score": "0.076236",
                    "ticker_sentiment_score": "0.144617",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.076236",
                    "ticker_sentiment_score": "0.21709",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.076236",
                    "ticker_sentiment_score": "-0.067693",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MU",
                    "relevance_score": "0.076236",
                    "ticker_sentiment_score": "0.143767",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABNB",
                    "relevance_score": "0.114137",
                    "ticker_sentiment_score": "-0.017859",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DAL",
                    "relevance_score": "0.076236",
                    "ticker_sentiment_score": "-0.098084",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ASML",
                    "relevance_score": "0.076236",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.076236",
                    "ticker_sentiment_score": "0.14478",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.076236",
                    "ticker_sentiment_score": "-0.038103",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PNT",
                    "relevance_score": "0.076236",
                    "ticker_sentiment_score": "0.179376",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "VTRS",
                    "relevance_score": "0.076236",
                    "ticker_sentiment_score": "0.067102",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.076236",
                    "ticker_sentiment_score": "0.179376",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ALXO",
                    "relevance_score": "0.076236",
                    "ticker_sentiment_score": "-0.146817",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GME",
                    "relevance_score": "0.114137",
                    "ticker_sentiment_score": "-0.130984",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BA",
                    "relevance_score": "0.076236",
                    "ticker_sentiment_score": "0.021659",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.114137",
                    "ticker_sentiment_score": "-0.064201",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TAK",
                    "relevance_score": "0.076236",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CRYPTO:NXC",
                    "relevance_score": "0.038162",
                    "ticker_sentiment_score": "-0.036553",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "3 Healthcare Stocks to Keep an Eye On",
            "url": "https://www.fool.com/investing/2023/10/03/3-healthcare-stocks-to-keep-an-eye-on/",
            "time_published": "20231003T134500",
            "authors": [
                "Jim Halley"
            ],
            "summary": "These three lesser-known healthcare companies have strong growth potential.",
            "banner_image": "https://media.ycharts.com/charts/708f4f4146d09672fb407e1bdf85ea69.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.17539,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.040078",
                    "ticker_sentiment_score": "0.146304",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TECH",
                    "relevance_score": "0.236972",
                    "ticker_sentiment_score": "0.222992",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BSX",
                    "relevance_score": "0.040078",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DNA",
                    "relevance_score": "0.198384",
                    "ticker_sentiment_score": "0.165547",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.040078",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SSUMF",
                    "relevance_score": "0.040078",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.040078",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.040078",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SOMMF",
                    "relevance_score": "0.040078",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.040078",
                    "ticker_sentiment_score": "0.02641",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SWAV",
                    "relevance_score": "0.11983",
                    "ticker_sentiment_score": "0.157705",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Pharma Giants Sanofi, Johnson & Johnson Join Forces To Develop E.coli Vaccine - Johnson & Johnson  ( NYSE:JNJ ) , Sanofi  ( NASDAQ:SNY ) ",
            "url": "https://www.benzinga.com/general/biotech/23/10/35054080/pharma-giants-sanofi-johnson-johnson-join-forces-to-develop-e-coli-vaccine",
            "time_published": "20231003T122542",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Sanofi SA SNY struck a deal with Janssen Pharmaceuticals, a unit of Johnson & Johnson JNJ, to develop and commercialize the vaccine candidate for extraintestinal pathogenic E. coli ( 9-valent ) .",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/03/sny.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.156513,
            "overall_sentiment_label": "Somewhat-Bearish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.504646",
                    "ticker_sentiment_score": "0.129704",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.636698",
                    "ticker_sentiment_score": "0.043427",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Medicare drug price negotiations move forward with all drugmakers participating, White House says",
            "url": "https://www.marketwatch.com/story/medicare-drug-price-negotiations-move-forward-with-all-drugmakers-participating-white-house-says-45b891dc",
            "time_published": "20231003T120000",
            "authors": [
                "Eleanor Laise"
            ],
            "summary": "Novo Nordisk is latest drugmaker to challenge negotiation program in court.",
            "banner_image": "https://images.mktw.net/im-861558/social",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.026422,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.1789",
                    "ticker_sentiment_score": "-0.043857",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.236972",
                    "ticker_sentiment_score": "-0.012794",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.11983",
                    "ticker_sentiment_score": "-0.027305",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.11983",
                    "ticker_sentiment_score": "-0.018592",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johnson & Johnson Vision's ACUVUE onboards Ranveer Singh; launches campaign #AcuvueSePoochho",
            "url": "https://www.financialexpress.com/business/brandwagon-johnson-amp-johnson-visions-acuvue-onboards-ranveer-singh-launches-campaign-acuvuesepoochho-3261578/",
            "time_published": "20231003T105700",
            "authors": [
                "BrandWagon Online"
            ],
            "summary": "Johnson & Johnson Vision's ACUVUE onboards Ranveer Singh. launches campaign #AcuvueSePoochho The Financial Express ...",
            "banner_image": "https://www.financialexpress.com/wp-content/uploads/2023/10/Godrej-4.png",
            "source": "The Financial Express",
            "category_within_source": "n/a",
            "source_domain": "www.financialexpress.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.400879,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.241684",
                    "ticker_sentiment_score": "0.367067",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Sanofi clinches vaccine deal with J&J to battle E. coli",
            "url": "https://www.financialexpress.com/healthcare/pharma-healthcare/sanofi-clinches-vaccine-deal-with-jj-to-battle-e-coli/3261648/",
            "time_published": "20231003T102740",
            "authors": [
                "Bloomberg"
            ],
            "summary": "Sanofi struck a deal to help fund and sell an experimental vaccine developed by Johnson & Johnson against an invasive form of the digestive pathogen E. coli. Sanofi will pay J&J's Janssen unit $175 million upfront, as well as development and commercial milestones, the French drugmaker said in a ...",
            "banner_image": "https://www.financialexpress.com/wp-content/uploads/2023/08/syring.jpg",
            "source": "The Financial Express",
            "category_within_source": "n/a",
            "source_domain": "www.financialexpress.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.03832,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.269776",
                    "ticker_sentiment_score": "-0.159895",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.699089",
                    "ticker_sentiment_score": "0.026922",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Sanofi in agreement with Janssen to develop E. coli the vaccine candidate",
            "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/sanofi-agreement-with-janssen-develop-e-coli-vaccine-candidate-2023-10-03/",
            "time_published": "20231003T054400",
            "authors": [
                "Reuters"
            ],
            "summary": "[1/2] The logo of French drugmaker Sanofi is seen a the Sanofi Genzyme Polyclonals in Lyon, France, September 30, 2023. REUTERS/Gonzalo Fuentes/File Photo Acquire Licensing Rights",
            "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/7HD6P27M3VN2FPAJVC4ZXNYOKQ.jpg",
            "source": "Reuters",
            "category_within_source": "Business",
            "source_domain": "www.reuters.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.148454,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.401331",
                    "ticker_sentiment_score": "0.354898",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.964732",
                    "ticker_sentiment_score": "0.265263",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Press Release: Sanofi announces agreement for potential first-in-class vaccine against extraintestinal pathogenic E. coli",
            "url": "https://www.globenewswire.com/news-release/2023/10/03/2753274/0/en/Press-Release-Sanofi-announces-agreement-for-potential-first-in-class-vaccine-against-extraintestinal-pathogenic-E-coli.html",
            "time_published": "20231003T053000",
            "authors": [
                "Sanofi - Aventis Groupe"
            ],
            "summary": "• Extraintestinal pathogenic E. coli ( ExPEC ) is a leading bacterial cause of sepsis, causing approximately 10 million cases of invasive ExPEC disease ( IED ) annually, worldwide1,2 • Phase 3 clinical trial of vaccine candidate ongoing. Novel ExPEC vaccine expected to complement existing older ...",
            "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/06da731a-67a1-4258-939f-6ef0531ee3bf",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.007307,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.036091",
                    "ticker_sentiment_score": "0.195905",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.282641",
                    "ticker_sentiment_score": "0.076525",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Press Release Biocartis Group NV: Disclosure of transparency notification",
            "url": "https://www.globenewswire.com/news-release/2023/10/03/2753267/0/en/Press-Release-Biocartis-Group-NV-Disclosure-of-transparency-notification.html",
            "time_published": "20231003T050000",
            "authors": [
                "Biocartis NV"
            ],
            "summary": "PRESS RELEASE: REGULATED INFORMATION 3 October 2023, 7:00 CEST ...",
            "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/c576d4bd-cacb-49bc-a12a-5c3607f3b067",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.77141"
                }
            ],
            "overall_sentiment_score": 0.136347,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.03473",
                    "ticker_sentiment_score": "0.081086",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.428632",
                    "ticker_sentiment_score": "0.23394",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Johnson & Johnson  ( JNJ )  Stock Sinks As Market Gains: What You Should Know",
            "url": "https://www.zacks.com/stock/news/2158852/johnson-johnson-jnj-stock-sinks-as-market-gains-what-you-should-know",
            "time_published": "20231002T214518",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Johnson & Johnson (JNJ) closed at $155.15 in the latest trading session, marking a -0.39% move from the prior day.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default319.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.961735"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                }
            ],
            "overall_sentiment_score": 0.166067,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.540358",
                    "ticker_sentiment_score": "0.277964",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Experts are worried about tuberculosis again",
            "url": "https://theweek.com/health/experts-are-worried-about-tuberculosis-again",
            "time_published": "20231002T211322",
            "authors": [
                "Devika Rao"
            ],
            "summary": "Tuberculosis is once again causing concern The Week ...",
            "banner_image": "https://cdn.mos.cms.futurecdn.net/SELv9BGJyGKCRRtmtio3oj-415-80.jpg",
            "source": "The Week News",
            "category_within_source": "n/a",
            "source_domain": "theweek.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.043918,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "FRNWF",
                    "relevance_score": "0.05234",
                    "ticker_sentiment_score": "0.058669",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.05234",
                    "ticker_sentiment_score": "0.076018",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Drugmakers opt in to Medicare drug price negotiations - here's what happens next",
            "url": "https://www.cnbc.com/2023/10/02/drugmakers-agree-to-medicare-price-negotiations-whats-next.html",
            "time_published": "20231002T193402",
            "authors": [
                "Annika Kim Constantino"
            ],
            "summary": "The lengthy negotiation process with Medicare won't end until August 2024, with reduced prices going into effect in January 2026.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/106330644-1578667127386rts2xt0x.jpg?v=1696275242&w=1920&h=1080",
            "source": "CNBC",
            "category_within_source": "Business",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Economy - Fiscal",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.684621"
                }
            ],
            "overall_sentiment_score": 0.014398,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.051221",
                    "ticker_sentiment_score": "0.183448",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.051221",
                    "ticker_sentiment_score": "0.2125",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.051221",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.102231",
                    "ticker_sentiment_score": "-0.114146",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.051221",
                    "ticker_sentiment_score": "-0.057993",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Drugmakers sign on to negotiate Medicare prices under protest",
            "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/drugmakers-sign-negotiate-medicare-prices-under-protest-2023-10-02/",
            "time_published": "20231002T171200",
            "authors": [
                "Michael Erman",
                "Patrick Wingrove"
            ],
            "summary": "U.S. President Joe Biden delivers remarks on Social Security and Medicare at the University of Tampa in Tampa, Florida, U.S. February 9, 2023. REUTERS/Jonathan Ernst/File Photo Acquire Licensing Rights",
            "banner_image": "https://graphics.reuters.com/HEALTH-USA/gdvzwdbjjpw/chart.png",
            "source": "Reuters",
            "category_within_source": "Business",
            "source_domain": "www.reuters.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.040332,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NVO",
                    "relevance_score": "0.169081",
                    "ticker_sentiment_score": "-0.101087",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.085022",
                    "ticker_sentiment_score": "0.033017",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.085022",
                    "ticker_sentiment_score": "0.033017",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.085022",
                    "ticker_sentiment_score": "0.033017",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johnson & Johnson Urged To Expand Access To Tuberculosis Medication - Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/general/biotech/23/10/35030857/johnson-johnson-urged-to-expand-access-tuberculosis-medication",
            "time_published": "20231002T162851",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Global health aid agency Unitaid is advocating for expanded access to tuberculosis ( TB ) drug, bedaquiline, produced by Johnson & Johnson JNJ. The push comes as countries like South Africa, Belarus, and Ukraine grapple with high TB cases but limited access to the medication.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/02/aapharma_2.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.045706,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.517168",
                    "ticker_sentiment_score": "-0.176073",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "J&J's  ( JNJ )  Rybrevant Combo Meets Primary Goal in NSCLC Study",
            "url": "https://www.zacks.com/stock/news/2158753/jjs-jnj-rybrevant-combo-meets-primary-goal-in-nsclc-study",
            "time_published": "20231002T144500",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "J&J (JNJ) meets the primary goal in the late-stage study of the combination therapy of Rybrevant and lazertinib against Tagrisso for EGFR-mutated first-line NSCLC.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/ff/1612.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.194358,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "AZN",
                    "relevance_score": "0.153961",
                    "ticker_sentiment_score": "0.043345",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.302243",
                    "ticker_sentiment_score": "-0.022095",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Capital Product Partners L.P. Announces the Appointment of Director by Capital GP L.L.C.",
            "url": "https://www.globenewswire.com/news-release/2023/10/02/2752834/20327/en/Capital-Product-Partners-L-P-Announces-the-Appointment-of-Director-by-Capital-GP-L-L-C.html",
            "time_published": "20231002T131000",
            "authors": [
                "L.P.",
                "Capital Product Partners"
            ],
            "summary": "ATHENS, Greece, Oct. 02, 2023 ( GLOBE NEWSWIRE ) -- Capital Product Partners L.P. ( NASDAQ: CPLP ) ( the \"Partnership\" ) today announced that Capital GP L.L.C., its general partner ( the \"General Partner\" ) , has appointed Mr. Atsunori Kozuki to act as a member of the Board of Directors of the ...",
            "banner_image": "https://ml.globenewswire.com/Resource/Download/c5469a46-a926-41a4-81a9-e4048250f529",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.009386,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KTERF",
                    "relevance_score": "0.089129",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IPXHF",
                    "relevance_score": "0.17715",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.089129",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Capital Product Partners L.P. Announces the Appointment of Director by Capital GP L.L.C. - Capital Product Partners  ( NASDAQ:CPLP ) ",
            "url": "https://www.benzinga.com/pressreleases/23/10/g35031145/capital-product-partners-l-p-announces-the-appointment-of-director-by-capital-gp-l-l-c",
            "time_published": "20231002T131000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "ATHENS, Greece, Oct. 02, 2023 ( GLOBE NEWSWIRE ) -- Capital Product Partners L.P.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.360215"
                }
            ],
            "overall_sentiment_score": 0.007024,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KTERF",
                    "relevance_score": "0.080458",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IPXHF",
                    "relevance_score": "0.160099",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.080458",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        }
    ]
}